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Bacteria and archaea have evolved an adaptive and heritable immune defense system 
comprising a CRISPR (clustered regularly interspaced short palindromic repeats) locus and Cas 
(CRISPR-associated) proteins that targets mobile genetic elements such as phages and plasmids. 
The molecular memory of previous infections is transcribed into crRNAs (CRISPR RNAs) which 
serve as a template to guide the hydrolysis of incoming foreign genetic material. The CRISPR-
Cas system is divided into three Types (I, II and III) on the basis of signature cas genes and 
further subtypes defined by the protein machinery and target specificity. During my PhD work, I 
investigated the Type I and Type III CRISPR-Cas systems using quantitative and structural mass 
spectrometry approaches.  
The first part of this work focused on using relative quantitative approach to study the effect of 
a cas gene deletion on the expression levels of other Cas proteins in Haloferax volcanii. A 
comparison between the proteomes of H. volcanii wild type and deletion strains using stable-
isotope dimethyl labeling showed that the removal of a cas gene is compensated by an overall 
increase in the expression of cas gene cluster. In addition, the absolute amounts of Cas protein 
components in multi-subunit Cascade complexes from H. volcanii and Clostridium thermocellum 
were determined using intensity based absolute quantification. The results were used to 
determine the stoichiometry of Cas proteins in these multi-subunit protein complexes which is 
valuable for the further investigation of molecular interactions within these complexes.  
Further in this work, the UV induced protein-RNA cross-liking approach was utilized to 
investigate RNA binding regions in single (recombinant) Cas proteins such as the archaeal and 
bacterial Cas6b proteins and the Cas7 family proteins from four different organisms. These 
structural studies were also extended to multi-subunit crRNP complexes such as the Type I-E 
Cascade complex from E. coli and Type III-A Csm complex from Thermus thermophilus. The 
information derived from the cross-linking studies could validate several protein-RNA 
interactions reported earlier in X-ray crystallography studies. In addition to identifying new RNA 
binding regions in the Cas proteins, the identified cross-links could also be mapped to 
conserved regions of these proteins within modified RNA binding domains. The results provided 
unbiased evidence of direct protein-RNA interaction in in vitro and in vivo purified crRNP 
complexes. Lastly, a lysine directed chemical cross-linking approach is presented for the 
investigation of protein-protein interactions between different Cas proteins in the C. 
thermocellum Cascade complex where more than 126 inter-protein interactions were 
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1.1 The immune system of bacteria and archaea 
The viruses that infect bacteria (bacteriophages) and archaea are the most abundant forms of 
life on this planet, even so that they have outnumbered their hosts in various orders of 
magnitude [1]. To survive the predation from these viruses both bacteria and archaea have 
evolved various defense mechanisms, such as modification of surface receptors to prevent virus 
adsorption, restriction enzymes (Restriction-Modification systems, RM systems) for nucleolytic 
cleavage of non-self DNA and abortive infection by undergoing lysis and sacrificing the infected 
cell [2]. These are referred to as the innate immune responses in prokaryotes. However, it is 
not just the viruses that represent a threat to these organisms. They are constantly exposed to 
foreign genetic material that is exchanged among related or unrelated species by various 
mechanisms of horizontal gene transfer (HGT) including transformation, conjugation and 
transduction [3, 4]. The acquisition of this foreign genetic material through viruses or HGT 
might not always be beneficial for the host and may lead to host cell lysis and death; therefore 
bacteria and archaea have developed an adaptive immune response for protection against 
these mobile genetic elements such as viruses and plasmids. Recently, an adaptive, heritable 
immune response has been identified in microbes, the CRISPR-Cas (clustered regularly 
interspaced short palindromic repeats – CRISPR associated) system [5]. Throughout this thesis, 
both conserved and unique features of the CRISPR based adaptive immune response found in 
prokaryotes have been investigated. 
1.1.1 CRISPR-Cas system 
Computational analyses have revealed that the genomes of around 90% of archaea and 40% 
bacteria comprise a family of DNA repeats known as CRISPR [6, 7]. These repeats are 
interspaced with non - repetitive spacer units which are acquired during the invasion of foreign 
genetic material. The spacer units in the CRISPR loci serve as a genetic memory for the acquired 
immune response, because they reflect the number of different phages and plasmids that were 
encountered by the host during past infections. These loci express small CRISPR RNAs that 
would target the invading DNA or RNA with complementary sequence during a subsequent 
infection. The mechanism of recognition and degradation of foreign genetic material is 
analogous to the RNA interference mechanism in eukaryotes. It also reflects the survival ability 
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of a bacterium or an archaeon because an expanded CRISPR locus would render the host with 
an efficient defense mechanism against mobile genetic elements [8]. 
1.1.1.1 CRISPR locus 
A hallmark feature of CRISPR-Cas system is the CRISPR locus. The first CRISPR array was 
described in E.coli in 1987 with 14 repeats of 29 base pairs that are interspaced with 32-33 bp 
spacer sequences [9, 10]. It was based on the particular structure of this loci that led Jansen 
and co-workers coin the term CRISPR in 2002 [11]. As the name suggests, a CRISPR locus 
consists of palindromic repetitive sequences (the repeats) that are separated by similar sized 
spacer sequences which are identical to the fragments of plasmids and viral genomes and 
therefore they specify the targets of CRISPR interference (Figure 1.1).  
The length of a CRISPR locus can vary in different microbial species due to several reasons. The 
size of both repeat and spacer units can vary between 25 – 40 bp [12], the number of repeats 
and spacers can range between a few to several hundred with an average around 66 [8] and 
the number of CRISPR loci per genome can also vary, mostly there is a single CRISPR locus but 
there are exceptions with 18 clusters in Methanocaldococcus jannaschii [13]. These sequences 
are preceded by a leader sequence that is AT rich, several hundred bp in length, but not 
conserved between different species [11]. The new spacer elements are inserted near the 
leader sequence which also comprises of binding sites for regulatory proteins that control 
spacer acquisition. Preceding or following the repeats are a set of CRISPR associated genes (cas 
genes) which encode the Cas protein machinery responsible for CRISPR activity. These cas 
genes also form the basis of CRISPR classification. 
1.1.1.2 Cas (CRISPR-associated) proteins  
In addition to the CRISPR locus, the Cas proteins encoded by cas genes are key players in the 
immune defense, they are responsible for mediating the adaptive immune response. Cas 
proteins are highly diverse in terms of functionality as they can act as a single protein catalyzing 
endonucleolytic cleavage of the target DNA, processing of CRISPR RNAs (crRNAs) and can even 
come together in the form of multi-subunit CRISPR ribonucleoprotein (crRNP) complexes along 
with the crRNAs for the processing of CRISPR loci transcripts as well as targeting and cleavage 
of invading DNA. The Cas proteins have been observed to comprise of several nuclease 
domains, distinct helicase domains and also certain domains that are characteristic of RNA 
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binding proteins [11]. The most conserved domains across various classes of RNA binding 
proteins are the RNA Recognition Motifs (RRMs) [14], which are also found in a special category 
of Cas proteins known as Repeat associated mysterious proteins (RAMPs) [15]. Recently solved 
crystal structures of RAMPs indicate the presence of one or two domains similar to the RRM 
(also called the ferredoxin fold) [16-19]. An overview of the major Cas protein families and their 
characteristics and distinct functions are summarized in Table 1.1. 





 CRISPR subtypes 
Characteristics and functions 
Cas1 Type I, II, III: Cas1 Metal dependent endonuclease, targets dsDNA, ssDNA or 
branched DNA in sequence independent manner. Involved 
in spacer acquisition. 
Cas2 Type I, II, III: Cas2 Metal dependent nuclease, RAMP-like fold with 
β1α1β2β3α2β4 arrangement. Involved in spacer acquisition. 
Csn2 Type II-A: Csn2 Accessory role during spacer acquisition (lacks catalytic 
activity). 
Cas3 Type I: Cas3  
Cas3’ Helicase domain 
Cas3’’ Nuclease HD 
domain 
ssDNA nuclease and ATP dependent helicase, both 
characteristics significant during interference, for strand 
separation and target DNA cleavage. 
Cas4 Type I-A-D and II-B: 
Cas4 
Stabilization of Cas1-Cas2 complex during spacer 
acquisition.  
Cas5 Type I: Cas5, 
III-A: Csm4,  
III-B: Cmr3 
Consists of RRM domains, belongs to RAMP superfamily. 
Part of the crRNP complex, important during Interference. 
When catalytically active, can substitute Cas6 in crRNA 
processing. 
Cas6 Type I and III: Cas6 Metal dependent endoribonuclease, consists of RRM 
domains, belongs to RAMP superfamily, involved in crRNA 
processing 
Cas7 Type I-A: Csa2, 





Consists of RRM domains, belongs to RAMP superfamily. 
Multiple copies that form the backbone of crRNP complex. 
Important during the interference step. 




Type I: Cas8 homologs 
I A-C: Cas8a-c,  
ID: Cas10 
I-E: Cse1,  
I-F: Csy1, 
Type III: Cas10 
Consists of RRM domains. Interacts with the Cas7 and Cas5 
in the multi-subunit crRNP complex, capping of the 5’end 
of crRNA. Important during interference step.  
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homologs 








Present in multi-subunit crRNP complexes, Weakly 
interacts with other proteins such as Cas7. Important in 
interference step. 
Cas9 Type II Involved in both crRNA processing and cleavage of the 
target DNA  
1.1.2 The three steps of CRISPR-Cas action 
The CRISPR-Cas based immunity is an acquired form of immune response where the mode of 
action involves three distinct stages: adaptation, expression and interference (Figure 1.1). 
1.1.2.1 Adaptation by spacer acquisition 
CRISPR loci acquire the fragments of invading DNA and therefore these newly acquired spacers 
would result in a sequence specific resistance mechanism to the corresponding phage. The new 
spacers are integrated into the CRISPR locus in a polarized manner, starting from the leader end 
[5, 25]. The spacers with specific protospacer adjacent motif (PAM) are selected by Cas proteins 
from the invading DNA and integrated into the CRISPR locus in a PAM dependent orientation 
[26-28]. The most highly conserved Cas proteins Cas1 and Cas2 have been reported to have a 
key role in this spacer acquisition process [5, 29]. This is how the cell is able to adapt to the 
mobile genetic elements in the environment, hence this stage is referred to as “Adaptation” 
phase [8]. 
1.1.2.2 Expression of CRISPR transcripts 
The CRISPR locus is transcribed into precursor crRNA or pre-crRNA. The pre-crRNA is then 
processed into smaller crRNA with the endonucleases such as Cas6 homologs (which might be 
present as a part of multi-subunit crRNP complex) or housekeeping endonucleases such as 
RNase III. At this step there are differences in the different CRISPR systems in terms of key 
candidates involved in crRNA processing (these distinct features are discussed under section 
1.1.3). The crRNA generated, comprises a part of repeat sequences flanking both ends of a 
complete spacer. The spacer sequence in this crRNA is then responsible for guiding the crRNP 
complex towards a complementary target sequence in any invading mobile genetic element 
such as a viral DNA or a plasmid [12, 22]. 
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Figure 1.1 Overview of the CRISPR-Cas Type I-E system in E. coli. 
The CRISPR locus showing the palindromic repeats (black) separated by spacers (green) that are acquired from the 
invading genetic elements such as bacteriophage DNA. The locus is preceded by a leader sequence (arrow) and a 
followed by set of cas genes. The cas genes are indicated with different colors (red, brown, orange and violet) with 
respect to their role in the CRSIPR system (indicated in colored boxes). The CRISPR immunity is mediated by 
crRNAs and Cas proteins that together form the crRNP complex (orange). The three stages of the CRISPR based 
adaptive immune response: (i) Adaptation: Acquisition of new spacer units (blue), (ii) Expression: Transcription of 
CRISPR locus and processing of the crRNAs by Cas6 (brown) (iii) Interference: Target surveillance by the crRNP 
complex and degradation of invading DNA by endonucleases e.g. Cas3 (violet). Adapted from [22] with permission 
from the publisher. 
6   
1.1.2.3 RNA directed CRISPR interference  
The mature crRNAs associate with Cas proteins to form crRNP complexes, which could 
comprise of multiple Cas protein subunits like the Type I and Type III systems or a single large 
protein (Cas9) like in Type II system. The assembled crRNP complex then scans the invading 
genetic element for a sequence similarity between the crRNA and a protospacer sequence. 
Hybridization of the crRNA and target strand, results in a conformational change in the crRNP 
complex which acts as a signal for the activation of endonucleases (Type I and III-B) or intrinsic 
nuclease activity of the crRNP complex (Type II and Type III-A) for the degradation of target 
DNA [30]. (Further details of the activity of different crRNP complexes and candidate proteins 
that assemble together to form these complexes is discussed under section 1.1.3). 
1.1.3 Three types of CRISPR-Cas systems 
The recent classification of CRISPR-Cas systems by Kira S. Makarova divides them into three 
distinct Types I, II and III [21, 23, 31]. Two universal cas genes cas1 and cas2 are present in all 
CRISPR subtypes, and they play a significant role in the spacer acquisition process [32-34]. The 
adaptation is therefore very similar in all the three types of CRISPR-Cas systems. Substantial 
difference between the three types lies in their sets of constituent genes and signature cas 
genes. These include: In Type I, cas3 gene (comprising of both helicase and nuclease domain) 
[35]; in Type II, cas9 gene (a large protein that singularly controls the process of crRNA 
processing and interference) and in Type III, cas10 gene (the large subunit, important during 
interference). Further the three types are divided into various subtypes along the phylogeny of 
universal cas1 gene [21]. The characteristics of different Cas protein components of the three 
systems are also described in Table 1.1. 
1.1.3.1 Type I CRISPR-Cas systems 
In Type I system the spacer acquisition, like all CRSPR-Cas subtypes, is mediated by Cas1 and 
Cas2 proteins. The distinct characteristics of Type I system that makes them different from the 
rest of CRISPR-Cas types are: the Cas6 endonuclease responsible for crRNA processing, the 
CRIPSR-associated complex for antiviral defense (Cascade) that is formed by assembly of 
multiple Cas proteins and the crRNA, the Cas3 endonuclease responsible for the degradation of 
target DNA [36-38], also illustrated in Figure 1.2.  
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Figure 1.2 RNA directed CRISPR interference in the three types of CRISPR-Cas systems. 
Adaptation phase of the CRISPR immunity is common in all the three types of CRSIPR-Cas systems (see Figure 1.1). 
However the key Cas protein candidates involved in processing of crRNA, formation of multi-subunit or single 
protein crRNP complex and target surveillance and degradation are the major criteria of difference between the 
subtypes. The three types are therefore characterized by the distinct features of their Cas proteins. In Type I, the 
crRNA are processed mostly by Cas6 (Figure 1.3) and other Cas proteins form multi-subunit Cascade complex that 
targets dsDNA. In Type II Cas9 is the sole player mediating these roles, whereas in Type III the assembled multi-
subunit Csm or Cmr complex is similar to the Cascade complex, with DNA or RNA as target. Adapted from [12] with 
permission from the publisher. 
The Cas6 endonucleases are responsible for the processing of pre-crRNA, resulting in a 
processed mature crRNA [24, 39]. This crRNA has three components (i) the complete spacer (ii) 
upstream of the spacer, 8 nucleotides (nt) derived from the repeat and (iii) downstream of the 
spacer a sequence of invariable size derived from the downstream repeat, comprising of a 
palindromic repeat that tends to form a stem-loop structure [30, 36, 40] (Figure1.3). 
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Figure 1.3 Generation of processed crRNA in Type I systems. 
Primary processing of pre-crRNA is performed by Cas6 by cleavage (red scissors) within the repeat sequences 
resulting in a crRNA with 5’ handle of 8 nt, a central spacer sequence and a longer 3’ handle. In some subtype the 
3’ handle forms a stem-loop structure and in some CRISPR-Cas systems the 3’ handle is further processed by 
unknown ribonucleases (blue scissors). Adapted from [22] with permission from the publisher. 
In the Type I-E system from E. coli, the mature crRNA and Cas proteins together form the 
Cascade complex. The complete complex has a stoichiometry of Cse11Cse22Cas51Cas76Cas61 
which is a typical feature in Type I and Type III complexes [30, 41]. The crRNP complexes over 
different CRISPR subtypes share a helical backbone formed of multiple copies of Cas7 protein, 
Cas5 and Cas8 proteins assembled around the crRNA with an addition of a small subunit in 
some cases (Figure 1.4). Due to these structural similarities the crRNP complexes in other 
subtypes of Type I are also referred to as Cascade complex [24, 42]. 
The fully assembled Cascade complex then scans the target dsDNA for a PAM (protospacer 
adjacent motif). On recognition of PAM by Cse1, the dsDNA destabilizes allowing the 
hybridization between the spacer region of crRNA and the complementary sequence on target 
DNA [37]. This base pairing results in an R-loop formation further triggering a conformational 
change in the Cascade complex [30, 43]. This structural change acts as a signal for the activation 
of Cas3. The Cas3 using both its helicase and nuclease activity, unwinds and then degrades the 
target DNA [36, 44]. 
1.1.3.2 Type II CRISPR-Cas systems 
The Type II system is most distinct from all other CRISPR subtypes. The only similarity with 
other types is in terms of spacer acquisition by Cas1 and Cas2. The signature protein of Type II 
system is Cas9, a large protein which acts as an endonuclease. It works as single protein 
machinery for the generation of mature crRNAs as well as the cleavage of target DNA. Recent 
reports of the high resolution crystal structures of Cas9 from Streptococcus pyogenes and 
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Actinomyces naeslundii have been a major achievement in the understanding of this system 
[45, 46]. 
The CRISPR locus of Type II system comprises of a gene (in addition to the cas genes) for the 
synthesis of trans-activating crRNA (tracrRNA). The tracrRNA has a sequence complementarity 
to the repeat region of the pre-crRNA and a duplex formation between the two results in 
processing of the crRNA-tracrRNA (dsRNA) hybrid by RNase III in presence of Cas9 [47]. This 
mature crRNA-tracrRNA hybrid is then responsible for the target recognition in a PAM 
dependent manner followed by cleavage [48, 49]. 
In the crystal structures it was shown that Cas9 has two distinct nuclease domains. The HNH 
domain responsible for the cleavage of target DNA (the one complementary to the guide RNA 
sequence) and a RuvC nuclease domain that cleaves the non-target strand (non-complementary 
strand), leading to double strand breaks in the target DNA [48, 50]. This ability of Cas9 for 
creating dsDNA breaks at specific sites defined by a guide RNA has led to its use as versatile tool 
in genome engineering [51]. 
1.1.3.3 Type III CRISPR-Cas systems 
The Type III systems are characterized with the presence of a signature gene cas10, that 
encodes the large subunit Cas protein, homologous to palm-domain polymerases. Also there 
are multiple genes encoding for RAMPs. Further the Type III systems are classified into subtypes 
based on cas1 gene phylogeny. There are two major subtypes, Type III-A systems have a 
signature csm2 gene and Type III-B systems have a signature cmr5 gene [21]. 
The crRNA biogenesis in Type III system is very similar to the Type I system where the sole 
player, Cas6 endonuclease, mediates the processing or pre-crRNAs into mature crRNAs. Also, 
the architecture of crRNP complexes in both Type I and Type III complexes have a lot of 
structural similarities [52-54] also depicted in Figure 1.4. The Type III-A Csm complex has a 
helical backbone of multiple copies of Csm3 and in Type III-B this backbone comprises of Cmr4 
proteins, in a similar morphology as Cas7 proteins in Type I-E Cascade complex. Also the crystal 
structure of Csm3 and Cmr4 revealed structural homology with Cas7 protein [55, 56].  
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Figure 1.4 Schematic representations of assembled crRNP complexes from Type I and Type III CRISPR-
Cas systems. 
The Cas proteins are assembled around the crRNA with a spacer component (green) and flanking repeats (black). 
The colored boxes/circles represent different Cas proteins components of the crRNP complexes, as indicated in the 
box below. Same color across different subtypes represents the homology of conserved Cas proteins. Numbers 
represent the nomenclature of a particular Cas protein in a given subtype, for e.g. The Cas 7 protein (blue) referred 
to as Csy3 in subtype I-F, Csm3 in subtype III-A and Cmr4 in subtype III-B. The two truncated domains of Cas3 are 
shown as Cas3’ and Cas3’’ in Type I-A Csa complex and as a fused component of the Type I-E Cascade complex. 
Adapted from [22] with permission from the publisher. 
 
In the interference stage, there is a major difference in the two Type III subtypes: 
• The Type III-A Csm complex targets dsDNA in a PAM dependent manner, with Cas10 also 
playing a significant role [57]. Also a helicase/nuclease Csm6 has been speculated to be 
involved in target degradation [58]. In addition, recent reports for the Type III-A Csm 
complex from T. thermophilus suggest that the Type III-A system targets RNA in a 
flexible manner without relying on a PAM [59].  
• The Type III-B Cmr complex has been shown to be the most unique out of all CRISPR-Cas 
systems in terms of targeting RNA and not DNA. The Cmr4 protein that forms the helical 
backbone of the Cmr complex was suggested as the catalytic subunit due to a multiple 
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1.2 Mass spectrometry  
Mass spectrometry (MS) is an analytical technique for the identification of compounds based 
on their elemental composition and charged state [61]. In a MS analysis, the chemical 
compounds are ionized in the gas-phase to generate charged molecules which are then 
measured on the basis of their mass-to-charge ratio and abundance. It is very widely used for 
the analysis of simple and complex biological samples such as proteins, nucleic acids, lipids and 
macromolecular complexes.  
A mass spectrometer consists mainly of three components: i) Ion source - to produce multiply 
charged ion droplets from the sample, ii) mass analyzer - to separate the ions based on their 
mass-to-charge (m/z) ratio and iii) detector - to count the number of ions at each m/z value 
emerging from the analyzer (Figure 1.5). Once the gas-phase ion droplets enter the instrument, 
they are inside a vacuum system comprising a mass analyzer and a detector. Before entering 
the mass analyzer the solvent in the droplets evaporates under high temperature. In the mass 
analyzer, ions are guided and separated by electric or magnetic fields according to their m/z 
ratio. After separation in the mass analyzer, ions are measured by a detector which transforms 
them into usable signals comprising the information of their m/z ratio and abundance. The 
detector is coupled to a data processing system which uses specialized software to produce a 
suitable form of mass spectrum for data analysis [61]. 
 
 
Figure 1.5 Basic components of a mass spectrometer. 
The mass spectrometer consists of three main components: Ion source for producing ions from the sample, mass 
analyzer for m/z based separation and a detector for measuring these ions and their abundance. The mass 
analyzer and detector are present inside the vacuum chamber of the instrument. The signals from the detector are 
then transferred to dedicated software to process the data for data analysis purposes.  
MS has become very popular in the last two decades due to the developments in soft ionization 
techniques such as electrospray ionization (ESI) and matrix-assisted laser desorption ionization 
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(MALDI) and it has become a method of choice for analyzing biological macromolecules, 
especially proteins. In addition, in 2002, the Nobel Prize in Chemistry was awarded to John Fenn 
and Koichi Tanka for the development of ESI and MALDI, respectively [62, 63]. 
1.2.1 Electrospray Ionization 
Electrospray ionization (ESI) is used to ionize the analytes out of a solution using high voltage. 
Due to the rapid transition of ions from liquid to gas phase, the ESI ion source is mostly coupled 
to a liquid chromatography (LC) system. The LC column is a narrow capillary that tapers into a 
fine needle tip at the end made of glass or metal, which makes sure that the outgoing liquid is 
sprayed in form of droplets. These droplets undergo extensive evaporation and solvent loss, 
facilitated by the presence of volatile organic solvents such as acetonitrile in the solution. In 
order to enable the ionization in positive mode, a proton rich environment is needed for which 
the pH of solution is kept very low using volatile acidic components such as formic acid. The 
spray needle is held at high potential difference (several kV) from the inlet of the mass 
spectrometer, to make sure these droplets undergo intense electrostatic dispersion due to 
repulsion of like charges resulting in smaller droplets [64, 65]. This is also referred to as 
‘Coulombic fission’ where the original droplet bursts creating more stable and smaller droplets 
[66]. These droplets further vaporize as they reach closer to the heated inlet of the mass 
spectrometer, becoming smaller as the like-charge repulsion increases, leading to further 
dispersion of these droplets. This phenomena is currently supported by two coexisting theories: 
i) Charge residue model – the cycle of coulombic fission and evaporation repeats until there is 
only one analyte ion left per droplet and ii) Ion evaporation model – the big and highly charged 
droplets burst to produce free ions [67]. The final charge that is present on the naked ion 
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1.2.2 Mass spectrometry instruments  
All mass spectrometers comprise three basic components as shown in Figure 1.6, however the 
nature of these components varies with respect to the type of data to be generated and the 
kind of sample to be analyzed. One of the key distinguishing features in these mass 
spectrometers is the mass analyzer.  
A mass analyzer is the core of a mass spectrometer that separates the ions based on their m/z 
ratio. Based on the principle of how m/z separation is achieved there is a wide variety of mass 
analyzers available. The three most common examples include:  
1. Quadrupole analyzer - It consists of four cylindrical metal rods held parallel to each other. 
Two opposite rods carry a positive charge while the other pair of opposite rods carry a negative 
charge. In addition to this direct voltage a high radio frequency (RF) voltage is applied to all the 
four rods, resulting in an oscillating electric field. The analyte ions are separated based on the 
stability of their trajectories as they fly through these electrodes. Direct and RF voltages are 
changed so that only the ions with very narrow interval of m/z values successfully pass through 
the rods to the detector [68]. 
2. Time-Of-Flight (Tof) analyzers - They are based on the basic principle that when same 
amount of force is applied to different ions, the resulting acceleration on the different ions is 
inversely proportional to their mass. Heavier ions will have a slower acceleration and thus will 
take longer to reach the detector whereas the lighter ions will move faster and reach the 
detector in less time. The ions are thus separated based on their time of flight to reach the 
detector [61, 68].  
3. Ion traps - They are also referred to as a 3D quadrupole and have an edge over canonical 
quadrupoles as they are able to perform tandem MS analysis. For tandem analysis a precursor 
ion is selected based on its m/z value and isolated in the trap followed by its collision with an 
inert gas (helium), resulting in dissociation. The ions that are generated after dissociation of the 
precursor are then scanned to produce MS/MS spectrum of the precursor. The most commonly 
used ion traps include: i) linear ion trap which is similar to the quadrupole with slight 
modifications that enables higher capacity to store more ions and ii) Orbitrap which is the latest 
advancement among mass analyzers, here the ions travel in a circular motion along a spindle 
shaped electrode as shown in Figure 1.6. The ions can be trapped inside the Orbitrap and it also 
serves as a detector generating the mass spectrum using fourier transformation [69]. The 
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Orbitraps also provide a very high resolution up to 280000 at 400 m/z and high mass accuracy 
of <5 ppm [70]. 
The performance of a mass spectrometer is evaluated based on two important characteristics: 
i) Resolution - ion separation with very small difference in their m/z values and ii) Mass 
accuracy - precision in determining the m/z value. However the instruments currently 
flourishing are hybrid instruments, which are comprised of two analyzers in order to overcome 
the limitations of a single mass analyzer and combine the strengths of different mass analyzers 
for better performance. Here, the schematic layout of one such hybrid instrument is explained, 
the LTQ (Linear trap quadrupole) Orbitrap mass spectrometer from Thermo Fischer Scientific 
(Schwerte, DE), a prototype for the current generation of mass spectrometers, which were 
routinely used in the progress of this thesis (Figure 1.6).  
1.2.2.1 LTQ Orbitrap mass spectrometer 
The LTQ Orbitrap XL mass spectrometer is a hybrid Fourier-Transform mass spectrometer 
(FTMS) which combines a linear ion trap (LTQ) and an Orbitrap mass analyzer (Figure 1.6). Ions 
generated from the ion source are collected in the LTQ followed by ejection into the C-shaped 
storage trap which is used to store the ions before injection into the Orbitrap. In the Orbitrap, a 
very high resolution precursor ion scan is performed to generate the MS1 spectrum and at the 
same time, the ions are separated in the ion trap and fragmented by low-energy collision 
induced dissociation (CID) to record the product ion scan i.e., the MS2 spectrum. The LTQ ion 
traps have very high sequencing speed as compared to the Orbitrap, therefore various product 
ion scans (MS2) can be performed in the LTQ while the Orbitrap is performing precursor ion 
scan (MS1). The Orbitrap can also perform CID with very high mass accuracy and resolution but 
owing to its low acquisition speed the MS2 scans are performed in LTQ. This is the advantage of 
combining the strengths of two mass analyzers in one hybrid instrument [71]. 
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Figure 1.6 Schematic layout of an LTQ-Orbitrap mass spectrometer. 
A hybrid mass spectrometer comprising an ion source through which the ions are sprayed into the mass 
spectrometer, ion transfer optics (multipole) for enabling the movement of ions through different parts of the 
mass spectrometer. It also comprises a C-shaped trap for ion storage and an HCD collision cell for fragmentation, 
although fragmentation can also occur in the ion trap.  
Additionally, this hybrid instrument is also equipped with an HCD collision cell, to perform high-
energy collision dissociation (HCD) for the fragmentation of selected precursors. For HCD 
fragmentation, the ions are collected in the LTQ, and the selected ions depending upon the 
MS1 are then passed into the HCD cell where they are fragmented under normalized collision 
energy. The product ions are then transferred into C-trap which further transfers them into the 
Orbitrap. In the Orbitrap the fragment spectrum or the MS2 scan is recorded [71]. The HCD 
collision cell provides the ability to perform a broad range of fragmentation experiments from 
advanced level of proteomics to even small molecule research but due to its slow speed it is 
used only for certain samples or questions. 
1.2.3 MS based fragmentation of peptides and RNA  
Mass spectrometry has been routinely used to gain deeper insight into the complexity of 
biological samples. Tandem MS plays a very important role in studying different biomolecules 
such as proteins and nucleic acids. Both CID and HCD based fragmentation can be used for the 
investigation of proteins and DNA/RNA in the samples. As most of the biological samples used 
during the course of this thesis comprised of proteins and RNA, here I discuss the basic principle 
of fragmentation of peptides and RNA in the MS experiments. 
For proteomics studies, the peptide fragmentation is carried out from acidic solutions in 
positive ion mode which can give rise to different ion species (Figure 1.7 A). The fragment ions 
that are generated are named according to Roepstorff-Fohlmann-Biemann nomenclature [72, 
73]. Under the low energy dissociation (CID) the most common fragment ions are generated 
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upon the cleavage of a peptide bond between two amino acids. Depending on whether the 
charge is retained at the amino-terminal or carboxy-terminal fragment of the peptide they are 
referred to as b- ions or y- ions, respectively. Another common observation is the pair of a- and 
b- ions, separated by a mass of 27.9949 Da (corresponding to loss of a C=O group). In the MS2 
scan from the quadrupole instruments the y- ions predominate whereas in the ion trap 
instruments both b- and y- ions are observed [64]. 
 
 
Figure 1.7 Schematic representations of peptide and RNA fragmentation and their nomenclature. 
(A) Nomenclature of different fragment ions generated upon fragmentation of peptide in low collision energy. The 
ions from carboxyl- terminal are named as x-, y- and z- ions whereas the amino- terminal ions are called a-, b- and 
c- ions. The cleavage of peptide bonds results in two sets of ion species: b- ions, if the charge resided N- terminal 
to the cleavage site and y- ions if the charge is C- terminal. (B) Nomenclature of fragment ions generated upon 
fragmentation of RNA from the cleavage of phosphate backbone. The fragment ions containing the 5’end are 
named as a-, b-, c- and d- ions and the ones containing 3’ end are called w-, x-, y- and z- ions.  
Although MS has gained immense popularity in proteomics field, it is also used as a viable tool 
for structural studies of nucleic acids. With the recent developments in ionization techniques, it 
has become easier to generate gaseous ions from heavy biomolecules. The fragmentation of 
nucleic acids is carried out from basic solutions in negative ion mode. The fragment ions 
generated from RNA are named according to the nomenclature proposed by McLuckey et al 
[74]. The nomenclature is analogous to the one widely used for peptides. There are four 
possible sites for cleavage along the phosphodiester chain (Figure 1.7 B) and they are named 
based on the retention of charge at 5’ or 3’ end. Under CID conditions it has also been noticed 
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that there is high tendency of the cleavage of N-glycosyl bond between different base and the 
sugar moiety, leading to the release of nucleobase as a separate ion or as a neutral loss [75].  
1.2.4 MS based proteomics and data analysis 
The term ‘proteome’ refers to the entire collection of proteins expressed by a genome, cell, 
tissue or a whole organism at a given point of time under different conditions and the study of 
proteome is referred to as ‘Proteomics’. It deals with study of different aspects of molecular 
and cellular biology at the protein level. Proteomics studies can be very challenging owing to 
the complexity of the protein populations extracted from cells and tissues and sometimes the 
protein of interest might be very low abundant in such a complex mixture. Therefore a sensitive 
and advanced analytical approach such as MS can be useful to deal with complex protein 
samples. In the past MS has become a method of choice for identification of proteins, post-
translational modifications and protein-protein interactions when applied to smaller protein 
datasets [76]. However with increasing developments in new experimental approaches, the 
MS-based proteomics is now also used for analysis of very large protein systems such as the 
analysis of entire human proteome [77, 78].  
For typical proteomics experiments, the proteins are extracted and isolated from cells or tissues 
by different fractionation and affinity purification strategies. The isolated proteins are then 
separated using one dimensional gel electrophoresis (1D-PAGE) [79]. For higher sensitivity of 
the MS analysis the proteins are digested into peptides enzymatically using endoproteinases 
such as trypsin and the protein identification is carried out by peptide sequencing in the MS 
analysis (Figure 1.8). Upon digestion of proteins multiple peptides that are generated might add 
to the sample complexity, therefore depending on the experimental requirements or scientific 
question being addressed the sample complexity can be further reduced by carrying out a 
separation at the peptide level. The complex peptide mixtures can be separated based on 
peptide characteristics such as isoelectric point using peptide isoelectric focusing (pIEF) [80].  
 
18   
 
Figure 1.8 Schematic representation of the workflow for proteomics data analysis. 
For the protein identification by MS, the protein is hydrolyzed with endoproteinases under in vitro conditions and 
the peptides generated are scanned in the mass spectrometer for their m/z values. After the MS1 analysis the 
precursor ions are selected based upon their m/z intensity, for the MS/MS fragmentation. From the MS2 spectrum 
the amino acid sequence of the peptide can be determined. For the identification of the protein, the 
experimentally determined mass of the precursor and the fragments are compared with the theoretically 
determined masses obtained from the database search performed in silico. 
 
Nonetheless before the MS analysis the peptides are separated by a step of high-pressure liquid 
chromatography (HPLC) and eluted into an electrospray. This is followed by the MS analysis 
where the MS1 scan is acquired and a selected precursor is fragmented to generate the MS2 
scan as shown in Figure 1.8. This mode of data collection in tandem MS analysis where a fixed 
number of precursor ions whose m/s values are recorded in a survey scan are selected using 
predetermined rules and subjected to a second stage of fragmentation in MS2 or MS/MS 
analysis is also referred to as data dependent acquisition (DDA) [81]. The MS and MS/MS data is 
used for matching against protein sequence databases to identify the peptides and therefore 
the proteins. The entire workflow of using liquid chromatography separation, followed by 
electron spray ionization and mass spectrometry is also called LC-ESI-MS/MS or in short LC-
MS/MS.  
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1.2.5 Quantitative proteomics 
One of the most challenging aspects of proteomics is to quantify the differences between 
different physiological states in a biological system. The MS based quantitation have gained 
immense popularity over the past decade making use of differential stable isotope labeling to 
create specific isotopic mass tags that can provide a basis for quantification. The isotopic tags 
can be introduced at the level of proteins or peptides as shown in Figure 1.9. Broadly, the 
quantitative MS approaches are classified into two categories i) Relative quantification - the 
comparison between amount of proteins or entire proteomes between two or more samples in 
order to yield a quantitative ratio and ii) Absolute quantification - determining the absolute 
amount of concentrations of proteins within a sample. Further these two categories can be 
divided on the basis of using stable isotope labeling or label free approach for quantitation, as 
summarized in Table 1.2. 
 
Table 1.2 An overview of different label-based and label free approaches used for absolute and 
relative quantification highlighting important examples in each category. Adapted from [82] 
 
Relative quantification Absolute quantification 
Label-Based Label-free Label-based Label-free 










SILAC - Stable isotope labeling by amino acids in cell culture, ITRAQ - Isobaric tags for relative and 
absolute quantification, TMT - Tandem mass tags, DML - Dimethyl labeling, XIC - Extracted ion 
chromatogram, AQUA - Absolute quantification and iBAQ - Intensity based absolute quantification. 
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Figure 1.9 Common workflows used for quantitative proteomics. 
Most commonly used approaches for protein quantification include: i) Metabolic labeling, ii) Chemical labeling and 
iii) Label-free approach. The labeling is achieved with stable isotope incorporation which can be at the metabolic 
level as the cells grow or using chemical reagents. The later can be performed at the protein or the peptide level 
using isotopically encoded reagents. After labeling the proteins or the peptides, the respective samples are pooled, 
followed by MS analysis. The relative level of expression is obtained on comparing the signal of labeled and 
unlabeled peptides. In the label-free approach the MS data from two samples is compared with respect to the 
intensity of peptide precursor ions or spectral counts of a particular peptide, for a given protein. Colors red and 
blue indicate the light and heavy labels respectively, at the level of cells, proteins or peptides [83]. 
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For the investigation of prokaryotic immune defense system two quantitative proteomics 
approaches were used as described below.  
1.2.5.1 Differential isotope labeling using dimethyl labeling of peptides. 
Chemical labeling of peptides using differential isotope labeling has been widely used in 
proteomics research. Dimethyl labeling is a very fast and straightforward approach using 
inexpensive chemical reagents that provide almost 100% labeling efficiency and multiplex 
quantification [84]. 
 
Figure 1.10 Labeling scheme for triplex stable isotope dimethyl labeling. 
Three different samples can be analyzed in parallel by labeling the peptides using three different isotopomers of 
formaldehyde. The labels result in light, intermediate or heavy labeled peptides with an additional mass of 28, 32 
or 36 Da. These labels provide a minimum of 4 Da mass differences between the peaks in the generated peptide 
triplets. Adapted from [84] with permission from the publisher.  
In dimethyl labeling, all the primary amines in a peptide mixture are converted into 
dimethylamines, which includes the N-terminus and the side-chain of lysine residues. A 
combination of isotopomers of formaldehyde and cyanoborohydride can be used to generate 
peptide triplets that differ in mass by a minimum of 4 Da between different samples (Figure 
1.10). The peptide mixture from a particular sample is labeled with light, medium or heavy 
labels and the labeled peptides from different samples are pooled and simultaneously analyzed 
by MS. The peptide abundance from different samples is then compared depending upon the 
mass difference of the dimethyl labels [85]. Moreover, dimethyl labeling can also be applied at 
the level of intact proteins, but this would limit the choice of proteases as trypsin and Lys-C 
would not be able to cleave modified lysine residues [86]. 
22   
1.2.5.2 Label-free approach (iBAQ) 
Quantitative proteomics also aim at determining the absolute amount of proteins in a sample. 
Intensity based absolute quantification (iBAQ) is a label-free approach in quantitative MS [87]. 
It estimates the absolute amount of a particular protein by summing the peak intensities of all 
detected peptides of the protein dividing it by the number of theoretically observable peptides 
[88]. iBAQ intensities are the most accurate measurement of the absolute abundance of all the 
proteins identified in a sample. In addition to determining the protein abundance, iBAQ has 
also been used to determine the protein stoichiometry in a multi-protein complex [89]. A 
reference protein mixture such as universal protein standard (UPS) is spiked into the sample 
and the iBAQ intensities of reference proteins are plotted against their known amounts to 
prepare a regression curve. The amount of different proteins in the sample is then determined 
from this regression curve using their experimental iBAQ intensities. Once the absolute amount 
of different proteins in a complex is determined, the stoichiometry of proteins in the complex 
can be calculated.  
The quantitative proteomics approaches such as dimethyl labeling and iBAQ have gained 
immense popularity due to the availability of computational platforms such as MaxQuant 
software [90] that have a provision for processing the raw data, performing database searches, 
quantification of peptides and proteins and statistical evaluation of the data. 
1.2.6 Structural Proteomics 
Different MS-based approaches have been used to study the structure and dynamics of 
macromolecular assemblies that comprise physically interacting proteins with/without nucleic 
acids. Determination of structural organization of these complexes has always contributed to 
the understanding of various biological functions. A variety of techniques such as NMR, X-ray 
crystallography and cryoEM have been widely used to determine the structure of protein 
complexes [91]. A major challenge for the structural biologists is to study the three dimensional 
structural organization of these complexes due to conformational dynamics, heterogeneous 
composition, asymmetric structure and the large complex size. Furthermore, for a complete 
understanding of the biological role and the mode of action of such macromolecular assemblies 
it has become important to have high resolution structural information about the identity, 
shape and structure of individual components, stoichiometry of different components and 
interactions between different components present in the complex [92]. 
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A majority of structural MS investigations are based on the principle that the non-covalent 
interactions can be maintained in the gas phase [93, 94]. Native MS approach has made it 
possible to analyze entire protein complexes in intact form in the mass spectrometer, for e.g., 
large MDa complexes such as ribosomes [95]. In addition, protein-protein cross-linking 
approach based on chemical cross-linkers that covalently connect the functional groups on 
proteins or protein complexes to create structurally defined interactions between proteins is 
also becoming a method of choice to study protein-protein interactions (Section 1.2.6.2). The 
advantage of using MS for structural studies, compared to other methods, lies in the 
requirement of very low sample amounts and the fast analysis speed enabling real time 
monitoring of molecular interactions [92]. To study the protein-RNA and protein-protein 
interactions in multi-subunit ribonucleoprotein complexes such as the crRNPs (CRISPR 
ribonucleoprotein complexes), we used two structural proteomics approaches as described 
below.  
1.2.6.1 UV induced protein-RNA cross-linking  
Ribonucleoprotein (RNP) complexes play a key role in mediating biological processes such as 
gene expression and regulation. A vast array of RNA binding proteins (RBPs) have been 
reported in eukaryotes that stabilize the RNA structure and also mediate its interactions with 
other biomolecules when they are part of a macromolecular assembly [96]. The RBPs can bind 
single or double stranded RNA through their conserved structural motifs known as the RNA 
binding domains (RBDs). The computational analysis has led to identification of such structural 
motifs in these RBPs, such as RNA-recognition motifs (RRMs) [97], K homology (KH) domains 
[98], zinc-finger domains [99], G-patch domains [100], Sm motifs [101], etc. The three-
dimensional structures of recently crystallized prokaryotic RBPs show presence of RBDs similar 
to eukaryotes, e.g., the Sm-fold in bacterial HfQ proteins [102] and the RRMs in Cas7 protein 
family [55, 103]. However, there is very little information available on interaction between 
RBDs and their cognate RNA. In order to understand the molecular details of these processes it 
becomes important to characterize the interactions between proteins and RNA.  
Structural studies using co-crystallization, NMR and high resolution EM are the gold standards 
for characterization of molecular interactions between RBDs and the cognate RNA molecules, 
as shown in the past [46, 104-106] and from the co-structures of various protein-RNA 
complexes available in the PDB. In recent years UV induced protein-RNA cross-linking coupled 
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with MS has emerged as a more specialized and direct approach for obtaining information 
about the protein-RNA interactions in RNPs [107]. 
UV induced protein-RNA cross-linking allows the identification of cross-linked peptides and RNA 
moieties and the exact contact sites within the RNA and protein at single nucleotide and single 
amino acid resolution [108]. This approach can be applied to single proteins such as the 
recombinant proteins that interact with RNA and to the complex assemblies of RNPs that have 
been reconstituted or purified from the cells (endogenous).  
 
Figure 1.11 Overview of the protein-RNA cross-linking workflow. 
Protein-RNA complex is UV irradiated at 254 nm and hydrolyzed by RNases and trypsin resulting in a mixture of 
non-cross-linked peptides and RNA fragments and cross-linked heteroconjugates. The non-cross-linked RNA 
fragments are removed with C18 desalting and the cross-linked heteroconjugates are enriched via TiO2 columns 
that remove non-cross-linked peptides. These enriched cross-linked samples are then analyzed by LC-ESI-MS/MS 
followed by database search. Adapted from [109] with permission. 
The principle underlying this approach is that upon UV induction the amino acid side chains of 
proteins cross-link to the nucleobases of RNA in close spatial proximity [109]. The cross-linked 
region and cross-linked amino acid and nucleotide can then be identified with high resolution 
MS. MS fragmentation allows sequence determination of the cross-linked peptide and the 
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composition of cross-linked RNA. An overview of the workflow for UV induced protein-RNA 
cross-linking is shown in Figure 1.11. 
After UV cross-linking, the cross-linked peptide and RNA are required to be isolated for the 
subsequent LC-MS/MS analysis. Both the RNA and protein moieties are completely digested 
with endonucleases and endoproteinases under denaturing conditions. Most commonly used 
endonucleases include combination of RNase A and T1 for single stranded RNA or benzonase 
which digests both single and double stranded RNA/DNA in an unspecific manner generating 
short fragments of mostly single nucleotides. When the RNA moiety is short, the MS analysis to 
determine the sequence of cross-linked peptide becomes more sensitive [110]. 
For the proteolysis, trypsin is the most commonly and widely used endoproteinase in MS-based 
proteomics. The UV cross-linking yield and the efficiency of RNA and protein hydrolysis 
determines the yield of cross-linked peptide-RNA heteroconjugates. 
The yield of UV induced cross-linking between proteins and RNA is relatively low [109], 
therefore it is essential to enrich the cross-linked species for subsequent MS analysis. The 
mixture obtained after digestion of protein-RNA comprises of mainly non-cross-linked peptides, 
non-cross-linked RNA oligonucleotides and cross-linked peptide-RNA heteroconjugates. For the 
removal of non-cross-linked oligonucleotides and the non-cross-linked peptides two successive 
purification steps are performed (Figure 1.11). The non-cross-linked RNA oligonucleotides are 
removed by C18 reversed-phase chromatography because they do not bind to the C18 material 
whereas both the cross-linked and non-cross-linked peptides have a strong affinity towards the 
C18 material. This step is also referred to as C18-desalting as it allows salts and other 
contaminants to be washed off from the sample [111]. After removal of the non-cross-linked 
RNA oligonucleotides, the sample mainly consists of cross-linked peptide-RNA 
heteroconjugates, non-cross-linked peptides, and residual non-cross-linked RNA 
oligonucleotides. To remove non-cross-linked peptides and enrich peptide-RNA 
heteroconjugates, titanium dioxide (TiO2) enrichment is used. It has been established as a 
method for enrichment of phosphopeptides in MS-based proteomics experiments [112, 113].  
If the proteins and RNA differ considerably in their size then the proteins are hydrolyzed prior 
to RNA hydrolysis. After proteolysis the intact RNA with or without cross-linked peptides is 
enriched using size exclusion chromatography. The approach has been used earlier in studying 
the protein-RNA interface of different RNP complexes [108, 114]. 
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Figure 1.12 An artificial MS/MS spectrum of a peptide-RNA cross-link. 
Sample spectrum of a peptide ‘CRISPR’ cross-linked to a uracil nucleotide to indicate the characteristic peaks and 
shifts observed during fragmentation of a peptide-RNA cross-link. The peptide sequence and fragment ions are 
indicated on the top and cross-linked residue is highlighted in yellow. Distinct fragment ions containing nucleic acid 
base and peptide fragments are indicated in red. Some of the b- and y- ions are shown with a mass shift of # 
corresponding to U’: U marker ion adduct of 112.0273 Da.  
The MS analysis of the purified peptide–RNA cross-links allows sequencing of the cross-linked 
peptide and RNA moieties in the gas phase. ESI coupled to a nano-LC system is a method of 
choice for analyzing such cross-links. The aim is to determine not only the amino-acid sequence 
of the cross-linked oligopeptide but also to identify the cross-linked amino acid. The mass of 
entire cross-linked species is a simple additive of the mass of cross-linked nucleotide and the 
mass of cross-linked peptide [109]. Thus to determine the cross-linked nucleotide, mass 
difference between the cross-linked species (experimental precursor) and the cross-linked 
peptide is calculated. An artificial MS/MS spectrum from a typical peptide-RNA cross-link 
fragmented under HCD conditions is shown in Figure 1.12. The signals from the fragment ions 
of the cross-linked peptide pre-dominate the MS/MS spectrum. The fragment ions from the 
peptide that contain the cross-linked residue are shifted by the mass of this nucleotide residue, 
when compared to the regular peptides fragments. Additionally, marker ions of the cross-linked 
nucleotides are also observed in the lower m/z regime of the fragment spectrum corresponding 
to the bases (e.g., U’ = 113.0351, Uracil base).  
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For protein-RNA cross-linking studies high resolution MS instruments are required that provide 
a high mass accuracy in determining the precise mass of precursors (the cross-linked species) 
and the product ions (the fragment ions from sequencing of cross-linked peptide and 
oligonucleotide). Orbitrap instruments that carry out fragmentation in HCD mode such as the 
LTQ-Orbitrap Velos, Q Exactive and Q Exactive High Field instruments, were used for MS 
analysis of the protein-RNA cross-linking experiments performed during the course of this 
thesis. The data analysis was carried out using the RNPxl tool [108] implemented in OpenMS 
[115, 116] using OMSSA [117] as the search engine. The detailed description for the data 
analysis workflow has been described in [108].  
Nonetheless, the interpretation of MS data from protein-RNA cross-linking experiments is 
challenging as every MS/MS fragment spectrum for an identified cross-link is manually 
validated. Up to now there has been no suitable software that can handle different features 
observed in fragment spectra of cross-linked heteroconjugates (as depicted in Figure 1.12). 
However the efforts are being made for automated identification of the cross-links in 
collaboration with the group of Prof. Oliver Kohlbacher, University of Tübingen, Tübingen.  
1.2.6.2 Protein-protein cross-linking using chemical cross-linker 
Interactions between different proteins can occur when these proteins co-exist in organized 
structural complexes or during transient encounters for mediating various biological processes. 
In order to derive more information on the spatial proximity and the arrangement of proteins in 
an assembled complex, chemical cross-linkers such as BS3 (Bis(sulfosuccidimidyl)suberate) are 
used which introduce specific and stable chemical linkages (covalent interactions) in the 
otherwise transiently associated proteins.  
BS3 is a widely used homobifunctional cross-linker. It contains two identical functional groups 
i.e., the N-hydroxysulfosuccinimide esters (NHS esters) at both reactive sites connected with a 
carbon chain spacer that bridges the defined distance of 11.4 Å, allowing the identical groups of 
the proteins to be cross-linked. It is water soluble due to the terminal sulfonyl substituents, 
thus excluding the need to use organic solvents that might interfere with protein structure. It is 
amine reactive i.e., the NHS esters at the two ends react specifically with primary amines. It 
targets the primary amines in the side chains of lysine residues on protein’s surfaces for 
targeted protein-protein cross-linking [118] and protein N-termini. It is highly reactive with a 
half-life of 20-30 min at pH 7.5. Therefore the BS3 solution for experimental purposes is always 
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prepared fresh and used immediately. The cross-linking reactions are carried out at room 
temperature and quenched with buffers containing primary amine reagents such as ammonium 
bicarbonate or Tris-HCl to consume the non-reacted cross-linker.  
After cross-linking the complex is hydrolyzed with endoproteinases such as trypsin, to generate 
different types of cross-linked and non-cross-linked peptides as shown in Figure 1.13. The cross-
linked peptides are a very small proportion of the overall mixture of different peptide species 
generated after tryptic digestion [119, 120]. For enrichment, size exclusion chromatography is 
used to separate the cross-linked peptides from linear and non-cross-linked peptides, 
considering the cross-linked peptide will have a higher mass than linear peptides [121]. This 
approach is usually applied for larger complexes. The cross-linking workflow applied for 
investigating the protein-protein interactions in Type I-B Cascade complex from C. 
thermocellum is described in Figure 1.13.  
Alternatively, for smaller complexes (<400 kDa) the cross-linked complex can be separated from 
non-cross-linked proteins using SDS-PAGE. Following which the bands of higher molecular 
weights corresponding to cross-linked complex can be digested [119].  
The cross-linked peptides have higher charge states and higher masses as compared to the 
linear peptides. The analysis of peptide-RNA cross-links by MS requires high resolution at MS1 
level for correct charge determination. The fragmentation can be performed using either CID or 
HCD. Hybrid Orbitrap instruments are often used for the MS analysis of cross-linked peptides 
providing a linear ion trap for CID fragmentation, identifying more number of cross-links and 
determination of fragment masses in the Orbitrap for higher accuracy. The Orbitrap Fusion 
Tribid mass spectrometer (Thermo Fischer Scientific, Schwerte, DE) was used for the analysis of 
protein-protein cross-linking experiments in the course of this thesis. 
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Figure 1.13 Overview of the protein-protein cross-linking workflow. 
Multi-subunit protein complex are cross-linked with chemical cross-linking reagents such as BS3. After cross-linking 
the cross-linked complex is digested with endoproteinases such as trypsin, generating different kinds of cross-
linked and non-cross-linked peptide species. The cross-linked peptides are enriched using size exclusion 
chromatography followed by MS analysis. Adapted from [122] with permission. 
Additionally, the increased sample complexity due to protein-protein cross-linking results in a 
very large search space that requires dedicated algorithms for the analysis of data derived from 
the protein-protein cross-linking experiments. Standard database search engines might not be 
able to handle such advanced algorithms. Data analysis for the identification of cross-links in 
the protein-protein cross-linking experiments reported in this thesis was performed using pLink 
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1.3 CRISPR-Cas systems studied with mass spectrometry 
In this section, the CRISPR-Cas proteins, crRNAs and the crRNP complexes that were 
investigated during the progress of this thesis are briefly described. Quantitative proteomics 
studies were carried out to determine the stoichiometry of Cas protein subunits in different 
Cascade complexes and to perform comparative proteome analysis between a wild type and a 
mutant strain of Haloferax volcanii. Structural proteomics studies were carried out to gain 
insights into the protein – RNA interactions in (i) recombinant Cas proteins and their cognate 
crRNAs and (ii) multi-subunit crRNP complexes, and also protein – protein interactions in multi-
subunit crRNP complexes. An overview of the objectives behind using these particular 
complexes is also discussed here; however the MS approaches are described under section 1.2 
1.3.1 Type I-B CRISPR-Cas system 
The Type I-B system is most commonly found in archaea such as methanogens and halophiles 
and some bacteria such as Clostridia. The characteristic features of this subtype are very similar 
to other Type I subtypes with respect to three stages of the mechanism of CRISPR-Cas action, 
however the composition of Type I-B complex has not been described yet. Here we describe 
some characteristics of Type I-B system in two different organisms, Haloferax volcanii and 
Clostridium thermocellum. Both organisms contain Cas proteins Cas5, Cas6, Cas7 and Cas8b. 
1.3.1.1 Haloferax volcanii Type I-B system 
H. volcanii is a halophilic archaeon that requires high salt concentration for growth. The CRISPR-
Cas system comprises of three different CRISPR loci as shown in Figure 1.14. Two loci are 
located on the chromosomal plasmid pHV4 (locus P1 and P2) and one on the main 
chromosome. The cas genes encoding for Cas protein 1 - 8b are located between the P1 and P2 
loci on the chromosomal plasmid [124, 125].  
 
1. INTRODUCTION  31 
 
 
Figure 1.14 Illustration of the CRISPR loci in H. volcanii. 
 
The CRISPR locus located on the main chromosome comprises of 25 repeats and 24 spacers. No cas genes are 
encoded next to this locus. In addition there are two CRISPR loci are located on the chromosomal plasmid 
pHV4.The cas gene cluster encoding the genes cas1 - cas8b is located between these two loci. Adapted from [126] 
with permission. 
 
Recently it was reported that the H. volcanii Type I-B system consists of Cascade like complex 
comprising at least Cas5, Cas6 and Cas7 proteins along with a crRNA [89]. Also to confirm the 
association of these proteins, a FLAG-tag version of Cas7 was expressed and purified along with 
different interaction partners. The proteins were identified by MS and the stoichiometry of 
these proteins in the complex was determined by using the intensity based absolute 
quantification (iBAQ) approach (Section 1.2.5.2). Also one of the Cas protein genes, cas7, was 
deleted to monitor the changes in the overall proteome upon deletion or mutation of a Cas 
protein. To achieve this, the wild type (WT) and Cas7 knock-out (Cas7KO) strains were 
compared at the proteome level using dimethyl labeling followed by MS analysis (Section 
1.2.5.1). 
1.3.1.2 Clostridium thermocellum type I-B Cascade complex 
The Type I-B complex found in C. thermocellum consists of the same set of Cas proteins like the 
archaeon H. volcanii. The Cascade complex comprising of proteins Cas6, Cas8b, Cas5 and Cas7 
assembled around the crRNA was used to determine the stoichiometry of these Cas proteins in 
the complex using iBAQ approach. Also to go one step further in terms of identifying the 
interaction sites between different Cas proteins in the Cascade complex, we used the protein-
protein cross-linking approach using a chemical cross-linker BS3 as described before under 
section 1.2.6.2.  
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1.3.1.3 Cas6 endonucleases from Clostridium thermocellum and Methanococcus maripaludis 
Cas6 enzymes are one of the most highly diverged families of Cas proteins. Two Cas6 
endonucleases were identified in subtype I-B, in the archaeal and bacterial model organisms, 
M. maripaludis and C. thermocellum. These two Cas6 variants were also investigated for the 
crRNA processing in vitro [127].  
It has been reported that the repeat sequences and Cas6b enzymes of M. maripaludis (archaea) 
and C. thermocellum (bacteria) are very similar [127], indicating a horizontal gene transfer 
event for these CRISPR-Cas systems. Furthermore to compare the two Cas6 enzymes in terms 
of RNA interaction sites, the Cas6b proteins were incubated with deoxy variants of their 
respective cognate crRNAs (deoxy variants, where first unprocessed nucleotide in the crRNA is 
replaced with a deoxynucleotide) to form a crRNP complex. These complexes were then 
analyzed for protein-RNA interactions using UV induced cross-linking and MS (Section 1.2.6.1), 
highlighting the similarities between an archeal and bacterial CRISPR/Cas subtype. 
1.3.2 Type I-E Cascade complex in Escherichia coli 
Recently published crystal structures of 3.03 Å [106] and 3.24 Å resolution [105] and the Cryo-
EM structure of 8-9 Å resolution [43] of the fully assembled, Type I-E Cascade complex of E. coli 
has been a major breakthrough in understanding the crRNA guide-surveillance complex. In one 
of the most extensively studied Cascade complexes, the 61 nucleotide long crRNA assembles 
into a 405 kDa multi-subunit surveillance complex along with eleven Cas proteins with a 
stoichiometry of Cse11Cse22Cas5e1Cas76Cas6e1. The 3’ and 5’ end of the crRNA are at the two 
ends of the complex and are anchored by Cas6e and Cas5e proteins respectively. The 32 
nucleotide long spacer along with six Cas7 proteins forms the helical backbone, giving the 
overall complex a seahorse-shaped architecture (Figure 1.15). 
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Figure 1.15 Crystal structure of E.coli Type I-E Cascade complex. 
Two views of the fully assembled, crRNA bound complex (180° rotation, PDB 1VY8) [105]. As per the stoichiometry 
of the complex, the respective Cas protein subunits are indicated in the crystal structure (Cse1: Blue, two Cse2 
subunits: Violet, six Cas7 subunits: Grey, Cas6e: Green, Cas5e: Orange) with the crRNA (red) in center.  
The pre-assembled complex from E.coli was pulled down with the help of a StrepTag on Cse2 
[29]. Further the protein-RNA cross-linking experiments were carried out on the assembled 
complex to gain deeper insight into the structural organization of the complex, by investigating 
the interactions between different Cas proteins and the crRNA.  
1.3.3 Type III-A Csm complex in Thermus thermophilus 
The Type III-A Csm complex in bacterium T. thermophilus consists of five different protein 
subunits Csm1 – Csm5 and a crRNA of size 35-53 nucleotides. Two models have been proposed 
for the stoichiometry of Csm proteins in the assembled complex: 
Csm11Csm23Csm36Csm42Csm51crRNA1 (model 1, 427.04 kDa complex) or 
Csm11Csm23Csm32Csm44Csm52crRNA1 (model 2, 427.462 kDa complex). The cryoEM structure 
of model 1 is depicted in Figure 1.16). The cryoEM structure of the complex shows a sea worm-
shaped architecture which is strikingly similar to the architecture of Type I-E Cascade complex, 
with the Csm3 protein forming a helical Cas7-like backbone [59].  
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Figure 1.16 Molecular architecture of the T. thermophilus Type III-A Csm complex. 
The CryoEM structure of the Tt Csm complex, reconstructed at 17 Å resolution, showing the “sea worm” 
architecture. Different segmented regions of the complex are indicated with different colors and respective labels: 
Csm1 (purple), Csm2 (red), Csm3 (alternating light blue and gray), Csm4 (green), and Csm5 (orange). Adapted from 
[59] with permission from the publisher. 
The major difference between the T. thermophilus, Csm complex (Tt Csm complex) and the 
E.coli Cascade complex is during the interference step. Unlike Cascade complex, the Csm 
complex has been reported to harbor RNase activity rather than DNase activity under in vitro 
conditions with multiple sites present along the backbone. Interestingly, the Csm complex in T. 
thermophilus catalyzes the cleavage of RNA targets in a similar mechanism like the one 
reported for Type III-B Cmr complex [52, 59, 128]. Here also the protein-RNA interactions were 
investigated using the UV induced protein-RNA cross-linking method. The results were also 
compared with the protein-RNA cross-linking studies done in the E. coli Cascade complex. 
1.3.4 Type III-B Cmr complex in Thermus thermophilus 
The Type III-B Cmr complex in T. thermophilus (Tt Cmr complex) is composed of six different 
subunits Cmr1-Cmr6 and one crRNA in Cmr11Cmr21Cmr31Cmr44Csm53Cmr61:crRNA1 
stoichiometry. Two breakthroughs in understanding the architecture of Type III-B Cmr complex 
have been: i) the sea-worm shaped cryoEM structure of the Tt Cmr complex [52] and ii) a 
pseudo-atomic model of the complex where the crystal structure of individual subunits were 
combined with the previous structural information to generate a cryoEM map of the 
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Pyrococcus furiosus Cmr complex [56] (Figure 1.17). The overall sea-worm shaped architecture 
of TtCmr complex resembles Type I-E Cascade, however the composition is different. It 
comprises of a heterodimer tail of Cmr2 and Cmr3 subunits, a helical backbone of Cmr4 
subunits capped with a Cmr5 subunit and a head comprising of Cmr1 and Cmr6 subunits [52].  
 
 
Figure 1.17 Molecular architecture of the T. thermophilus Type III-B Cmr complex. 
The crystal structure of the Tt Cmr complex, reconstructed at 22 Å resolution, showing the “sea worm” 
architecture. Different segmented regions of the complex are indicated with different colors and respective labels: 
Cmr1/Cmr6 (orange), Cmr2 (purple), Cmr3 (green), Cmr4 (alternating light blue and gray) and Cmr5 (red). Adapted 
from [52] with permission from the publisher. 
The distinct characteristic of Type III-B Cmr system, making it different from all the other 
CRISPR-Cas system is that it targets ssRNA and not DNA. Both endogenous and reconstituted 
Cmr complexes have been used to study the degradation of ssRNA target. The cleavage of 
target RNA starts at the 3’ end with sequential endonucleolytic activity after every six 
nucleotides, proceeding towards the 5’ end, also known as the 5’ ruler mechanism [52]. 
Considering a similar approach we used both endogenous and reconstituted Cmr complexes to 
look for protein-RNA interaction sites using the UV induced protein-RNA cross-linking 
procedure. This way we could also check the reproducibility of our approach in the 
differentially assembled multi-subunit crRNP complexes.  
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1.3.5 The Cas7 protein family 
The Cas proteins have been classified into different families on the basis of their sequences and 
functions. As mentioned above, the different Cas7 proteins are a characteristic feature of Type I 
and Type III systems, forming the backbone of the large multi-subunit interference complexes. 
The Cas7-family proteins belong to the RAMP superfamily comprising a highly conserved RRM 
domain and having a distinct nomenclature in every subtype (Table 1.1). Recently published 
crystal structures of Cas7 proteins from different subtypes indicate it is one of the most 
frequently investigated Cas protein for structural studies, at the same time highlighting a 
structural homology between different Cas7 proteins.  
The overall architecture of these Cas7 proteins comprises of four domains, the core domain 
which has a β-α-β-β-α-β topology typical of RRM-like and ferredoxin-like folds and three 
insertion domains (a lid domain, a metal binding domain and a helical domain) flanking the core 
domain. The core domain is highly conserved within the three proteins and the topology of the 
insertion domains also show striking similarities [103] (Figure 1.18). 
 
Figure 1.18 Comparison between the topology of three Cas7-family proteins Tp Csc2, Ss Csa2 and Mk 
Csm3. 
The highly conserved core domain is highlighted in the center (grey) also showing the connectivity with three 
insertion domains. The topological arrangement of the three insertion domains is also similar in the three proteins. 
Adapted from [103] with permission from the publisher. 
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Some of these examples include: the 2.4 Å resolution crystal structure of Type III-A 
Methanopyrus kandleri Csm3 (Mk Csm3) [55], 2.0 Å resolution structure of Type I-A Sulfolobus 
solfataricus Csa2 (Ss Csa2) [19] and 1.8 Å resolution structure of Type I-D Thermofilum pendens 
Csc2 (Tp Csc2) [103]. The topology diagrams of these three proteins show a high structural 




Figure 1.19 Crystal structures of the three Cas7-family proteins: Tp Csc2, Ss Csa2 and Mk Csm3.  
Cartoon representation of the recently published crystal structures of Cas7 orthologs depicted after 
superimposition of their RRM-like domains. Tp Csc2 (salmon) (PDB 4TXD) [103], Ss Csa2 (orange) (PDB 3PS0) [19] 
and Mk Csm3 (blue) (PDB 4N0L) [55].  
In order to identify the RNA-binding interface of Cas7 proteins, we used UV induced protein-
RNA cross-linking approach. Two Cas7 proteins, T. pendens Csc2 and Thermoproteus tenax Cas7 
were used for this study. Moreover the results were also compared with the cross-links 
identified in other Cas7 homologs: Cas7 protein in Type I-E Cascade complex and Csm3 protein 
in Type III-A Csm complex to look for putative RNA-protein interfaces in structurally conserved 































2. Materials and Methods 
2.1 Materials 
2.1.1 Chemicals and Solvents 
Acetone Merck, Darmstadt, DE 
Acetonitrile, LiChrosolv (ACN) Merck, Darmstadt, DE 
Ammonium Hydroxide 28-30% (w/v) Acros Organics, New Jersey, USA 
Ammonium persulfate Serva Electrophoresis, Heidelberg, DE 
BS3 (bis(sulfosuccinimidyl)suberate) Pierce, Thermo Fischer, Schwerte, DE 
Chloroform Merck, Darmstadt, DE 
Coomasie Brilliant Blue G-250   Sigma-Aldrich, Steinheim, DE 
Dihydroxybenzoic acid (DHB) Sigma- Aldrich, Steinheim, DE 
Dimethylsulfoxide (DMSO)  Roth, Karlsruhe, DE 
Dithiothrietol (DTT) Roth, Karlsruhe, DE 
Dodecyl sulfate sodium salt (SDS) Merck, Darmstadt, DE 
Ethanol Merck, Darmstadt, DE 
Ethylenediaminetetraacetic acid,  
(EDTA, disodium salt) 
Roth, Karlsruhe, DE 
Formic acid (FA) Fluka, Sigma- Aldrich, Steinheim, DE 
Formaldehyde (CH2O) 37% (v/v) Sigma-Aldrich, Steinheim, DE 
Formaldehyde (CD2O) 28% wt., 98%D Isotec, Miamisburg, OH, USA 
Glycogen Roche, Mannheim, DE 
Glycerol Merck, Darmstadt, DE 
Hepes Merck, Darmstadt, DE 
Iodoacetamide (IAA)  Sigma-Aldrich, Steinheim, DE 
Magnesium chloride  Merck, Darmstadt, DE 
Methanol, Lichrosolv Merck, Darmstadt, DE 
n-Hexane Merck, Darmstadt, DE 
Ortho-phosphoric acid Merck, Darmstadt, DE 
RapiGest Waters, Manchester, UK 
Sodium acetate Merck, Darmstadt, DE 
Sodium chloride Merck, Darmstadt, DE 
Sodium cyanoborohydride (NaBH3CN) Fluka, Sigma- Aldrich, Steinheim, DE 
N,N,N’,N’-tetramethylenethyldiamide (TEMED) Sigma-Aldrich, Steinheim, DE 
TFA (trifluoroacetic acid) Roth, Karlsruhe, DE 
TRIS tris(hydroxymethyl)aminomethane Roth, Karlsruhe, DE 
Urea Sigma-Aldrich, Steinheim, DE 
Universal Protein Standard 2 (UPS2) Sigma-Aldrich, Steinheim, DE 
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2.1.2 Commercial buffers and solutions 
Acrylamide/Bis-acrylamide, Rotiphorese Gel 
30 (37.5:1) 
Roth, Karlsruhe, DE 
Bradford solution Bio-Rad Protein Assay, Bio-Rad, Munich, DE 
Imperial protein stain 
IPG ampholytes buffer 
Pierce, Thermo Fischer, Schwerte, DE 
GE Healthcare, Munich, DE 
NuPAGE Antioxidant Invitrogen, Karlsruhe, DE 
NuPAGE LDS sample buffer (4X) Invitrogen, Karlsruhe, DE 
NuPAGE MOPS SDS running buffer (10X) Invitrogen, Karlsruhe, DE 
NuPAGE Sample reducing agent (10X) Invitrogen, Karlsruhe, DE 
PCI solution (phenol/chloroform/isoamyl 
alcohol 25:24:1) 
Roth, Karlsruhe, DE 
PNK buffer (10X) New England Biolabs, Frankfurt, DE 
Protein marker, Precision Plus (Unstained) Bio-Rad, Munich, DE 
Triethylammonium bicarbonate buffer 
(TEAB) 1.0 M, pH 8.5 ± 0.1 
Sigma-Aldrich, Steinheim, DE 
 
2.1.3 Enzymes and Enzyme inhibitors 
Benzonase Novagen, EMD Chemicals, CA, USA 
Protease inhibitors, EDTA free Roche, Mannheim, DE 
RNase A Ambion, Applied Biosystems, Darmstadt, DE 
RNase T1 Ambion, Applied Biosystems, Darmstadt, DE 
T4 polynucleotide kinase (T4 PNK) New England Biolabs, Frankfurt, DE 
Trypsin, modified (sequencing grade) Promega, Madison, WI, USA 
Trypsin Serva Electrophoresis, Heidelberg, DE 
 
2.1.4 Proteins, peptides and oligonucleotides  
ATP, [ϒ-32P]-labeled PerkinElmer, Waltham, MA, USA 
BSA standard, Bradford Thermo Fischer, Schwerte, DE 
d(-1) repeat M. maripaludis: 
5'-CUAAAAGAAUAACUUGCAAAAUAACA 
AG(dC)AUUGAAAC-3' 
MWG, Eurofins Genomics, Ebersberg, DE 
d(-1) repeat C. thermocellum: 
5'-GUUUUUAUCGUACCUAUGAGG(dA)AU 
UGAAAC-3' 
MWG, Eurofins Genomics, Ebersberg, DE 
poly(U)15  Purimex, Grebestein, DE 
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2.1.5 CRISPR proteins and protein – RNA complexes for quantitative and structural 
proteomics studies 
Proteins and protein – RNA complexes Provided By 
For quantitative proteomics studies 
H. volcanii (H119 WT and H119 ∆Cas7) 
protein extract  
Britta Stoll, Prof. Anita Marchfelder, Ulm 
University, Ulm, DE 
H. volcanii FLAG-Cas7 purified fraction with 
Cas5 and Cas6 proteins co purified. 
Jutta Brendel, Prof. Anita Marchfelder, Ulm 
University, Ulm, DE 
C. thermocellum Type I-B Cascade complex Judith Zöphel, Prof. Lennart Randau, MPI 
Terrestrial Microbiology, Marburg, DE 
For structural proteomics studies 
M. maripuldis Cas6b and C. thermocellum 
Cas6  
Hagen Richter, Prof. Lennart Randau, MPI 
Terrestrial Microbiology, Marburg, DE 
T. tenax Cas7 and T. pendes Csc2 Ajla Hrle, Prof. Elena Conti, MPI 
Biochemistry, Martinsried, DE 
C. thermocellum Type I-B Cascade complex Judith Zöphel, Prof. Lennart Randau, MPI 
Terrestrial Microbiology, Marburg, DE 
E.coli Type I-E Cascade complex Tim Kunne, Dr. Stan Brouns, Wageningen 
Univesity, NL 
T. thermophilus Type III-A Csm Complex 
(endogenous) 
Raymond Staals, Prof. Jon van der Oost, 
Wageningen Univesity, NL 
T. thermophilus Type III-B Cmr Complex 
(both endogenous and reconstituted) 
Raymond Staals, Yifan Zhou, Prof. Jon van 
der Oost, Wageningen Univesity, NL 
2.1.6 Commonly used buffers and solutions 
10 mM DTT  1.54 mg/ml DTT in water (prepared fresh) 
60 mM IAA  11.3 mg/ml IAA in water (prepared fresh, 
kept in dark) 
1 M Tris-HCl buffer, pH 7.9 Tris base, desired pH adjusted with 37% 
(v/v) HCl 
8M Urea  9.6g Urea in 12.8 ml water, Filtered 
(prepared fresh) 
BS3 Stock solution 2 mg BS3, 100 µl DMSO (prepared fresh) 
Colloidal Coomasie staining solution 0.08% (w/v) Coomasie Brilliant Blue G-250 
20% (v/v) Methanol 
1.6% (v/v) Orthophosphoric acid 
8% (w/v) Ammonium sulfate 
CE Buffer 10 mM Cacodylic acid pH 7.0,  
0.2 mM EDTA pH 8.0 
LC-MS Sample Loading buffer 5% (v/v) acetonitrile, 0.1% (v/v) formic acid 
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SDS Resolving gel buffer 4x 1.5 M Tris-HCl, pH 8.8 
SDS Stacking gel buffer 4x 0.5 M Tris-HCl, pH 6.8 
SDS Running buffer 1X 25mM Tris, 192 mM Glycine, 0.1% (w/v) SDS 
SDS Sample buffer 60 mM Tris, 1 mM EDTA, 16% (v/v) 
Glycerine, 2% SDS, 0.1% (w/v) Bromophenol 
blue, 50 mM DTT 
  
2.1.7 Other consumables 
C18 Column Material  
• Reprosil-Pur basic C18-HD, 120 Å, 3 or 
5µm 
Dr. Maisch, Ammerbuch, DE 
C18 Empore Octadecyl 47 mm Extraction 
Discs  
3M, Bellefonte, PA, USA 
IPG Strip 7 cm and 18 cm GE Healthcare, Munich, DE 
IPG Dry Strip cover fluid, Plus One  Pharmacia Biotech, Uppsala, Sweden 
IPG Strip Holders for 7 cm and 18 cm strips GE Healthcare, Munich, DE 
IPG Strip Holder cleaning solution GE Healthcare, Munich, DE 
Microtiterplates for UV cross-linking 
• Black polypropylene 96-well microtiter 
plates (#655209) 
Greiner Bio-One, Frichenhausen, DE 
MicroSpin Columns G-25 (for RNA isolation) GE Healthcare, Munich, DE 
NuPAGE Novex 4-12% Bis-Tris Mini Gels, 
1mm 
Invitrogen, Karlsruhe, DE 
Phosphoimager Screens 
•  Storage Phosphor Screens 
Molecular Dynamics, GE Healthcare, 
Munich, DE 
Sep-Pak Vac C18 Columns Waters, Eschborn, DE 
Superdex 200 PC 3.2/30 
Superdex 75 PC 3.2/30 
Superdex Peptide PC 3.2/30 
GE Healthcare, Munich, DE 
GE Healthcare, Munich, DE 
GE Healthcare, Munich, DE 
Titanium dioxide TiO2 Column Material 
• Titansphere 5 µm 
GL Sciences, Tokyo, JP 
 
Whatman 3mm, CHR GE Healthcare, Munich, DE 
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2.1.8 Instruments and Laboratory equipments 
Autoclave, Varioklav steam sterilizer H+P  Thermo Fisher Scientific, Schwerte, DE 
Centrifuges 
• Eppendorf Centrifuge 5415R 
• Heraeus Fresco 17 
• Heraeus Pico 17 
• Heraeus Biofuge pico 
• Heraeus Megafuge 1.0 R  
 
Eppendorf, Hamburg, DE 
Thermo Fisher Scientific, Schwerte, DE 
Thermo Fisher Scientific, Schwerte, DE 
Thermo Fisher Scientific, Schwerte, DE 
Thermo Fisher Scientific, Schwerte, DE 
Clean Bench, HeraSafe, Heraeus Thermo Fisher Scientific, Schwerte, DE 
Cross-linking Apparatus (Build In-house) 
operated with four 8W lamps, 254 nm, G8T5 
  
Sankyo Denki, Japan 
Gel Dryer Model 583 Bio-Rad, Munich. DE 
IPGphor for pIEF Pharmacia Biotech, San Francisco, CA, USA 
LC-MS 
• HPLC, 1100 series 
• Dionex, Ultimate 3000 UHPLC 
• LTQ Orbitrap XL 
• LTQ Orbitrap Velos 
• Q Exactive HF 
• Orbitrap Fusion 
 
Agilent Technologies, Böblingen, DE 
Thermo Fisher Scientific, Schwerte, DE 
Thermo Fisher Scientific, Schwerte, DE 
Thermo Fisher Scientific, Schwerte, DE 
Thermo Fisher Scientific, Schwerte, DE 
Thermo Fisher Scientific, Schwerte, DE 
Thermomixer Comfort 
ThermoStat plus 
Eppendorf, Hamburg, DE 
Eppendorf, Hamburg, DE 
Pharmacia SMART system Pharmacia, GE Healthcare, Munich, DE 
Phosphoimager, Typhoon 8600 GE Healthcare, Munich, DE 
Scintillation Counter, Tri-Carb 2100TR Packard, PerkinElmer, Waltham, MA, USA 
Spectrophotometer, Ultrospec, 3000 pro Pharmacia, GE Healthcare, Munich, DE 
SpeedVac Concentrator 
• Savant SPD121P 
• Eppendorf Concentrator 5301 
 
Thermo Fisher Scientific, Schwerte, DE 
Eppendorf, Hamburg, DE 
Vortex Genie 2 Scientific Industries, Roth, Karlsruhe, DE 
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2.2 Methods 
 
2.2.1 Cell culture, expression and purification of proteins and protein – RNA 
complexes 
2.2.1.1 Protein extracts for quantitative proteome analysis of H. volcanii wild type and cas7 
knock out  
The following steps for generating the cas7 KO strain and preparation of protein extracts for 
proteome analysis were performed by Britta Stoll, in the lab of Prof. Anita Marchfelder, Ulm 
University, Ulm, DE. 
H. volcanii strain Special features for auxtrophic selection [129] 
H119 wild type (H119 WT) DS70 Wildtype (∆pHV2) ∆pyrE2 ∆trpA ∆leuB 
Cas7 knock out (∆cas7 KO) DS70 Wildtype (∆pHV2) ∆pyrE2 ∆trpA ∆leuB ∆cas7 
The cas7 gene was knocked out by transformation of H119 WT using the Pop In/ Pop Out 
method [130] and the knockouts were verified with PCR and Southern blot. The method for 
generation of knock out strains and preparation of protein extracts has been described 
previously in [126]. Briefly, the cells were grown in YPC medium and harvested and washed in 
ice-cold salt-water. The cells were lysed in Sodium Taurodeoxycholate (0.006% final 
concentration) and the insoluble cell components were separated with ultracentrifugation. The 
supernatant (extract) was dialyzed (in 10 mM Tris-HCl, 6 mM MgCl2, pH 7.5) overnight and was 
treated with DNase1, Exonuclease III and RNaseA. The extract was further dialyzed (in 2 mM 
Tris-HCl, pH 7.5) overnight. The proteins were precipitated from the extract with 100% acetone 
(at -20 °C overnight), washed with ice-cold 80% (v/v) ethanol and frozen in liquid nitrogen and 
stored at -80 °C.  
2.2.1.2 Expression and purification of H. volcanii Cas5, Cas6 and Cas7 proteins for iBAQ 
analysis 
The following steps were performed by Jutta Brendel, in the lab of Prof. Anita Marchfelder, Ulm 
University, Ulm, DE. Further details for every step have been described in [89]. Briefly, H. 
volcanii strain H26∆casCluster28 (with no cas genes at all) [129] carrying a Haloferax-
overexpression-vector comprising cas-genes cas6, cas8, cas7 and cas5 was used in this study. 
The cas7 was fused to a combined His-and-FLAG-tag for purification [89]. To express the tagged 
Cas7 protein, the cells were grown in Hv-Ca medium (enhanced casamino broth) containing 
tryptophan. The cells were harvested and lysed (in 1 M NaCl, 100 mM Tris-HCl, pH 7.5, 1 mM 
EDTA, 10 mM MgCl2, 1 mM CaCl2, 8 units/μl DNase RQ1, 13 μl/ml protease inhibitor mixture) by 
sonification. Insoluble cell debris was removed by ultracentrifugation. The 3×FLAG tagged 
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protein was purified using the anti-FLAG M2 affinity gel (Sigma-Aldrich, Steinheim, DE). The 
final elution was performed using the 3×FLAG peptide (Sigma-Aldrich, Steinheim, DE). This 
FLAG-Cas7 purified fraction comprising co-purified Cas5 and Cas6 proteins was used for the 
iBAQ analysis. 
2.2.1.3 Expression and purification of M. maripaludis Cas6b and C. thermocellum Cas6b  
The following steps were performed by Hagen Richter, in the lab of Prof. Lennart Randau, MPI 
Terrestrial Microbiology, Marburg, DE. The details for expression and purification of M. 
maripaludis Cas6b have been described in [127]. Briefly, the respective cas6 genes were cloned 
into pET-20b vector for the protein expression with a C-terminal His-tag. To generate Cas6 
variants, mutations were induced using site-directed mutagenesis. These Cas6 variant proteins 
were expressed in E. coli (Rosetta2 DE3) cells with IPTG induction. After induction the cells were 
harvested and lysed ( in 10 mM Tris–HCl pH 8.0, 300 mM NaCl, 10% (v/v) glycerol and 0.5 mM 
DTT) with lysozyme (1 mg/g cell pellet) using sonication. The lysate was cleared with 
centrifugation and the supernatant was applied to a Ni–NTA–Sepharose column for 
purification. Elution of the proteins was performed by a linear imidazole gradient (0–500 mM) 
and the purified proteins were dialyzed into lysis buffer (without glycerol) and used for further 
analysis. 
2.2.1.4 Expression and purification of T. tenax Cas7 and T. pendens Csc2 
The following steps were performed by Ajla Hrle, in the lab of Prof. Elena Conti, MPI 
Biochemistry, Martinsried, DE. The details for expression and purification of T. pendens Csc2 
and T. tenax Cas7 have been described in [103, 131]. Briefly, the gene construct for T. tenax 
Cas7 was cloned in pET24a (+) and the gene for T. pendens Csc2 was ordered as a synthetic 
construct (GeneArt, Life technologies). The full-length proteins were expressed as a 
recombinant His-SUMO-tagged using E. coli BL21-Gold (DE3) Star pRARE cells (Stratagene). The 
cells were harvested and lysed in 50 mM Tris-HCl, pH 7.5, 1 M NaCl, 10 mM imidazole and 10% 
glycerol, supplemented with protease inhibitors. The lysate was cleared with centrifugation and 
the supernatant was applied to Ni2+ affinity chromatography and further a HiTrap Heparin 
column (GE Healthcare) for purification. The proteins were treated with SUMO protease for the 
removal of His-tag. Final purification was performed on a Superdex 75 column using 20 mM 
Hepes pH 7.5, 150 mM NaCl and 5 mM DTT and 10% glycerol.  
2.2.1.5 Preparation of E.coli Type I-E Cascade complex 
The following steps were performed by Tim Künne, in the lab of Dr. Stan J. J. Brouns, 
Wageningen University, Wageningen, NL. The details for the assembly and purification of Type 
I-E Cascade complex from E. coli have been described in [29, 30, 44]. Briefly, the cas genes and 
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CRISPRs were PCR amplified from E. coli K12 genomic DNA and directionally cloned into 
compatible expression vectors as described in [29]. The Plasmids were transformed into E. coli 
BL21 (DE3) lacking endogenous cas genes. Cells were harvested, resuspended in lysis buffer (20 
mM Hepes, 75 mM NaCl, 1 mM DTT, pH 7.5) and disrupted using a French Pressure Cell. The 
pre-assembled complex was pulled down using the Strep-Tactin column (IBA, Germany) 
following manufacturer’s instructions using different elution buffer (20mM Hepes, 75mM NaCl, 
1mM DTT, 2.5 mM (Desthiobiotin).  
2.2.1.6 Preparation of T. thermophilus Type III-A Csm complex 
The following steps were performed by Raymond Staals, in the lab of Prof. John van der Oost, 
Wageningen University, Wageningen, NL. The details for the assembly and purification of Type 
III-A Csm complex from T. thermophilus are described in [59]. Briefly, the C-terminal (His)6-
tagged Csm5 was produced by inserting the tag-coding sequence within the genome of T. 
thermophilus HB8 by homologous recombination using pUC-csm5h plasmid. The cells were 
resuspended in lysis buffer (20 mM Tris-HCl, pH 8.0, 50 mM NaCl, 0.1 mM phenylmethylsulfonyl 
fluoride) and disrupted by sonication. The lysate was separated by ultracentifugation, and the 
supernatant was applied to a series of columns in a sequential manner for purification and 
desalting. The columns used included: HisTrap HP column (GE Healthcare), HiPrep 26/10 
desalting column (GE Healthcare), RESOURCE Q column (GE Healthcare), HiLoad 16/60 
Superdex 200 pg column (GE Healthcare), HiPrep 26/10 desalting column, HiTrap Heparin 
column (GE Healthcare), HiPrep 26/10 desalting column and finally CHT2-1 column (Bio-Rad 
Laboratories, Inc.). The final purified complex was resuspended in 20 mM Tris-HCl, pH 8.0, 150 
mM NaCl. 
2.2.1.7 Preparation of T. thermophilus Type III-B Cmr complex 
The following steps were performed by Yifan Zhu and Raymond Staals, in the lab of Prof. John 
van der Oost, Wageningen University, Wageningen, NL. The details for assembly and 
purification of Type III-B Cmr complex from T. thermophilus are described in [52]. Briefly, The C-
terminal (His)6-tagged Cmr6 was produced by inserting the tag-coding sequence within the 
genome of T. thermophilus HB8 by homologous recombination using pUC-cmr6h plasmid. The 
cells were resuspended in lysis buffer (20 mM Tris-HCl, pH 8.0, 50 mM NaCl, 0.1 mM 
phenylmethylsulfonyl fluoride) and disrupted by sonication. The lysate was separated by 
ultracentifugation, and the supernatant was applied to a series of columns in a sequential 
manner for purification. The columns used included: HisTrap HP column (GE Healthcare), 
HiPrep 26/10 desalting column (GE Healthcare), RESOURCE Q column (GE Healthcare) and 
finally, HiLoad 16/60 Superdex 200 pg column (GE Healthcare). The final purified protein-
complex was resuspended in 20 mM Tris-HCl, pH 8.0, 150 mM NaCl.  
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For the reconstituted Cmr complex, cmr1, cmr2, cmr3, cmr4, cmr5, and cmr6 genes were each 
amplified by genomic PCR. Each recombinant protein was expressed in E. coli by means of pET-
expression system (Merck). The purified proteins were then mixed in vitro with the crRNA in 
the required stoichiometry. 
2.2.1.8 Preparation of C. thermocellum Type I-B Cascade complex  
The following steps were performed by Judith Zöphel, in the lab of Prof. Lennart Randau, MPI 
Terrestrial Microbiology, Marburg, DE. The Cas5-SUMO, Cas6-HIS, Cas7-SUMO and Cas8b-HIS 
proteins were expressed as described in [127, 131] and purified with a Nickel-NTA column. The 
elution was carried out with a linear imidazole gradient of 0-500 mM imidazole. Cas5 and Cas7 
were dialyzed together with SUMO-protease (since both proteins contain a N-terminal SUMO-
tag that needs to be cleaved off) overnight. Cas8b was further purified using a Heparin column 
(as it was highly contaminated with nucleic acids) and the elution was carried out with a linear 
salt gradient of 0-1 M NaCl [127]. In order to generate the crRNA, a substrate consisting of 
Spacer-Repeat-Spacer-Repeat-Spacer was cloned in puc19. The precursor RNA was generated 
via in-vitro transcription using the linearized vector [127] and was cleaved with Cas6 protein to 
generate the crRNA.  
For the assembly, Cas6 protein along with crRNA, was mixed with Cas 8b and the dialyzed Cas7 
and Cas5 proteins and incubated at 50°C for 30 min. 
2.2.2 Standard molecular biology methods 
2.2.2.1 PCI extraction 
In order to separate the nucleic acids from proteins, phenol-chloroform-isoamylalcohol (PCI) 
extraction was used. The sample was mixed with 1 volume of PCI solution and 1 μl of 1 μg/μl 
glycogen followed by vigorous shaking for 15 min. The sample was then centrifuged for 5 min, 
13000 rpm at room temperature. The upper aqueous phase containing the nucleic acids, was 
transferred into a fresh tube. This aqueous phase was further purified with addition of 1 
volume of chloroform, followed by vigorous shaking and phase separation as mentioned above. 
Again the upper phase was collected and the nucleic acids were recovered from this aqueous 
mixture by ethanol precipitation. 
2.2.2.2 Ethanol precipitation 
Proteins, nucleic acids or RNP complexes were precipitated by the addition of 3 volumes of ice 
cold (-20 °C) ethanol and 1/10 volume of 3 M NaOAc pH 5.3 and incubation at -20 °C for at least 
2 h. The precipitated sample was then centrifuged for 30 min at 13000 rpm and 4 °C and the 
supernatant was removed with thin tips. The pellet was washed with 2 volumes of 80% ice cold 
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(-20 °C) ethanol and centrifuged as above. The supernatant was removed and the pellet was 
dried in a SpeedVac concentrator only for a short duration until all the solvent was gone. 
2.2.2.3 5’ labeling of RNA with γ-[32P]-ATP 
RNA oligonucleotides were labeled at the 5’ end with γ-[32P]-ATP and T4 polynucleotide kinase 
(PNK). The reaction mixture comprised of 5 pmol of RNA oligo, 1 μl of 10X PNK buffer, 5 μl γ-
[32P]-ATP and 1 μl of T4 polynucleotide kinase and the final volume was made up to 10 μl with 
water. This mixture was incubated at 37 °C for 1 h. After the reaction, 40 μl CE buffer were 
added to the mixture and free γ-[32P]-ATP was removed by loading the mix on a G-25 MicroSpin 
column, followed by centrifugation at 3000 rpm for 2 min. To the elute, 150 μl CE buffer and 1 
μl glycogen were added and the RNA was purified with PCI extraction (see 2.2.2.1). Final RNA 
pellet was dissolved in CE buffer. 
2.2.3 Standard protein biochemical methods 
2.2.3.1 Determination of Protein concentration 
Protein concentrations were determined by using the Bradford protein assay [132]. The protein 
sample was diluted with water to make a final volume of 800 μl, followed by the addition of 
200 µL Bradford solution. The mix was kept in dark, for 10 min at room temperature and the 
absorbance was measured at 595 nm. The protein concentration was determined by 
comparison with a standard curve. For this purpose a standard curve was determined for a 
standard dilution series of BSA 0-20 µg using BSA standard stock solution (0.2 mg/mL), to which 
the Bradford solution was added. Three independent measurements of three different protein 
concentrations were performed for the same protein sample and averaged to determine the 
final protein concentration. 
2.2.3.2 Denaturing polyacrylamide gel electrophoresis using NuPAGE system  
Proteins were separated using the NuPAGE system according to the manufacturer’s protocols. 
Briefly, the protein samples were mixed with 10X NuPAGE sample reducing agent, 4X NuPAGE 
sample buffer heated for 10 min at 70 °C. Running buffer was prepared by diluting 20X NuPAGE 
MOPS SDS running buffer. Samples were loaded onto pre-cast 4-12% Bis-Tris 1.0 mm gels and 
run for 50 min at 200V with the addition of NuPAGE antioxidant in the center buffer chamber. 
2.2.3.3 Denaturing polyacrylamide gel electrophoresis using self-cast gels 
The protein separation was performed using self-cast gels, samples were mixed with the SDS 
sample buffer in 1:1 ratio (v/v) and heated at 95 °C for 2 min prior to loading. Both stacking and 
resolving gels were prepared using the recipe below. Gels were run with 1X SDS buffer at 28 mA 
for stacking and 45 mA during protein separation in resolving gel. 
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H2O 6.1 ml 3.1 ml 
Acrylamide/Bis-acrylamide 1.3 ml 4 ml 
4x buffer 2.5 ml 2.5 ml 
10% SDS 100 μl 100 μl 
10% APS 100 μl 100 μl 
TEMED 10 μl 10 μl 
 
2.2.3.4 Colloidal Coomassie staining 
The proteins separated by SDS-PAGE were stained with colloidal coomassie [133]. The gel was 
covered in colloidal coomassie staining solution and incubated overnight with gentle shaking. 
The destaining was performed with several wash and rinse cycles with water. For fast staining, 
the gel was incubated with Imperial protein stain for 30 min and destained the same way as 
mentioned above.  
2.2.4 Quantitative proteomics by differential isotope labeling   
Quantitative proteome analysis of H. volcanii wild type and cas7 knock out (H119 WT vs H119 
∆cas7) was carried out using the dimethyl labeling approach. Protein extracts were digested in 
the presence of 8M Urea. The sample was free of any primary-amine containing molecules, 
other than the peptides, to achieve maximum labeling efficiency. The peptide mixture was then 
separated into fractions using peptide isoelectric focusing to overcome the high complexity of 
sample prior to MS analysis.  
2.2.4.1 In-solution digestion in presence of 8M Urea 
The dried protein pellets or protein complexes were dissolved in 20 µl 8 M Urea, with vigorous 
shaking for 30 min at 25 °C. The disulfide bridges in proteins were reduced with addition of 1 µl 
200 mM DTT (in 100 mM TEAB), followed by incubation for 1 h at 600 rpm in a thermomixer at 
25 °C. Further, the –SH groups were alkylated with addition of 1 µl 1.2 mM IAA (in 100 mM 
TEAB), followed by incubation as in the previous step. The reaction mixture was taken to a final 
volume of 200 µl with 100 mM TEAB and modified trypsin was added in a 1:40 w/w ratio for 
overnight hydrolysis at 600 rpm in a thermomixer at 25 °C. 
2.2.4.2 Dimethyl labeling of peptides from In-solution digestion  
The peptides were labeled with dimethyl labeling as described in [84] with slight modifications. 
To the in-solution digested mix from above, the dimethyl labeling reagents were added directly 
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and all the steps for labeling were carried out in a fume hood. To generate light dimethylation 8 
µl of 4% (v/v) formaldehyde and to generate medium dimethylation 8 µl of 4 % (v/v) CD2O 
(heavy formaldehyde) was added to the sample. The samples were mixed with gentle 
vortexing, followed by addition of 8 µl of 0.6 M NaBH3CN and incubation in a fume hood for 1 h 
at 600 rpm (in a thermomixer) at 17 °C. The labeling reaction was quenched by addition of 32 µl 
of 1 % (v/v) Ammonia solution. After mixing and spinning the solutions down, 10 µl formic acid 
was added to further quench the reaction and to acidify the samples for further steps. Both 
light and medium labeled samples were then pooled in a 1:1 ratio. 
2.2.4.3 Desalting with Sep-Pak Vac C18 column 
Desalting was carried out in Sep-Pak Vac C18 column placed in a 15 ml falcon. All washing, 
loading and elution steps were performed by centrifugation at 500 g for 1 min. The column was 
equilibrated successively by passing 500 µl of methanol, 500 µl of 80% (v/v) ACN, 1.0% (v/v) FA 
and 500 µl of 1.0% (v/v) FA. The pooled sample after dimethyl labeling was loaded onto the 
column, followed by washing the column twice with 500 µl of 1.0% FA. The peptides were 
eluted with 500 µl of 80% ACN, 1.0% FA in a fresh 15 ml falcon. The elute was dried in a 
SpeedVac concentrator. 
2.2.4.4 Peptide iso-electric focusing (pIEF) and LC-MS/MS analysis 
The pIEF was performed using 18cm IPG strips (pH 3-10). The dried peptides were dissolved in 
350 µl 8 M Urea, 0.2% (v/v) IPG ampholytes buffer and the peptide solution was pipetted into 
the middle of an 18 cm strip holder, between the electrodes in a drop wise manner. The IPG 
strip was placed on top (gel facing the electrodes) and it was covered with 1.5 ml IPG Dry Strip 
cover fluid. The gel was left to rehydrate over night at 20 °C without applied voltage. Following 
the rehydration, the peptides were separated on an IPGPhor for a total of 30,000 Vh at max 50 
µA per strip. The following parameters were used: 500 Vh at 500 V, then 1750 Vh at a gradient 
from 500 V to 3000 V and 27750 Vh at 8000V, all the steps were performed at 20 °C. 
Immediately after pIEF, the IPG strip was removed and immersed in n-hexane for 10 sec to 
remove excessive cover fluid. Afterwards, the gel on the strip was manually cut into 18 slices (1 
cm each) and each slice was further cut into three small pieces before putting in reaction tubes. 
The peptides were extracted from these slices in a sequential manner at 26 °C, 1050 rpm with 
30 min for each step. Gel slices were subjected to a series of extraction steps with 50% (v/v) 
ACN, 1% (v/v) FA and 100% (v/v) ACN, 1% (v/v) FA and the supernatant from each step was 
pooled in a reaction tube and dried in a SpeedVac. 
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2.2.4.5 C18 Desalting and LC-MS/MS analysis 
The desalting and removal of interfering substances was performed using STAGE-Tips as 
described in [134] with two C18 discs. The eluted peptides were dried in a SpeedVac until all 
the solvent was removed. The dried peptides were frozen at -20 °C.  
Before submission for MS analysis the samples were dissolved in 20 µl LC-MS sample loading 
buffer. For every slice 5 out of 20 µl was injected into the LTQ Orbitrap XL (details under Section 
2.2.8). The data analysis was performed using MaxQuant software (details under Section 
2.2.9.1). 
2.2.5 Absolute quantification using iBAQ  
The iBAQ analysis was performed to determine the stoichiometry of Cas proteins in Type I-B 
Cascade complexes from H. volcanii and C. thermocellum respectively.  
The in-solution digestion was performed using 1 µg of protein sample, mixed with UPS2 protein 
mix in a 1:1 (w/w) ratio, in 10 µl 1% (w/v) Rapigest (in 100 mM TEAB). In order to reduce 
disulfide bridges, 10 µl of 10 mM DTT (in 100 mM TEAB) was added, and the sample was 
incubated for 1 h at 600 rpm. In order to alkylate –SH groups, 10 µl of 60 mM IAA (in 100 mM 
TEAB) was added and incubated as in the previous step. The reaction mixture was taken to a 
final volume of 100 µl with 100 mM TEAB and modified trypsin was added in a 1:20 w/w ratio 
for overnight hydrolysis at 600 rpm in a thermomixer at 37 °C. After overnight proteolysis, 20 µl 
5% (v/v) TFA was added to decompose the Rapigest. Samples were centrifuged at 13000 rpm 
for 30 min and the supernatant was transferred to a new tube, dried in a SpeedVac and either 
stored at -20 °C or directly dissolved in 20 µl LC-MS sample loading buffer. 
For the LC-MS analysis, the dissolved sample was measured in three technical replicates of 5 µl, 
in a LTQ Orbitrap Velos (Section 2.2.8). The data analysis was performed using iBAQ function in 
MaxQuant software (Section 2.2.9.2). 
2.2.6 UV induced protein-RNA cross-linking 
The UV induced cross-linking was performed with recombinant RNA-binding proteins and their 
(cognate) RNA oligonucleotides and also with the endogenous protein-RNA complexes isolated 
from prokaryotic cells 
2.2.6.1 UV induced cross-linking of γ-[32P]-ATP labeled crRNA and Cas6b proteins 
The single stranded crRNA oligonucleotide (5 pmol) was radiolabeled with γ-[32P]-ATP (6000 
Ci/mmol) following standard procedures (Section 2.2.2.3). The resulting labeled RNA was 
incubated for 30 min on ice with approximately 250 pmol (50 fold molar excess) of purified 
Cas6b proteins. The resulting protein-RNA complex was purified with ethanol precipitation. The 
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complex was then UV irradiated at 254 nm for 10 min, using a cross-linking apparatus build in-
house. For cross-linking, the samples were placed on ice at approximately 1 cm distance from 
the lamps. The cross-linked samples were analyzed by SDS-PAGE and the gel was coomassie 
stained. The bands containing radiolabeled RNA were visualized with a STORM phosphoimager 
(Figure 3.4). 
2.2.6.2 Protein-RNA cross-linking for Cas6b proteins with their cognate crRNAs 
UV induced protein-RNA cross-linking and enrichment of cross-linked heterconjugates was 
performed using the standard workflow as described in [108, 109, 135]. Briefly, 1 nmol of the 
crRNA was incubated in a 1:1 molar ratio with the Cas6b protein and incubated on ice for 30 
min. The volume of the resulting mixture was raised to 100 µl in buffer containing 10 mM Tris–
HCl pH 8.0, 300 mM NaCl and 0.5 mM DTT and transferred to black polypropylene micro-plates 
(Greiner Bio-One) positioned under the UV lamp at a distance of about 1 cm. The sample was 
then irradiated at 254 nm for 10 min (maximum) and then transferred back into a reaction 
tube. Cross-linked samples were ethanol precipitated and redissolved in 50 µl 4 M Urea, 50 mM 
Tris-HCl pH 7.9. Sample volume was raised to 200 µl with Tris-HCl pH 7.9 buffer and RNA 
hydrolysis was performed with Benzonase (25 U/µl) (Novagen), for which MgCl2 was added to 
the digestion buffer to a final concentration of 1 mM and the hydrolysis was carried out at 37 °C 
for 1 h. RNA digestion was followed by overnight trypsin proteolysis at 37 °C. Modified trypsin 
was added at a 1:20 w/w ratio. Samples were then subjected to enrichment via C18 and TiO2 
chromatography. The dried sample pellets after enrichment, were dissolved in 2 µl 50% ACN, 
0.1% FA and diluted to final concentration of 10% ACN, 0.1% FA by addition of 10 µl 0.1% FA. Of 
the 12 µl sample volume, 8 µl were injected for a single LC-MS run. The LC-MS analysis was 
performed on an LTQ Orbitrap Velos mass spectrometer. 
2.2.6.3 Protein-RNA cross-linking for T. tenax Cas7 and Tp Csc2 proteins with poly(U)15 
The T. tenax Cas7 and Tp Csc2 proteins were purified as described in 2.2.1.4. For cross-linking, 1 
nmol of the purified protein was incubated in a 1:1 molar ratio with poly(U)15 and incubated at 
50 °C for 15 min. Final volume of the mixture was raised to 100 µl in a buffer containing 20 mM 
HEPES pH 7.5, 150 mM NaCl and 5 mM DTT. UV cross-linking was performed at 50 °C for 10 min 
as described in Section 2.2.6.2. Cross-linked samples were purified by ethanol precipitation and 
redissolved in 50 µl 4M Urea, 50 mM Tris-HCl pH 7.9. The sample volume was raised to 200 µl 
with Tris-HCl pH 7.9 buffer and RNA hydrolysis was performed with 1 µl RNase A (1 µg/µl) 
(Ambion, Applied Biosystems) at 52 °C for 2 h. RNA digestion was followed by overnight trypsin 
proteolysis at 37° C. Modified trypsin was added at a 1:20 w/w ratio. Enrichment of cross-links 
was performed as described in 2.2.6.2 and the LC-MS analysis was performed on an LTQ 
Orbitrap Velos mass spectrometer. 
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2.2.6.4 Protein-RNA cross-linking for the E. coli Cascade complex 
The endogenous complex from E. coli was purified as described in 2.2.1.5. Prior to cross-linking, 
1 nmol of the pre-assembled complex was incubated at 37 °C for 10 min. The sample volume 
was taken to 100 µl in buffer containing 20 mM HEPES, 75 mM NaCl, 1 mM DTT, 2.5 mM 
(Desthiobiotin). UV cross-linking was performed as described in 2.2.6.2. Cross-linked samples 
were purified by ethanol precipitation and redissolved in 50 µl 4 M Urea, 50 mM Tris-HCl pH 
7.9. The sample volume was raised to 200 µl with Tris-HCl pH 7.9 buffer and RNA hydrolysis was 
performed for 2 h at 52 °C using 1 µl each of (1 µg/µl) and T1 (1 U/µl) (Ambion, Applied 
Biosystems). In addition, further hydrolysis was performed with 1 µl Benzonase, for which 
MgCl2 was added to the digestion buffer to a final concentration of 1 mM and the hydrolysis 
was carried out at 37 °C for 1 h. After RNA hydrolysis, trypsin (Promega) was added in a protein-
to-enzyme ratio of 20:1 (w/w) followed by an overnight incubation at 37 °C. Enrichment of 
cross-links was performed as described in 2.2.6.2 and LC-MS analysis was performed using Q 
Exactive HF mass spectrometer. 
2.2.6.5 Protein-RNA cross-linking for Tt Csm and Tt Cmr complex  
The Tt Csm and Tt Cmr complexes from T. thermophilus were purified as described in 2.2.1.6 
and 2.2.1.7. Prior to cross-linking, 1 nmol of the pre-assembled complex was incubated at 65 °C 
for 10 min. The sample volume was raised to 100 µl in buffer containing 20 mM Tris-HCl, pH 
8.0, 150 mM NaCl. UV cross-linking was performed at room temperature for 10 min as 
described above. Cross-linked samples were purified by ethanol precipitation and redissolved in 
50 µl 4 M Urea, 50 mM Tris-HCl pH 7.9. Samples were then taken to 200 µl with Tris-HCl pH 7.9 
buffer and RNA hydrolysis was performed for 2 h at 52 °C using 1 µl each of RNase A (1 µg/µl) 
and T1 (1 U/µl). RNA digestion was followed by overnight trypsin proteolysis at 37 °C. Modified 
trypsin was added at a 1:20 w/w ratio. Enrichment of cross-links was performed as described in 
2.2.6.2 and LC-MS analysis was performed using LTQ Orbitrap Velos mass spectrometer. 
2.2.7 Protein-protein cross-linking 
The protein-protein cross-linking experiments were performed for the investigation of protein-
protein interactions in Type I-B Cascade complex from C. thermocellum. The complex was 
incubated at 50 °C for 10 min prior to any in vitro experiments. 
2.2.7.1 Determination of optimal cross-linker to protein ratio 
The optimal cross-linker to protein ratio was determined by incubating 30 pmol aliquots of the 
purified Cascade complex with freshly prepared BS3 cross-linker in a series of molar excesses of 
5, 10, 25, 50, 100 and 200 as well as a control. Samples were allowed to react with the cross-
linker for 30 min at room temperature. The reaction was quenched by adding 2 µl of 2 M Tris-Cl 
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pH 7.9 to the reaction mix. The cross-linked samples were analyzed by SDS page on a 4-12% Bis-
Tris gel (Invitrogen) using the manufacturer’s protocol and stained with coomassie (Figure 
3.15). From the SDS-PAGE analysis the cross-linker to protein ratio of 75:1 was considered 
optimal for carrying out further experiments. 
2.2.7.2 Protein-protein cross-linking of Cascade complex 
For MS analysis, 150 pmol Cascade complex was cross-linked with freshly prepared BS3 in a 
cross-linker to protein ratio 75:1, for 30 min at room temperature. The reaction was quenched 
by adding 2 µl of 2 M Tris-Cl pH 7.9 to the reaction mix. The reaction volume was reduced to 2-
5 µl by drying in a SpeedVac.  
Further, the cross-linked sample was digested in-solution. The dried sample was dissolved in 20 
µl 8 M Urea (in water), with vigorous shaking for 30 min at 25 °C. The disulfide bridges in 
proteins were reduced with the addition of 20 µl 10 mM DTT (in water), followed by incubation 
for 30 min at 600 rpm in a thermomixer at 25 °C. Further the–SH groups were alkylated with 
addition of 20 µl 60 mM IAA (in water), followed by incubation as in the previous step. The final 
volume of reaction mixture was raised to 200 µL with water and modified trypsin was added in 
a 1:20 w/w ratio for overnight hydrolysis. 
2.2.7.3 Enrichment of cross-linked peptides and LC-MS 
The cross-linked peptides were enriched as previously reported in [136]. The peptide mixture 
was desalted with C18 chromatography as described under the Section 2.2.4.3. Peptides were 
reconstituted in 30% ACN, 0.1% TFA and injected onto a Superdex Peptide column and eluted 
at 50 µl/min collecting fractions of 50 µl. These fractions were dried in a SpeedVac and 
reconstituted in 20 µl LC-MS sample loading buffer of which 8 µl were injected for a single LC-
MS run. MS analysis was performed using Orbitrap Fusion mass spectrometer. 
2.2.8 LC-ESI-MS/MS 
The LC-ESI-MS/MS analysis was carried out using nano-liquid chromatography (nano-LC) system 
directly coupled to the electrospray (ESI) source of a mass spectrometer. Four different mass 
spectrometers were used in this thesis.  
The LTQ Orbitrap XL and LTQ Orbitrap Velos instruments (Thermo Fisher Scientific) coupled to 
an Agilent LC-system (Agilent 1100 series) and the Orbitrap Fusion and Q Exactive HF 
instruments (Thermo Fisher Scientific) coupled to Thermo Fisher Scientific LC-system (Dionex 
Ultimate 3000, UHPLC). Details for the LC separation and MS analysis are described below. 
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2.2.8.1 Nano-LC separation  
Nano-LC separation (Agilent 1100 series, Agilent Technologies) 
The samples were injected onto a nano-LC system including a C18 trapping column (length ~2 
cm, inner diameter 150 μm) in-line with a C18 analytical column (length ~15 cm, inner diameter 
75 μm). Both packed in-house by Uwe Pleßmann using C18 AQ, 120 Å, 5 μm (Dr. Maisch 
GmbH). Analytes were loaded on the trapping column at a flow rate of 10 μL/min in buffer A 
(0.1% v/v FA) and subsequently eluted and separated on the analytical column with a gradient 
of 7–38% buffer B (95% v/v acetonitrile, 0.1% v/v FA) for 33 min in a 50 min gradient, followed 
by a column wash with 90% buffer B at a flow rate of 300 nl/min. 
UHPLC separation (Dionex, Ultimate 3000, Thermo Fisher Scientific) 
The samples were injected onto a nano-liquid chromatography system including a C18 trapping 
column (length ~2 cm, inner diameter 150 μm) in-line with a C18 analytical column (length ~30 
cm, inner diameter 75 μm), both packed in-house by Uwe Pleßmann. The trapping column was 
packed as above, however the analytical column was packed using C18 AQ 120 Å 1.9 μm (Dr. 
Maisch GmbH). Analytes were loaded on the trapping column at a flow rate of 10 μl/min in 
buffer A (0.1% v/v FA) and subsequently eluted and separated on the analytical column with a 
gradient of 8–46% buffer B (80% v/v acetonitrile, 0.08% v/v FA) with an elution time of 45 min 
in a 50 min gradient or 75 min in a 90 min gradient, followed by a column wash with 90% buffer 
B at a flow rate of 300 nl/min. 
2.2.8.2 ESI-MS/MS  
LTQ Orbitrap XL (Thermo Fisher Scientific) 
The instrument was operated in data-dependent mode using a TOP8 method. MS scans were 
recorded in the Orbitrap (m/z range 350-1600) with a resolution of 30,000 at 400 m/z and 
automatic gain control (AGC) target at 106. For subsequent MS/MS, top 8 most intense ions 
were selected. Fragment ions were generated in the ion trap by CID activation (collision 
induced dissociation, normalized collision energy=35). In order to avoid re-fragmentation, the 
dynamic exclusion was set to 60 s.  
LTQ Orbitrap Velos (Thermo Fisher Scientific) 
The instrument was operated in data-dependent mode using a TOP10 method. MS scans were 
recorded in the Orbitrap (m/z range 350-1600) with a resolution of 30,000 at 400 m/z and AGC 
target 106. For subsequent MS/MS, top 10 most intense ions were selected. Both precursor ions 
as well as fragment ions were scanned in the Orbitrap. Fragment ions were generated by HCD 
activation (higher energy collision dissociation, normalized collision energy=40). In order to 
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avoid re-fragmentation, the dynamic exclusion was set to 60 s. The MS/MS fragment spectra 
were recorded with a first fixed mass of m/z=100 and a resolution of 7500. 
Q Exactive HF (Thermo Fisher Scientific) 
The instrument was operated in data-dependent mode using a TOP20 method. MS scans were 
recorded in the Orbitrap (m/z range 350-1600) with a resolution of 60,000 and AGC target 106. 
For subsequent MS/MS, top 20 most intense ions were selected. Both precursor ions as well as 
fragment ions were scanned in the Orbitrap. Fragment ions were generated by HCD activation 
(higher energy collision dissociation, normalized collision energy=35). In order to avoid re-
fragmentation, the dynamic exclusion was set to 30 s. The MS/MS fragment spectra were 
recorded with a first fixed mass of m/z=110 and a resolution of 15000, AGC target 105. 
Orbitrap Fusion (Thermo Fisher Scientific) 
The instrument was operated in data-dependent mode using a TOP20 method. MS scans were 
recorded in the Orbitrap (m/z range 350-1600) with a resolution of 120,000 and AGC target 
5x105. For subsequent MS/MS, top 20 most intense ions were selected. Both precursor ions as 
well as fragment ions were scanned in the Orbitrap. Fragment ions were generated by HCD 
activation (higher energy collision dissociation, normalized collision energy=30). In order to 
avoid re-fragmentation, the dynamic exclusion was set to 10 s. The MS/MS fragment spectra 
were recorded with a first fixed mass of m/z=110 and a resolution of 30000, AGC target 5x104. 
2.2.9 Data analysis 
2.2.9.1 Quantitative proteome analysis after dimethyl labeling using MaxQuant 
Raw MS data were analyzed using MaxQuant software v1.2.2.5 incorporated with Andromeda 
[90, 137]. The following settings were used as default settings: MS/MS tolerance 0.5 Da, FDR at 
both peptide and protein level 1 %, maximum peptide posterior error probability (PEP) 1.0, 
minimum peptide length 6 amino acids, minimum ratio count 2, maximum number of 
modifications per peptide 4, maximum precursor charge 5, “re-quantify” True, “keep low-
scoring versions of identified peptides” False, “use razor and unique peptides” True. 
Carbamidomethylation of cysteine was used as fixed modification and oxidation of methionine 
and acetylation of N-terminal of protein were used as variable modifications. Trypsin specificity 
with no proline restriction and up to 2 missed cleavages were allowed. Specifically for the 
dimethyl labeling analysis: Multiplicity was set to 2, with maximum 3 labeled amino acids per 
peptide, DimethLys0 and DimethNter0 were used as light labels and DimethLys4 and 
DimethNter4 were used as heavy labels. The search was performed using H. volcanii protein 
database from UniPROT.  
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The output from MaxQuant (proteinGroups.txt) was imported in Perseus. All “Reverse” and 
“Contaminant” entries were deleted. P-value (Significance B) was calculated and set as a main 
criterion for the data interpretation. Total summed peptide intensities were plotted in log10 
scale, normalized enrichment ratios in log2 scale as scatterplots using R [138] (R scripts were 
previously published in [139].  
2.2.9.2 Quantitative proteome analysis after iBAQ using MaxQuant 
Results were analyzed using the MaxQuant software v1.2.7.4, using the default settings as 
above. The multiplicity for labels was set to 1 as this was a label free analysis and the iBAQ 
function was set to true. The MS data was matched against the H. volcanii protein database 
from UniPROT supplemented with the sequences of the 48 proteins contained in the UPS2 
standard. The iBAQ values from three replicates were averaged and the standard deviation was 
calculated to judge the precision of analysis. The UPS2 standard proteins observed in all the 
three replicate analyses were used for calibration. A calibration curve was obtained by linear 
regression from a double logarithmic plot (log(iBAQ) vs. log(amount). The calibration function 
was then used to calculate the amount of different Cas proteins in the respective samples.  
2.2.9.3 Identification of protein-RNA cross-links with RNPxl 
The MS .raw files were converted into the .mzML format with msconvert, part of the 
ProteoWizard software bundle [140] or with Proteome discoverer 1.10 software provided by 
Thermo Fischer Scientific (http://www.thermoscientific.com/en/product/proteome-discoverer-
software.html). Protein-RNA cross-links were analyzed using RNPxl tool [108] implemented in 
OpenMS [115, 116] and using OMSSA [117] as search engine. Data analysis workflows were 
assembled especially for our laboratory by Timo Sachsenberg (Prof. Oliver Kohlbacher, 
University of Tübingen, Tübingen). The high scoring cross-linked peptides were manually 
annotated for confirmation.  
The cross-linked regions/residues identified were mapped on the crystal structures (where 
available) using PyMOL (an open source software maintained and distributed by Schrödinger 
(http://www.pymol.org), structure modelling was performed using Phyre2 [141] and 
superposition was performed using Secondary structure matching (SSM) in COOT [142]. 
Online tools used for the calculation of monoisotopic masses of peptides, RNA oligonucleotides 
and their fragments: 
ProteinProspector v5.14.0 – University of California, San Francisco:  
http://prospector.ucsf.edu/prospector/mshome.htm 
Peptide Mass Calculator v3.2 – Immunology Division, University of Utrecht, NL:  
http://immweb.vet.uu.nl/P&P_fac/pepcalc.htm 
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Mongo Oligo Mass Calculator v2.06 – University at Albany, State University of New York: 
http://mods.rna.albany.edu/masspec/Mongo-Oligo 
2.2.9.4 Identification of protein-protein cross-links with pLink 
The protein-protein cross-links were identified with pLink using the data analysis workflow 
described in their publications and manuals [123]. Briefly, the .raw files from the MS 
instruments were converted to the .mgf format using MSConvertGUI and submitted to 
database search with standard parameters. Oxidation of methionine was selected as a variable 
modification whereas carbamidomethylation of cysteine was selected as a fixed modification. 
Spectra were searched against a database containing the UniPROT sequences of the protein 







The MS investigation of prokaryotic immune defense system in the course of this work was 
based on two key aspects of proteomics. 
• Quantitative proteomics - For comparison between the proteomes of wild-type strains 
with the strains that carry deletion mutants of Cas proteins and for the absolute 
quantification of Cas proteins in the multi-subunit CRISPR-Cas complexes to determine 
their stoichiometry. 
• Structural proteomics - For investigating the protein-RNA and protein-protein 
interactions within various CRISPR complexes.  
3.1 Quantitative MS investigations in the CRISPR-Cas system  
Quantitative proteomics have numerous applications as described under Section 1.2.5. Here I 
present the results from protein quantification using differential stable-isotope labeling 
(dimethyl labeling) and label-free absolute quantification (iBAQ) carried out in Haloferax 
volcanii comprising Type I-B CRISPR-Cas system. Both quantitative analyses were performed in 
collaboration with the group of Prof. Anita Marchfelder, Ulm Univeristy, Ulm.  
3.1.1 Quantitative proteome analysis of H. volcanii WT and ∆cas7 KO using dimethyl 
labeling 
The Cas7 proteins are one of the key proteins of the CRISPR ribonucleoprotein complexes as 
they constitute the core of these complexes in the form of a helical backbone [22]. The goal of 
this project was to investigate the effects of deletion of cas7 gene in H. volcanii on the 
expression of other Cas proteins and at the proteome level, the proteomes of wild-type strain 
(H119 WT) and cas7 deletion strain (∆cas7 KO, where cas7 gene was knocked out) were 
compared using a dimethyl labeling strategy. The protein extracts for both strains were 
prepared by Britta Stoll in Prof. Anita Marchfelder’s Lab in Ulm (Section 2.2.1.1). For relative 
quantification, the peptides from the two samples were chemically labeled using ‘Light’ and 
‘Medium’ dimethyl labeling reagent [84]. Although dimethyl labeling is a triplex labeling 
approach with a provision of ‘Heavy’ label in addition to the ‘Light’ and ‘Medium’ [84], in this 
experiment only two labels were used for the comparison between two samples (Section 2.2.4). 
After this point the ‘Medium’ labeled sample is referred to as ‘Heavy’ and all the comparisons 
60   
thereafter are attributed as between a ‘Light’ labeled and a ‘Heavy’ labeled sample. Two 
experimental workflows were designed for quantitative analysis, the “Forward” and “Reverse” 




Figure 3.1 Workflow for the H119 WT vs ∆cas7 KO, quantitative analysis: Forward Experiment. 
For the wild-type and cas7 deletion mutant, the proteins were digested in solution using trypsin. The peptides 
were isotopically labeled with dimethyl labeling (DML) reagents and pooled in a 1:1 ratio. Excess of salts and the 
unused labeling reagents were removed with desalting using C18 columns. Peptides were separated using peptide 
iso-electric focusing and the peptide fractions were further desalted using STAGE-tips, followed by MS analysis. For 
the Reverse experiment only the labeling reagents were exchanged at the starting point and the same procedure 
was followed thereafter.  
For quantitative proteome analysis ~100 µg dried acetone precipitated protein extracts from 
both H119 WT and ∆cas7 KO were dissolved in 8M Urea followed by in-solution digestion using 
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trypsin (in presence of 1 M urea). The labeled peptides derived from the two samples, were 
pooled in 1:1 ratio and the complex peptide mixture was then separated using pIEF (Section 
2.2.4). This results in focusing of peptides into very sharp regions of pH gradient on an IPG gel 
strip, based on their iso-electric points [143].  
Pooling the peptide mix from two differentially labeled samples before enrichment ensures 
that all the processing steps such as fractionation and MS analysis are performed 
simultaneously for all the peptides from both the samples thereby avoiding the introduction of 
undesired variability. The intensities of both ‘light’ and ‘heavy’ labeled versions of a particular 
peptide derived from a protein will be measured at the same time. Therefore the ratio of the 
signal from the ‘heavy peptide’ and the signal from the ‘light peptide’ can be used to derive 
relative amount of differences in the proteins from the wild-type and the cas7 deletion strains. 
High (>1) H/L (heavy/light) peptide ratios in the forward experiment would indicate that the 
corresponding proteins are up-regulated or more abundant upon cas7 deletion with respect to 
the wild-type. Conversely, peptides with low (<1) H/L ratio would indicate down-regulation or 
less abundance upon cas7 deletion relative to the wild-type. This can be further confirmed with 
a reverse experiment. The results of relative quantification are shown in Figure 3.2. 
In both forward and reverse experiments approximately 1800 proteins (after removing 
contaminants such as keratin) were identified and quantified. For relative quantification the 
log2 normalized ratio (H/L) was determined for different proteins, using MaxQuant software 
(Section 2.2.9.2). For the forward experiment this ratio would be calculated from the intensities 
of ‘heavy’-labeled ∆cas7 KO proteins divided by intensities of ‘light’-dimethyl-labeled H119 WT 
proteins and for the reverse experiment this ratio would be intensities of ‘heavy’-dimethyl-
labeled H119 WT proteins divided by intensities of ‘light’-labeled ∆cas7 KO proteins.  
In both the experiments, majority of the proteins (approximately 90% of the total number of 
identified proteins) presented a log2 normalized ratio (H/L) close to zero, i.e. a ratio of 
heavy/light close to 1 (as indicated in the Figure 3.2 A and B based on the MaxQuant 
significance B, p-value >0.05). This result is expected, as the major part of the proteome for 
both wild-type and deletion strain should remain unchanged. 
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Figure 3.2 Scatter-plot analysis of protein quantification in H119 WT and ∆cas7 KO mutants. 
 (A) Forward experiment and (B) Reverse experiment; the log2 normalized ratios (H/L) of the proteins identified are 
plotted against the log10 of the Intensity. Significantly up or downregulated proteins are colored according to their 
corresponding p-value as shown in the legend. (C) Forward vs. Reverse experiment; the log2 ratios of the “Forward 
experiment” are plotted against the -log2 ratios of the “Reverse experiment”. The up-regulated proteins appear in 
upper-right quadrant and the down-regulated proteins appear in the lower-left quadrant. All proteins showing an 
average ratio higher than 1 (log2 scale) are indicated in light-red. The Cas proteins identified in this experiment are 
shown in red.  
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For the forward experiment, from all the quantified proteins (~1800), approximately 155 
proteins were significantly regulated i.e., either up- or down- based on the MaxQuant 
significance B (p <0.05) (Figure 3.2 A) and for the reverse experiment approximately 150 
proteins were significantly regulated (Figure 3.2 B). In order to increase the confidence of the 
proteins with significant difference in the wild-type and deletion strain and to restrict the list of 
potential proteins presenting biological significance, the log2 normalized ratio (H/L) for the 
forward and reverse experiment were plotted against each other (Figure 3.2 C). The proteins 
which were significantly regulated in both the experiments are summarized in Table 3.1 for the 
down-regulated proteins and Table-3.2 for the up-regulated proteins. These include mainly 
certain cytosolic proteins and proteins belonging to ABC-transport system in addition to the Cas 
proteins. Two parameters considered for summarizing this list of significant proteins included 
the Ratio H/L normalized and the PEP value. The latter being the posterior error probability 
(PEP) of the identification. The PEP value essentially operates as a p-value, where smaller is 
more significant. 
Table 3.1 Proteins “Down-regulated” upon cas7 deletion, significant in both forward and reverse 
experiments. The proteins of interest are shaded in orange. 
 Forward Experiment Reverse Experiment 
UniPROT 
ID 
Protein Name Ratio H/L 
Normalized 
PEP value Ratio H/L 
Normalized 
PEP value 
D4GQN6 CRISPR-associated protein, Csh2 
family (Cas7) 
0.03 2.92E-126 42.92 6.25E-18 
D4GYK7 IMP cyclohydrolase  0.10 0.027485 34.37 0.007626 
D4GPI4 Aspartate racemase  0.15 0.028474 2.06 2.77E-09 
D4GWI7 Homoserine kinase 0.29 9.76E-17 1.74 2.21E-28 
D4GPP7 Short-chain family oxidoreductase  0.31 3.57E-173 3.14 3.60E-107 
D4GQN7 CRISPR-associated protein Cas5 0.38 6.12E-128 2.60 2.59E-18 
D4GPE5 ABC-type transport system 
periplasmic substrate- binding 
protein (Probable substrate iron-III)  
0.41 6.95E-16 1.74 8.83E-07 
D4GW66 Coenzyme PQQ synthesis protein E 
homolog  
0.42 4.51E-141 2.40 9.79E-88 
D4GVN2 Trk potassium uptake system 
protein  
0.44 8.77E-46 1.66 1.14E-33 
D4GSJ2 OsmC-like protein superfamily  0.48 5.45E-61 2.08 0.000249 
D4GW62 Putative uncharacterized protein  0.48 1.75E-102 2.03 1.18E-78 
D4GW08 Translation initiation factor aIF-2B 
delta subunit  
0.48 9.88E-92 1.73 9.02E-107 
D4GS83 Thioredoxin reductase  0.49 4.95E-67 2.25 1.24E-36 
D4GYN6 Ornithine carbamoyltransferase  0.50 4.23E-32 2.12 0.000182 
D4GYV1 Flavoprotein reductase homolog 0.51 2.51E-26 1.81 1.03E-39 
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Table 3.2 Proteins “Up-regulated” upon cas7 deletion, significant in both forward and reverse 
experiments. The proteins of interest are shaded in orange. 
 Forward Experiment Reverse Experiment 
UniPROT 
ID 
Protein Name Ratio H/L 
Normalized 
PEP value Ratio H/L 
Normalized 
PEP value 
D4GWP5 ABC-type transport system ATP-
binding protein (Probable substrate 
zinc)  
9.20 0 0.11 0 
D4GWP4 ABC-type transport system 
periplasmic substrate-binding 
protein (Probable substrate zinc)  
7.55 0 0.13 0 
D4GQP0 CRISPR-associated protein Cas1  4.70 5.58E-10 0.33 1.34E-20 
D4GPV2 Putative uncharacterized protein 3.06 3.07E-71 0.31 9.07E-95 
D4GQN5 CRISPR-associated protein Cas8 2.79 0 0.37 0 
D4GZR8 ATP-dependent DNA helicase  2.75 8.26E-23 0.37 8.92E-13 
D4GZR4 Cupin superfamily  2.51 9.20E-42 0.33 7.39E-81 
D4GZR3 Archaea-specific helicase AshA  2.29 5.39E-46 0.39 2.20E-38 
D4GWP3 Glutaredoxin-like protein  2.29 6.68E-40 0.45 1.05E-37 
D4GZR5 SpoIVFB-type metallopeptidase, 
transmembrane (TBD)  
2.27 2.07E-12 0.22 1.48E-08 
D4GTW9 Predicted protein, putative 2.18 1.10E-94 0.48 8.05E-119 
D4GQN4 CRISPR-associated protein Cas6  2.17 1.04E-259 0.40 1.48E-225 
D4GPA4 Glycosyl Hydrolase Family 88 
superfamily 
2.17 4.61E-72 0.54 5.61E-72 
D4GRI4 Acetyl-CoA C-acyltransferase 2.07 2.00E-182 0.50 8.65E-253 
D4GPX0  Oxidoreductase  1.93 1.70E-24 0.49 6.38E-08 
D4GQB5 Rieske-type [2Fe-2S] iron-sulfur 
protein  
1.73 4.24E-103 0.42 2.36E-11 
 
The proteins of interest i.e., the Cas proteins could be identified and quantified. As expected, 
Cas7 was observed as the most significantly down-regulated protein. Although the cas7 gene 
was deleted, the ratio of Cas7 can be determined against the background noise and hence it 
was observed as the most distant point in all the three scatterplots in Figure 3.2. Other Cas 
proteins whose expression was affected upon cas7 deletion include Cas5 protein, which was 
down-regulated or weakly expressed in the cas7 KO strain and Cas1, Cas6 and Cas8 which were 
up-regulated i.e., more abundantly expressed in the cas7 KO strain. This observation suggests 
that the deletion of a single gene (cas7) within the CRISPR locus, in a single operon, strongly 
affects the expression of other genes within the same operon. 
Another significant protein belonging to CRISPR-Cas system which was identified in this 
experiment was the archaeal-specific helicase (AshA), which was observed to be up-regulated 
3. RESULTS  65 
upon Cas7 deletion (Table 3.2). In addition, this protein has been shown to play a significant 
role in CRISPR interference step (Marchfelder Lab, unpublished data). 
3.1.2 Determination of stoichiometry of Cas5:Cas6:Cas7 in H. volcanii with iBAQ 
The H. volcanii Type I-B system contains a Cascade-like complex comprising Cas7, Cas5 and Cas6 
that is required for the biogenesis and stability of crRNA. It has been shown that when the 
whole cas gene cluster (cas1-8) is removed, the organism is not able to produce and stably 
maintain mature crRNAs. The crRNA production and stability can be rescued only if cas5, cas6 
and cas7 are present. The Cas6 protein is necessary for crRNA generation but is not sufficient 
for its maintenance and Cas5 and Cas7 are additionally required for crRNA generation or 
stabilization [89]. 
To confirm the association of these three Cas proteins, a FLAG-Cas7 fusion protein was 
expressed and purified together with all potential interaction partners (Section 2.2.1.2). The 
FLAG-purified fraction when analyzed with SDS-PAGE showed co-purification of two additional 
proteins when analyzed with SDS-PAGE. With western blot analysis using anti-FLAG antibody, 
the largest band was confirmed to be Cas7 protein (Cas7-FLAG fusion protein) (Figure 3.3 A and 
B). These experiments were performed by Jutta Brendel in Prof. Anita Marchfelder’s Lab in Ulm. 
The two additional proteins in SDS-PAGE were identified as Cas5 and Cas6 with MS analysis.  
Furthermore, the stoichiometry of Cas5, Cas6 and Cas7 proteins in the complex was 
determined using a label-free absolute quantification approach (iBAQ). A mixture of quantified 
standard proteins (UPS2) was spiked into the complex of three Cas proteins isolated in a co-
purification (Section 2.2.5). UPS2 is a universal protein standard comprising 48 different human 
proteins of various molecular weight and abundances that span a concentration range of five 
orders of magnitude and is used to generate a calibration curve. Together this mixture of 
proteins is digested in-solution with trypsin followed by MS analysis, as described in the 
workflow in Figure 3.3 C. The iBAQ intensity for a protein is measured by summing the peak 
intensities of all detected peptides for the protein dividing it by the number of theoretically 
observable peptides. iBAQ intensities were determined using MaxQuant software. 
 




Figure 3.3 Determination of stoichiometry of Cas5:Cas6:Cas7 in H. volcanii with iBAQ  
A FLAG-tagged Cas7 protein was expressed in Haloferax cells and purified together with all potential interaction 
partners using the FLAG-tag. (A) Western blot analysis of the FLAG-purified fraction, probed with an anti-FLAG 
antibody. (B) SDS-PAGE analysis of the FLAG-purified fraction, showing three proteins visible on the Silver-stained 
gel. According to the western blot the largest band corresponds to Cas7 protein (Cas7-FLAG fusion protein probed 
with FLAG antibody). According to the MS analysis the two smaller proteins are Cas5 and Cas6 respectively. The 
protein size marker depicted on the left in kDa. Figure originally reported in [89] and reproduced with permission. 
(C). Overview of the iBAQ analysis workflow. (D). iBAQ calibration curve of UPS2 proteins used in determining the 
stoichiometry of Cas5, Cas6 and Cas7 from H. volcanii. Double logarithmic plot of log(iBAQ) vs log(amount) using 
20 out of 48 UPS2 proteins observed in all three technical replicates for the absolute quantification (Table 3.3) 
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Table 3.3 iBAQ quantitative mass spectrometry analysis of Cas7 co-purification to determine the 
absolute amounts of Cas5, Cas6 and Cas7 proteins. 












UPS2 Standard 47 426 13 1.674 2.630  
>P16083ups| 
NQO2_HUMAN 
UPS2 Standard 47 457 83 1.674 2.660 
>P61626ups| 
LYSC_HUMAN 
UPS2 Standard 47 858 85 1.674 2.934 
>P06732ups| 
KCRM_HUMAN 
UPS2 Standard 47 862 133 1.674 2.936 
>P02753ups| 
RETBP_HUMAN  
UPS2 Standard 47 617 275 1.674 2.790 
>P63165ups| 
SUMO1_HUMAN 
UPS2 Standard 472 4074 254 2.674 3.610 
>P02144ups| 
MYG_HUMAN 
UPS2 Standard 472 3745 345 2.674 3.573 
>P15559ups| 
NQO1_HUMAN 
UPS2 Standard 472 4791 558 2.674 3.680 
>P01133ups| 
EGF_HUMAN 
UPS2 Standard 472 6039 395 2.674 3.781 
>P62937ups| 
PPIA_HUMAN 
UPS2 Standard 472 6963 854 2.674 3.843 
>Q06830ups| 
PRDX1_HUMAN 
UPS2 Standard 472 6475 170 2.674 3.811 
>P04040ups| 
CATA_HUMAN 
UPS2 Standard 472 6633 463 2.674 3.822 
>P00167ups| 
CYB5_HUMAN 
UPS2 Standard 472 11428 1643 2.674 4.058 
>P69905ups| 
HBA_HUMAN 
UPS2 Standard 4717 22246 1469 3.674 4.347 
>P68871ups| 
HBB_HUMAN 
UPS2 Standard 4717 27773 4132 3.674 4.444 
>P62988ups| 
UBIQ_HUMAN 
UPS2 Standard 4717 33625 3406 3.674 4.527 
>P00918ups| 
CAH2_HUMAN 
UPS2 Standard 4717 40906 6958 3.674 4.612 
>P41159ups| 
LEP_HUMAN 
UPS2 Standard 4717 52631 1567 3.674 4.721 
>P00915ups| 
CAH1_HUMAN 
UPS2 Standard 4717 54385 6349 3.674 4.735 
>P01031ups|C 
O5_HUMAN 
UPS2 Standard 4717 53181 5761 3.674 4.726 
H. volcanii Cas6 FLAG-
purification 
249 1259 353 2.396 3.100 1.0 
H. volcanii Cas5 FLAG-
purification 
419 2004 228 2.622 3.302 1.7 
H. volcanii Cas7 FLAG-
purification 
2119 8522 362 3.326 3.931 8.5 
Originally published in [89], reproduced with permission from the publisher.  
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The proteins that were confidently identified and quantified from three technical replicates are 
listed under Table 3.3. iBAQ values for the standard proteins, from the three replicates, were 
averaged. The known amounts of the standard proteins in UPS2 and the average iBAQ values 
were used to prepare a calibration curve. A double logarithmic plot where the log (amount) of 
the standard proteins identified was plotted against the log (iBAQ value). The concentration of 
Cas5, Cas6 and Cas7 proteins were calculated using the log/log linear regression (Appendix, 
Figure 3.3 D).  
The derived protein concentrations indicate a Cas5:Cas6:Cas7 stoichiometry of 1.7: 1: 8.5 (Table 
3.3). This low:low:high type stoichiometry is in agreement with previously observed 
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3.2 UV induced protein-RNA cross-linking for investigation of protein-RNA 
interactions in the CRISPR-Cas systems 
As a part of the structural proteomics based investigations into the CRISPR-Cas system, the UV 
induced protein-RNA cross-linking strategy was used for identifying the protein-RNA contact 
sites in the CRISPR ribonucleoprotein (crRNP) complexes [108]. It is a straightforward approach 
for the identification of not only the proteins that cross-link to RNA but also to unambiguous 
identification of the cross-linked peptide or amino-acid and the cross-linked nucleotide(s) [108]. 
The method is applicable to single (e.g., recombinant) Cas proteins that interact with crRNAs 
but could not be co-crystallized in complex with the crRNA. Furthermore, it can be also applied 
to assembled crRNPs of varying complexity, obtained either by reconstitution or by purification 
from extracts. In this section, I present the results obtained during the investigation of protein-
RNA interactions in both fully assembled multi-subunit crRNP complexes as well as single Cas 
protein-crRNA complexes. These projects were a part of extensive collaboration with the 
members of DFG Forschergruppe 1680 and the groups of Prof. John van der Oost and Stan 
Brouns (Wageningen University, Wageningen, NL). 
3.2.1 Protein-RNA cross-linking in Cas6b proteins from M. maripaludis and C. 
thermocellum with their cognate crRNA  
The CRISPR-Cas system presents a broad diversity with different types and subtypes, the 
general aspects and the mechanism of three major CRISPR types are however very similar. The 
Type I CRISPR systems have a similar mechanism for the processing of the transcribed CRISPR 
locus to yield mature crRNA. All the Type I subtypes use a Cas6 homolog to process pre-crRNA 
yielding a mature form of interfering RNA. The Cas6 endoribonucleases share some basic 
features, e.g., a ferredoxin-like fold in the structure, metal independent processing of pre-
crRNA and always yielding mature crRNA with a 5’ terminal repeat tag of 8 nucleotides [18, 
144-146]. Recently, novel Cas6 enzymes have been identified from the archaeal and bacterial 
model organisms M. maripaludis and C. thermocellum [127] referred to as “Cas6b” 
(corresponding to the subtype I-B). The crRNA processing for both these Cas6 enzymes was also 
characterized with the identification of individual spacer sequences [127].  
As a follow up of this investigation, UV induced protein-RNA cross-linking was used to identify 
the RNA interaction sites in the bacterial and archaeal Cas6 proteins. The experiments were 
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performed in collaboration with Hagen Richter and Judith Zöphel from the group of Prof. 
Lennart Randau (MPI Terrestrial Microbiology, Marburg), who expressed and purified the Cas6b 
proteins from M. maripaludis C5 (Mm Cas6b) and C. thermocellum 3205 (Ct Cas6b). The 
cognate crRNA for these proteins with a substitution of the first unprocessed nucleotide against 
a deoxynucleotide were synthesized by Eurofins MWG Operon. 
M. maripaludis Cas6b cognate crRNA: 5’-CUAAAAGAAUAACUUGCAAAAUAACAAG(dC)AUUGAAAC-3’ 
C. thermocellum Cas6b cognate crRNA: 5’-GUUGAAGUGGUACUUCCAGUAAAACAAG(dG)AUUGAAAC-3’ 
One deoxy-nucleotide is introduced in the sequence to allow the Cas6b protein and the crRNA 
to form a complex when incubated together under optimal conditions as well as to prevent the 
Cas6b (an endoribonuclease) from hydrolyzing the crRNA. 
3.2.1.1 Analysis of Cas6b-crRNA cross-linking with SDS-PAGE 
The UV induced cross-linking between the Cas6b proteins and their cognate crRNAs was first 
analyzed using SDS-PAGE. Since the MS based approach requires a comparatively higher sample 
amount owing to the low cross-linking yield upon UV induction, it becomes essential to first 
check the cross-linking efficiency on a gel before proceeding with the MS analysis. The crRNA 
was labeled at the 5’ end with ϒ-32P-ATP and purified using PCI extraction (Section 2.2.2). The 
labeled crRNA was incubated with Cas6b protein (50 times molar excess of the protein) to form 
a binary complex of Cas6b-crRNA which was UV irradiated at 254 nm (Section 2.2.6.1). The 
cross-linked complex and a non-cross-linked control which also comprised Cas6b protein and 
crRNA (32P labeled) complex but with no UV treatment, were analyzed using SDS-PAGE. The 
results of SDS-PAGE analysis were visualized with both coomassie staining and autoradiography 
as shown in the Figure 3.4.  
The SDS-PAGE analysis clearly showed cross-linking between Mm Cas6b and the cognate crRNA, 
presenting a single band at 30 kDa on the coomassie stained gel. In the autoradiograph the 32P 
signal was observed at approximately the same molecular weight in the cross-linked sample 
and no signal was observed in the non-cross-linked sample. In the analysis of the Ct Cas6b there 
was a strong 32P signal present in the cross-linked sample which was absent in the control. 
Nonetheless, the Ct Cas6b protein purification was not sufficient pure as evident from multiple 
bands on the coomassie stained gel. From the presence of the 32P signal in the autoradiograph 
it can be speculated that UV induced cross-linking might have resulted in higher-order complex 
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formation with Cas6b and some contaminants in the sample. These results are sufficient to 
confirm that cross-linking between Cas6 proteins and crRNA took place and the interaction can 
be further analyzed with MS.  
3.2.1.1 Analysis of Cas6b-crRNA cross-linking with mass spectrometry 
UV cross-linking in combination with MS was performed to assess which regions of the Cas6b 
proteins are involved in direct interactions with the crRNA. The purified Cas6b proteins were 
reconstituted in vitro with their cognate crRNAs (in 1:1 ratio, one nmol each) to form the binary 
Cas6b-crRNA complex. The complex was UV irradiated as described using the standard protocol 
(Section 2.2.6.2). LC-MS analysis was carried out with an LTQ-Orbitrap Velos instrument and 
data analysis was performed as described in Section 2.2.9.3. In both Mm Ca6b and Ct Cas6b a 
single region of the protein was identified as cross-linked. Close inspection of the corresponding 
spectra enabled identification of the cross-linked residues in both cases (Table 3.4). 
Representative spectra of the cross-linked region for both the proteins are shown in Figure 3.5. 
 
Table 3.4 Cross-links identified for the Cas6b-crRNA cross-linking. 
Protein 
(Uniprot ID) 
Peptide Amino acid RNA Figure 
Mm Cas6b 
(A4FXZ3) 
182NQNM(ox)VGFR189 M185 UG-PO3, UG, UGC, UUCA-




184MIGFK188 M184 UGA, UUG 3.5 (B) 
 
Protein: Cross-linked protein (Uniprot ID); Peptide: Sequence of the cross-linked peptide, specified with 
the position of the peptide in the protein sequence; Amino acid: One-letter code specified with the 
position of cross-linked amino acid, RNA: composition of the RNAs observed cross-linked. 
For peptides cross-linked to the RNA depicted in bold, the corresponding MS/MS spectra are shown in 
Figure 3.5.  
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Figure 3.4 SDS-PAGE analysis of UV cross-linked Cas6b protein and ϒ-32P-ATP labeled crRNA. 
 (A) M. maripaludis Cas6b cross-linked ϒ-32P labeled crRNA, (B) C. thermocellum. Cas6b cross-linked with ϒ-32P-ATP 
labeled crRNA. The protein-RNA cross-linking was analyzed using regular SDS-PAGE. Left panel: Coomassie stained 
gel and Right Panel: Autoradiography of the gel after 30 minutes exposure to the Phosphoimager screen. The 
Coomassie staining shows the purified Cas6b protein and the autoradiography shows cross-linking products of 
Cas6b-crRNA cross-linking.  
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Figure 3.5 MS/MS spectra of the M. maripaludis Cas6b peptide 182NQNM(ox)VGFR189 cross-linked to 
UUGC-PO3 and C. thermocellum Cas6b peptide 184MIGFK188 cross-linked UGA. 
The cross-linked peptide sequence and its corresponding y- and b- type fragment ions are indicated at the top, 
with the cross-linked amino acid highlighted in yellow. The fragment ion peaks with their corresponding m/z values 
are marked in the spectrum. Ions with a mass shift corresponding to the cross-linked nucleotides are indicated 
with #, #1, #2, #3, #4 and #5 with the respective adduct composition mentioned below the peptide sequence. The 
cross-linked nucleotide in both the cases is one of the uracil residues as the bases of nucleotides A, G and C are 
present as marker ions in the lower m/z regime of the spectrum. A’: Base of A with marker ion of 136.06 m/z, G’: 
Base of G with marker ion of 152.05 m/z, C': Base of C with marker ion of 112.05 m/z. U’: Base of U observed in 
this case as adduct of 112.02 Da. 
74   
In Mm Cas6b, the peptide 182NQNM(ox)VGFR189 was cross-linked to different RNA moieties as 
listed in Table 3.4. The methionine residue (M185) in its oxidized state was identified as the 
cross-linked amino-acid residue. The cross-link spectra were manually validated and one 
example spectrum is shown in Figure 3.5 A. The b2 ion and the y- ion series until the y4 ion was 
observed without any mass shifts. All y- ions following y4 were observed shifted by a mass 
corresponding to the neutral loss from the oxidized methionine plus the RNA adduct [U-H3PO4; 
226.0490 Da]. The neutral loss from oxidized methionine is a commonly observed phenomenon 
that occurs upon CID or HCD fragmentation, and it corresponds to a loss of methanesulfenic 
acid (CH3SOH, 64 Da) as reported earlier [147-149]. Additionally, the cross-linked nucleotide 
could also be identified from the different RNA moieties that were observed cross-linked to 
182NQNM(ox)VGFR189. From the manually annotated spectrum of peptide 182NQNM(ox)VGFR189 
cross-linked to UUGC-HPO3, the cross-linked nucleotide was identified as one of the uracil 
residues, due to the shifted y- ions presenting mass-shifts corresponding to different uracil 
adducts (Figure 3.5 A) and the bases of nucleotides G and C were being present as marker ions 
(G’: Base of G with marker ion of 152.05 m/z, C': Base of C with marker ion of 112.05 m/z) in the 
lower m/z regime of the spectrum. In all the different RNA moieties identified to be cross-linked 
to this particular peptide, the uracil was identified as the cross-linked nucleotide. When 
mapping the different cross-linked RNA moieties identified (UG, UGC, UUCA and UUGC) in the 
crRNA sequence, the 5’ end U15 was identified as the only possible cross-linked nucleotide. 
(Figure 3.6A, crRNA sequence).  
In Ct Cas6b, the peptide 184MIGFK188 was observed to be cross-linked to UGA and UUG (Table 
3.4) and M184 was identified as the cross-linked amino acid residue. The cross-links were 
validated manually and one example spectrum is shown in Figure 3.5 B. The y- ion series until 
the y3 was observed without any mass shifts. The b3 ion however, was observed with U-H2O 
adduct (306.012 Da) indicating M184 or I185 as the probable cross-linked amino acid residue. In 
addition, the immonium ion of methionine was observed shifted by the mass of U-H2O adduct 
at 410.0812 m/z, which confirmed M184 as the cross-linked amino acid residue. The cross-linked 
nucleotide was mapped on the crRNA sequence using the same approach as discussed above 
and U3 and U32 from the 5’end were identified as possible candidates (Figure 3.6 B, crRNA 
sequence). 
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Figure 3.6 Cas6b-crRNA cross-linking in the archaeal and bacterial Cas6 proteins. 
(A) Homology models of Mm Cas6b and Ct Cas6b (Phyre2 modeling on the basis of the Pyrococcus furiosus Cas6 
[PDB: 3I4H]) as cartoon representations. The cross-linked peptides mapped on these models are indicated in cyan 
and the side-chains of the cross-linked amino acid residues (methionine) are indicated in blue and the conserved 
glycine-rich region is indicated in green. The RNA region observed as cross-linked moiety (in Table 3.3) is indicated 
in orange and the possible cross-linked nucleotide residue is highlighted in red on the respective crRNA sequence. 
(B) Alignment of Cas6b homologs (Clustal W) of subtype I-B showing the conserved amino acid residues (black). 
The cross-linked residues are indicated in the red circle. Figure 3.6 B was kindly provided by Prof. Lennart Randau 
(MPI, Terrestrial Microbiology, Marburg).  
The Cas6 proteins comprise a conserved glycine-rich loop at the C-terminal of the protein [24] 
which is known for its RNA binding properties. The conserved glycine-rich loop for the two 
Cas6b proteins is shown in green in Figure 3.6A. The sequence alignment of the Cas6b 
homologues indicates the presence of a conserved glycine-rich region near the C-terminal of 
the protein. In addition, the cross-linked methionine residue identified for both Mm Cas6b and 
Ct Cas6b is also conserved across different archaeal and bacterial Cas6b proteins. These 
methionine residues are not an integral part of the C-terminal glycine-rich loop however they 
are in a close spatial proximity (Figure 3.6). Nonetheless, the structural and sequence alignment 
of Cas6b homologues indicate that with the protein-RNA cross-linking a new conserved RNA-
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binding region was identified in addition to the evolutionary conserved gycine-rich region in the 
Cas6b proteins.  
Further, our collaborators confirmed the results for the cross-linked amino acid residue 
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3.2.2 Protein-RNA cross-linking in the Cas7 family proteins, Thermofilum pendens Csc2 
and Thermoproteus tenax Cas7 
In continuation with the approach for identification of protein-RNA interactions in single 
(recombinant) proteins and RNA, the investigation was extended to the two Cas7 proteins: T. 
pendens Csc2 (Tp Csc2) and T. tenax Cas7 from Type I-D and Type I-A CRISPR-Cas systems 
respectively. Both the proteins are representatives of the RAMP superfamily [21, 24]. They 
contain at least one RRM-like domain and although there is limited sequence conservation, 
they have a conserved glycine rich region between the α2 and β2 of the RRM domain [150]. The 
Cas7 proteins are characteristic of Type I and Type III systems and constitute the core subunit of 
interference complexes. Multiple copies of these proteins assemble in a helical fashion around 
the processed crRNA to form the backbone of large multi-subunit crRNP complexes [19, 40, 41, 
43]. Recently they have become an important subject for structural studies. The first published 
structure of a Cas7 representative was of Type I-A Sulfolobus solfataricus Csa2 (Ss Csa2) [19], 
followed by Methanopyrus kandleri Csm3 (Mk Csm3) [55] and Tp Csc2 [103]. In addition, given 
the interesting results involving glycine rich regions in the Cas6b proteins, I wanted to verify 
whether this was a general mode of RNA binding in the extended protein family including the 
Cas7 proteins. 
In this section I report the results for the investigation of RNA binding regions in the Tp Csc2 
and T. tenax Cas7 using UV induced cross-linking and MS. For this study, the main focus was on 
the determination of specific regions of the two Cas7 proteins that interact with RNA along with 
the identification of the exact amino acid residues in these regions that cross-link to RNA. The 
experiments were performed in collaboration with Ajla Hrle from the group of Prof. Elena Conti 
(MPI Biochemistry, Martinsried), who expressed and purified the two Cas7 proteins. The 
protein-RNA cross-linking study was carried out after our collaborators successfully crystallized 
the Tp Csc2 [103]. In addition, these results were compared with the cross-links identified for 
the Cas7 family proteins in the Type I-E E. coli Cascade complex and Type III-A T. thermophilus 
Csm complex, where the protein-RNA cross-linking was performed at the level of fully 
assembled crRNP complexes (Details under Section 4.2.2).  
In the EMSA studies performed by our collaborators, the Tp Csc2 was able to bind a polyU-RNA 
of 15 nucleotide length (polyU(15)) [103] in a comparable fashion as previously reported for Mk 
Csm3 [55] where the latter was observed to bind polyU(15) RNA about ten times stronger than 
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the repeat sequence in the crRNA. Tp Csc2 was observed to bind to both polyU(15) and the Tp 
crRNA in a similar way [103]. The RNA used in this experiment was a synthetic polyU(15), more 
easily available compared to the Tp crRNA.  
Both the purified protein and the polyU(15) RNA were incubated together in 1:1 ratio (1 nmol 
each) at 50 °C for 15 minutes for the protein-RNA cross-linking experiment. The UV cross-linking 
was performed using the standard protocol (Section 2.2.6.3). LC-MS analysis was carried out 
with the Orbitrap Velos and data analysis was performed as described in Section 2.2.9.3. 
3.2.2.1 Cross-linked regions observed in the two Cas7 proteins 
Three protein regions in Tp Csc2 and five protein regions in T. tenax Cas7 were identified cross-
linked to RNA (Table 3.5). The cross-links were manually validated and the corresponding 
spectrum for each cross-link identified is shown in the Appendix, Figure 6.1.  
In the Tp Csc2, the three cross-linked peptides identified were 82LMAVTR87, 
124KVSEEWNCTIQPPLAEFGEK143 and 346WVEELKGGGQK356 and for each of them the cross-linked 
residue could also be identified. These included M83, C131 and W346 respectively.  
In the T. tenax Cas7 five cross-linked regions were identified. For the peptides 3VAPPYVR9 and 
164SKEEQEGTEMMVFK177 the cross-linked amino acid residues were identified as Y7 and M163 
respectively. However, for the peptide 14FEAQLSVLTGAGNMGNYNMHAVAK37 and 
127VSFAVPVLEEK137 the cross-linked residue could not be identified. In the former peptide 28G-
N29 was observed as a probable cross-linked region. Since asparagine has never been observed 
to cross-link [108] we speculate the G28 to be the cross-linked amino acid residue. The peptide 
145FAVVHNRVDPFKR158 was observed as with a missed cleavage at R151 and also as two separate 
tryptic peptides 145FAVVHNR151 and 152VDPFKR158. In the former V148 was identified as the cross-
linked residue and in the latter two V148 and F155 were identified as the cross-linked amino acid 
residues after manual validation of the fragment spectra (Figure 6.1 G and H). 
The solved crystal structure of Tp Csc2 and the modelled structure of T. tenax Cas7 were used 
for mapping the RNA binding regions identified in these two proteins (Figure 3.7). 
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82LMAVTR87 M83 U, UU 6.1 A 
124KVSEEWNCTIQPPLAEFGEK143 C131 U 6.1 B 




3VAPPYVR9 Y7 U, UU 6.1 D 
14FEAQLSVLTGAGNMGNYNMHAVAK37 28G-N29 U 6.1 E 
127VSFAVPVLEEK137 - U-H2O, U 6.1 F 
145FAVVHNRVDPFKR158 V148 U, UU - 
145FAVVHNR151 V148 U, UU, UUU 6.1 G 
152VDPFKR158 F155 U, UU 6.1 H 
164SKEEQEGTEMMVFK177 M173 U, UU 6.1 I 
 
Protein: Cross-linked protein (Uniprot ID); Peptide: Sequence of the cross-linked peptide, specified with 
the position of the peptide in the protein sequence; Amino acid: One-letter code specified with the 
position of cross-linked amino acid, RNA: composition of the RNAs observed cross-linked. 
For peptides cross-linked to mono- di- or tri-nucleotides depicted in bold, the corresponding MS/MS 
spectra are given in Appendix, Figure 6.1.  
3.2.2.2 Mapping the cross-linked residues on Tp Cscs2 crystal structure and T. tenax Cas7 
model 
The cross-linked residues identified for the Cas7 proteins were mapped on their respective 
structures as dpecited in a cartoon representation in Figure 3.7. For Tp Csc2 a high resolution 
crystal structure was available [PDB 4TXD] [103] whereas for T. tenax Cas7 a sturctural model 
was generated using Phyre2 server [141]. 
The three cross-linked residues identified in Tp Csc2 are present in a central positively-charged 
groove on the surface of the protein (Figure 3.8), suggesting that this region is important in 
mediating the Csc2 binding to RNA. Meanwhile, our collaborators performed mutagensis 
studies on the surface exposed regions of Tp Csc2, targeting K179 and R183 and observed a 
reduction in the RNA binding activity compared to the wild-type protein [103].  
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Figure 3.7 Cross-linked regions mapped on the Tp Csc2 crystal structure and T. tenax Cas7 model. 
Left Panel: A cartoon representation (gray) of (A) Tp Csc2 solved crystal structure [PDB 4TXD] and (B) T. tenax Cas7 
modelled structure generated using Phyre2 server [141] with the lid domain and the central cleft domain indicated 
in circles, with the cross-linked peptides colored in cyan and the cross-linked residues colored in blue (stick 
representation). Right panel: Surface representation of Tp Csc2 (A) and T. tenax Cas7 (B) (in the same orientation 
as in the left panel) depicting the electrostatic potential (red for electronegative and blue for electropositive). An 
arrow points to the prominent positively charged groove. Upper panel: Figure (A) originally published in [103] and 
reproduced with permission. 
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A model of four copies of Tp Csc2 arranged in the Type I-D Cascade assembly was derived from 
the interpretation of the cryo-EM structure of the Type I-E Cascade complex [43]. Both the 
cross-linked residues and the mutated residues were mapped on this model (Figure 3.8) and 
compared with the surface representation of the model showing the electrostatic potential. 
The surface representation showed that both the cross-linked and the mutated residues are 




Figure 3.8 Cross-linked residues mapped on the model arrangement of four copies of Tp Csc2. 
A model arrangement of multiple copies of TpCsc2 (gray) upon Type I-D Cascade assembly; based on fitting a Tp 
Csc2 monomer into the EM density of the Type I-E Cascade [43]. Left Panel: Surface representation of the model 
showing the position of cross-linked (yellow) and mutated residues (blue). Right panel: Surface representation of 
the model (in the same orientation as the left panel) depicting the electrostatic potential (red for electronegative 
and blue for electropositive). Figure originally published in [103] and reproduced with permission. 
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Next, the five cross-linked amino acid residues identified in the T. tenax Cas7 were also mapped 
on a Phyre2 generated homology model structure of the protein (Figure 3.7). The mapped 
residues were localized in two regions of the protein i.e., the lid domain and the central cleft. 
The surface representation shows that cross-linked regions are placed in the positively charged 
central groove and the lid domain. Four out of five cross-linked residues identified are in the lid 
domain, which is in agreement with the previous reports from Ss Csa2 and Mk Csm3 in which 
the lid domain is involved in the nucleic acid binding [19, 55]. However, no such residues cross-
linking to RNA were identified in the lid domain of Tp Csc2. The positively charged surface 
groove appears to be a conserved functional site for crRNA recognition whereas the influence 
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3.2.3 Protein-RNA cross-linking in Type I-E Cascade complex from E. coli 
The UV induced protein-RNA cross-linking approach is not limited to the investigation of single 
protein and RNA complexes and can also be applied to multi-subunit RNP assemblies of varied 
complexity. Here, I report the results from protein-RNA cross-linking investigations in the multi-
subunit CRISPR ribonucleoprotein (crRNP) complex in E. coli. 
 The Type I-E surveillance complex in E. coli also referred to as Cascade complex was the first 
crRNP complex to be identified. It is a 405 kDa complex comprising 11 Cas protein subunits 
(from five Cas proteins) in a Cse11Cse22Cas5e1Cas76Cas6e1 stoichiometry and a crRNA. The 61 
nucleotide crRNA spans the entire length of the complex. Amongst these 11 protein subunits, 
all except the two Cse2 subunits make a direct contact with the crRNA and all RNA-binding 
proteins except Cse1 contain a modified RRM [105]. The recently published high resolution 
crystal structures of the sea-horse shaped Cascade complex constituted a significant 
development in understanding the mechanism of crRNP complex assembly and target 
recognition [105, 106].  
To this end, my part of the work focused on identification of RNA binding regions in the Cas 
protein and to identify the exact amino acid residues that interact with RNA using UV cross-
linking and MS and to validate the interactions determined by the co-crystallization. A pre-
assembled Cascade complex comprising 11 protein subunits and a crRNA was used for this 
study. The proteins and RNA components were cloned and co-expressed in E. coli. The complex 
was allowed to self-assemble in vivo and then affinity purified using the StrepTag on Cse2 [29]. 
The complex was purified by Tim Künne, from the group of Stan Brouns (Wageningen 
University, Wageningen, NL). 
Approximately, one nmol of pre-assembled crRNP complex was used for the UV cross-linking 
and MS analysis. The standard protocol for cross-linking and enrichment of cross-linked 
peptides was followed as described in Section 2.2.6.4. LC-MS analysis was carried out in a Q 
Exactive HF mass spectrometer and data analysis was performed as described in Section 
2.2.9.3. The cross-linked regions identified in different Cas proteins are listed in Table 3.6. In 
90% of the cross-linked regions (10 out of 12) the exact cross-linked residue could also be 
identified and was validated with manual annotation of the corresponding spectrum (Appendix, 
Figure 6.2). 
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The 3.24 Å crystal structure of E. coli Cascade [105] (Figure 3.9A) was used as the core for our 
protein-RNA cross-linking investigations in the Type I-E E. coli Cascade complex. All the cross-
links identified in our study were mapped on this crystal structure. However, there was a 
potentially important difference in the Cascade complex used for crystallization in [105] and the 
one used for protein-RNA cross-linking study. The two complexes were assembled around a 
different crRNA, i.e., the crRNA in both the complexes had a different spacer (as shown in the 
sequence below) which would influence the RNA binding in solution.  
The sequence for the two crRNAs is indicated below. Both the crRNA had same 5’ and 3’ repeat 
sequence (upper case) derived from the conserved repeat regions but different spacer 
sequence (lower case). The crRNA in crystallized Cascade complex [105] (upper sequence) and 
the crRNA in UV cross-linked Cascade complex (crRNA*: lower sequence). The potential sites for 
cross-linking (uracil) are indicated in red. 
crRNA : 5’ AUAAACCGacgguauuguucagauccuggcuugccaacagGAGUUCCCCGCGCCAGCGGGG 3‘ 
crRNA*: 5‘ AUAAACCGcugacgaccgggucuccgcaaguggcacuuuuGAGUUCCCCGCGCCAGCGGGG 3‘ 
This difference in the crRNA led to some ambiguity while mapping the cross-linked residues on 
the crystal structure as some of the cross-linked residues could not be confidently assigned. 
However in such cases the most feasible interaction between the identified cross-linked amino 
acid residue and the closest uracil residue was indicated (Figure 3.9 – 3.12), as the cross-linked 
nucleotide in all the cross-links identified was uracil (Table -3.6). The representative spectra for 
each cross-linked region are shown in the Appendix, Figure 6.2. Below, a detailed comparison 
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103LDSKGNIK110 K106 U-H2O 6.2 A 
136VEDVHPISERPQYFSGDGK154 145R-Y148 * U, UU 6.2 B 
Cse2 
(P76632) 
13AWQQLDNGSCAQIR26 C22 U, UG 6.2 C 
43LVQPFGWENPR53 W49 U 6.2 D 
61M(Ox)VFCLSAGK69 F63 U 6.2 E 
78KSEQTTGISLGR89 K78 U-H2O 6.2 F 
136MLTWWGK142 W139 U 6.2 G 
Cas7 
(I2ZSV0) 
21DDMNMQKDAIFGGK34 K27 U-H2O 6.2 H 
51SGYYAQNIGESSLRTIHLAQLR72 - U, UG-H2O 6.2 I 
83FDQKIIDK90 K86 U-H2O 6.2 J 
91TLALLSGKSVDEAEK105 97G-K98* U-H2O 6.2 K 
129AEADNLDDKK138 K137 U-H2O 6.2 L 
139LLKVLK144  K141 U-H2O 6.2 M 












M166 U-H2O, U, UU, AU, UC, 
UG, UUC 
6.2 O 





U-H2O, U, UA-H2O, 
UA, UC, UG, UU, UUC 
- 
M166 U-H2O, U, UG-H2O, UA - 
- U-H2O, U, UA - 
- U, UC, UA - 
M166 U, UA ,UC, UU, UUC - 





W16 U 6.2 P 
W16 U - 
84DYHTVLGAR92 Y85 U, UA 6.2 Q 
142YTPYLGR148 Y145 U, UA, UU,UUA 6.2 R 
198DEPMITLPR206 
198DEPM(Ox)ITLPR206 
P200 U,UU 6.2 S 
P200 U,UU - 
Cse1 
(Q46901) 
395ALYTFAEGFK404 F403 U 6.2 T 
 
Protein: Cross-linked protein (Uniprot ID); Peptide: Sequence of the cross-linked peptide, specified with 
the position of the peptide in the protein sequence; Amino acid: One-letter code specified with the 
position of cross-linked amino acid, RNA: composition of the RNAs observed cross-linked. 
For peptides cross-linked to mono- di- or tri-nucleotides depicted in bold, the corresponding MS/MS 
spectra are given in the Appendix, Figure 6.2.  
* Exact cross-linked residue could not be unambiguously identified; the residues which are most likely 
cross-linked are indicated instead.  
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3.2.3.1 Cross-links identified in Cas6e (head of the crRNP complex) 
The Cas6 proteins are metal dependent endoribonculeases that process the long crRNA 
transcripts [39]. In E. coli Cascade complex the Cas6e protein binds 3’ end of the crRNA at the 
head of the complex (Figure 3.9B). Upon UV cross-linking of the entire crRNP complex, two 
cross-linked regions were identified for the Cas6e protein. In the first region 103LDSKGNIK110, 
K106 was identified cross-linked to U-H2O. The K106 is located in the positive charged groove-loop 
(A98-E119) on the C-terminal RRM domain of the Cas6e, that has been reported to make 
extensive electrostatic contacts with the 3’ crRNA stem-loop [105].  
The second cross-linked region identified for Cas6e was 136VEDVHPISERPQYFSGDGK154, but the 
exact cross-linked residue could not be unambiguously identified. Mass shifts present in the 
fragment spectrum identify 145R-Y148 as the cross-linked region. The exact amino acid residue 
could not be identified due to a lack of fragment ions in that region of the ion-series (Figure 6.2 
B).  
Both cross-linked regions are located in the flexible loops that are in a close spatial proximity to 
the two adjacent uracil residues (U44 and U45) present in the conserved 3’ repeat sequence of 
the crRNA. The cross-linked regions mapped on the crystal structure of Cas6e are depicted in 
Figure 3.9B. 
3.2.3.2 Cross-links identified in Cse1 and Cas5e (tail of the crRNP complex) 
Together the three proteins Cse1, Cas5e and Cas7.6 form the tail of the crRNP complex and the 
5’ end of crRNA is sandwiched between these three proteins (Figure 3.9). One RNA binding 
region was identified for Cse1 and four for Cas5e in the protein-RNA cross-linking studies 
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Figure 3.9 Cross-linked regions identified for proteins Cas6e, Cas5e and Cse1 mapped on the crystal 
structure. 
 (A) Cartoon representation of the Type I-E Cascade complex from E. coli [PDB 1VY8] [105] comprising 11 Cas 
proteins (gray) and one crRNA (light orange). The nucleotide positions on the crRNA where a corresponding uracil 
residue is present in the crRNA* are indicated in red. The cross-linked regions for Cas6e, Cas5e and Cse1 are 
indicated in cyan and the side-chains of cross-linked residues as sticks (blue). The zoomed in structures of Cas6e 
(B), Cse1 (C) and Cas5e (D) with the cross-linked regions and the cross-linked residues as depicted in (A) (other 
subunits were removed for clarity).  
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Cse1 
Cse1 is the largest protein in the Cascade complex comprising two-domains. A globular fold that 
interacts with RRM domain of Cas5e and C-terminal four-helix bundle that contacts the C-
terminal of Cse2.2. Only one cross-linked region was identified in Cse1. The peptide 
395ALYTFAEGFK404 was found cross-linked to a uracil nucleotide and F403 was identified as the 
cross-linked residue (Figure 6.2 T). In addition, the cross-linked region was mapped on the 
crystal structure of Cse1 and it was observed that F403 was in close spatial proximity to the U10 
(nearest uracil residue) on the crRNA (Figure 3.9 C). The cross-linked region is located in a 
significant domain of the Cse1 protein i.e., the four-helix bundle at C-terminal of Cse1 that 
connects with C-terminal of Cse2.2, forming a structural bridge between the Cse1 tail and the 
Cas6e head [105]. 
Cas5e 
The Cas5e protein has a “right-handed fist-shape” structure with the thumb arching across the 
top of the fist/palm (Figure 3.9D) [105, 106]. Out of the four cross-linked regions identified for 
Cas5e; the peptide 84DYHTVLGAR92 is located in the arch of the Cas5e thumb. The arch is 
considered a modified RRM comprising 50 amino acid insertion between two β strands, the 
residues from V79-A114 form together the thumb [106]. The cross-linked residue identified in this 
peptide was Y85 (Figure 6.2 Q), which was observed to be in close spatial proximity to U10 
residue when mapped onto the crystal structure.  
The protein regions M1-S78 and S115-Q224 form the fist/palm of Cas5e. Three cross-linked regions 
were identified for the palm domain of Cas5e. The peptides 9LAGPMQAWGQPTFEGTRPTGR29, 
142YTPYLGR148 and 198DEPMITLPR206 were observed cross-linked to uracil residue and W16, Y145 
and P200 were identified as the cross-linked residues in the three peptides, respectively (Figure 
6.2 P, R and S). In the crystal structure, all three cross-linked residues are present in close 
spatial proximity to the U2 residue, in the conserved 3’ repeat sequence of the crRNA. As 
observed in the crystal structure, the side-chain of U2 is adjacent to the aromatic side-chains of 
Y145 and W16 (Figure 3.9 D). 
The peptide 42YTPYLGR148 was observed cross-linked to UA RNA, and in the crRNA the 
nucleotides adjacent to U2 are adenine. This further confirms U2 as the RNA nucleotide cross-
linked to Y145, in agreement with previous reports [106].  
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3.2.3.3 Cross-links identified in Cas7 (helical backbone of the crRNP complex) 
Cas7 proteins are one of the major constituents of the crRNP complex as they form the helical 
backbone of the complex and connect the head and the tail proteins. In the E. coli Cascade 
complex six Cas7 subunits (Cas7.1, Cas7.2, Cas7.3, Cas7.4, Cas7.5 and Cas7.6) assemble along 
the crRNA as depicted in Figure 3.9 A and Figure 3.10 A. The Cas7 proteins fold into a right hand 
shaped structure with a modified RRM domain forming the palm, residues G59-A181 forming a 
helical domain that resembles the fingers, residues V193-V223 forming a loop in the shape of a 
thumb [105] (Figure 3.10 B and C). The Cas7 filament is organized in such a way that the thumb 
of one Cas7 subunit extends towards the fingers of the adjacent subunit (Figure 3.10 A).  
With protein-RNA cross-linking five cross-linked regions were identified for Cas7, 
21DDMNMQKDAIFGGK34, 51SGYYAQNIGESSLRTIHLAQLR72, 83FDQKIIDKTLALLSGKSVDEAEK105, 
129AEADNLDDKKLLKVLKVLKEDIAAIR151 and 166MATSGMMTELGK177. The third and fourth regions 
were observed as different tryptic peptides resulting from missed cleavages at lysine residues, 
because most of these lysine residues were the sites for cross-linking (Table 3.6). Only for the 
second protein region no cross-linked amino acid residue could be identified. Details of the 
cross-linked peptides identified are listed in Table 3.6 and the corresponding fragment spectra 
and corresponding manual annotation are depicted in the Appendix (Figure 6.2 H-O).  
The six cross-linked residues in the Cas7 protein included K27, K86, K98, K137, K141, K144 and M166. 
On the crystal structure these cross-linked residues could not be mapped unambiguously owing 
to the multiple stoichiometry of the Cas7 proteins. Given that six copies of the Cas7 protein are 
present in the complex, the cross-linked residues could not be assigned to a specific 
residue/protein in the crystal structure. Possible representations are depicted in Figure 3.10 
and 3.11. 
Cas7.1  
All the cross-linked residues were mapped on Cas7.1 due to this protein being adjacent to the 
stretch of four consecutive uracil residues U33-U36 and U31 in the crRNA used in the cross-linked 
Cascade complex. Two residues, K27 located in the palm domain and M166 in the finger domain 
present their side-chains in close proximity to this uracil-rich region (Figure 3.10 C). It can 
therefore be expected that these two particular residues in Cas7.1 are cross-linked. 
The K86, K98, K137, K141 and K144 are located in the lysine-rich helix i.e., the finger domain of 
Cas7.1. Although the finger domain has never been reported to have a direct contact with the 
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crRNA, our investigation revealed that the lysine rich-loop is a favorable region for cross-linking. 
In addition, the presence of the four uracil residue stretch in close proximity gives an indication 
that the crRNA (in the Cascade complex used in our study) weakly interacting with the lysine-
rich region could potentially flip over to the finger domain of the Cas7.1 when in solution. In 
previous protein-RNA cross-linking studies both the lysine and uracil have been reported as 
likely candidates for cross-linking (Urlaub lab, unpublished data). In addition, in all other Cas7 
subunits, the lysine-rich helix is not in a close spatial proximity to the crRNA, which limits the 
number of feasible option for assigning cross-linked amino acid residues to these regions.  
Other Cas7 subunits  
The crRNA sequence close to the Cas7.2 subunit contains a single uracil residue (Figure 3.10 B). 
Two cross-linked amino acid residues (K27 and M166) were identified in Cas7.2, both in close 
spatial proximity to U31 in the crRNA.  
None of the cross-linked amino acid residues was mapped onto Cas7.3, due to its proximal 
crRNA region not having any uracil residue present.  
In Cas7.4, Cas7.5 and Cas7.6 only one cross-linked residue could be unequivocally assigned to 
the structure. In Cas7.4, K27 amino acid residue is proximal to U21 nucleotide residue on the 
crRNA (Figure 3.11 B). In addition the proposed cross-linked regions from Cas7.5 and Cas7.6 are 
depicted in Figure 3.11C. The U10 residue is tightly located between the side chains of M166 in 
Cas7.5 and K27 in Cas7.6, which indicates this contact constitutes one of the identified protein-
RNA cross-linking regions. 
3. RESULTS  91 
 
Figure 3.10 Cross-linked regions identified for the Cas7 proteins mapped on the crystal structure at 
the possible sites for cross-linked residues in Cas7.1 and Cas7.2. 
(A) Cartoon representation of the six Cas7 subunits (gray) wrapped around the crRNA (light orange) in the Type I-E 
Cascade complex from E. coli [PDB 1VY8] [105] (other subunits were removed for clarity). The nucleotide positions 
on the crRNA where a corresponding uracil residue is present in the crRNA* are indicated in red. The proposed 
cross-linked regions are indicated in cyan and the side-chains of cross-linked residues as sticks (blue). The zoomed 
in structures of Cas7.2 (B) and Cas7.1 (C) with the cross-linked regions and the cross-linked residues as depicted in 
(A). 
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Figure 3.11 Cross-linked regions identified for the Cas7 proteins mapped on the crystal structure at 
the possible sites for cross-linking in Cas7.4, Cas7.5 and Cas7.6. 
(A) Cartoon representation of the six Cas7 subunits (gray) wrapped around the crRNA (light orange) in the Type I-E 
Cascade complex from E. coli [PDB 1VY8] [105] (other subunits were removed for clarity). The nucleotide positions 
on the crRNA where a corresponding uracil residue is present in the crRNA* are indicated in red. The proposed 
cross-linked regions are indicated in cyan and the side-chains of cross-linked residues as sticks (blue). The zoomed 
in structures of Cas 7.4 (B) and Cas7.5/Cas7.6 (C) with the cross-linked regions and the cross-linked residues as 
depicted in (A). 
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Additionally, the peptide 166MATSGMMTELGK177 and several modified versions of the peptide 
with oxidized methionine/s were observed cross-linked to a wide range of RNA moieties, with 
M166 identified as the cross-linked residue in 40 out of 70 cross-links observed for the E. coli 
Cascade complex (Table 3.6). Therefore, the M166 residue indicated in Cas7.1, Cas7.2, and 
Cas7.5 (Figure 3.10 B, C and Figure 3.11 C) is proposed to cross-link to the indicated uracil 
residues. This is in agreement with the previous X-ray studies showing the side-chain of highly 
conserved M166 intercalating between the 3rd and 4th bases of each crRNA segment close to the 
respective Cas7 subunit [105, 106].  
In general, the six Cas7 subunits together forming the Cas7 filament have been reported to 
have extensive interactions with the crRNA in the Cascade complex. A major portion of the 
sugar-phosphate backbone of crRNA is buried by the Cas7 proteins, leaving only the bases 
exposed to the solvent [105, 106]. 
3.2.3.4 Cross-links identified in Cse2 (belly of the crRNP complex) 
In the fully assembled crRNP complex the Cse2 protein is present as two copies Cse2.1 and 
Cse2.2 that assemble along the “belly” of the Cascade complex. The two subunits form a head-
to-tail dimer that contacts the backbone of Cas7 proteins as shown in Figure 3.9A. Additionally, 
both available crystal structures [105, 106] show that the two Cse2 subunits do not form any 
direct contacts with the crRNA (Figure 3.12). 
However, in the protein-RNA cross-linking studies five different cross-linked regions were 
identified in Cse2 protein and in all five peptides the exact cross-linked residue could be 
identified (Table 3.6, Figure 6.2 C-G). It cannot be unambiguosly indicated which of the cross-
linked region/residue corresponds to which of the two Cse subunits, but the possibilities are 
considered in Figure 3.12. 
When mapped on the crystal structure, all the cross-linked amino acid residues are located on 
the surface opposite to the surface facing the crRNA. Despite the fact the two Cse2 subunits do 
not contact the RNA directly, the electrostatic calculations indicate that both the faces of the 
Cse2 dimer are positively charged and constitute potential RNA binding regions [43, 151]. In 
addition, the Cse2 proteins have been reported to play an important role in stabilizing the 
interaction with the target DNA [106]. Presence of residual crRNA or residual nucleotides from 
purification and the conformational variability of the Cascade complex in solution are potential 
explanations for the identification of protein-RNA cross-links in Cse2. 
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Figure 3.12 Cross-linked regions identified for the Cse2 proteins mapped on the crystal structure of 
both Cse2.1 and Cse2.2. 
Cartoon representation of the six Cse2 subunits (gray) and the neighboring crRNA (light orange) in the Type I-E 
Cascade complex from E. coli [PDB 1VY8] [105] (other subunits were removed for clarity). The nucleotide positions 
on the crRNA where a corresponding uracil residue is present in the crRNA* are indicated in red. The cross-linked 
regions are indicated in cyan and the side-chains of cross-linked residues are indicated as sticks (blue). The mass 
spectrometric analysis does not allow for an unambiguous identification of the individual cross-links in the 
respective subunits. Cross-links are represented in both. 
Overall this cross-linking study shows the power of UV induced protein-RNA cross-linking to 
identify direct protein-RNA interaction sites on the peptide or amino-acid level in a large, 
heterogeneous assemblies such as the multi-subunit E. coli Cascade complex. In addition, it 
provides invaluable in solution information, which can reflect the conformational landscape 
that occurs in the cell. 
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3.2.4 Protein-RNA cross-linking in Type III-A Csm complex from T. thermophilus 
In continuation with our investigation of protein-RNA interactions in complex systems such as 
the multi-subunit crRNP complexes, the UV induced protein-RNA cross-linking approach was 
also tried on the Type III-A Csm complex from T. thermophilus (Tt Csm complex). This crRNP 
complex is composed of five protein subunits (Csm1-Csm5) in a proposed stoichiometry of 
Csm11Csm23Csm36Csm42Csm51 and one crRNA of variable size (35-53 nucleotides) [59]. The 
complex has not been crystallized till date, however an EM structure of the complex (Figure 
1.16) [59] exhibits the characteristic architecture of Type I-E Cascade and Type III-B Cmr 
complexes, as reported in [43, 52]. I set out to investigate whether the mode of RNA interaction 
was similar to the previous observations in Type I-E Cascade complex (Section 3.2.3). The 
endogenous complex was purified from its native host Thermus thermophilus HB8 using a 
genomic tag (His-tag) as described in [59]. The purified complex was provided by Raymond 
Staals from the group of Prof. John van der Oost (Wageningen University, Wageningen, NL).  
UV cross-linking was performed using one nmol of pre-assembled Tt Csm complex. The cross-
linking and data analysis was performed as described in the standard protocol (Section 2.2.6.5 
and 2.2.9.3). Using this approach, nine cross-linked regions (corresponding to 12 cross-linked 
peptides) were identified in the entire crRNP complex. The composition of the cross-linked 
peptides and the RNA moieties is listed under Table 3.7. However, the Tt Csm complex used for 
cross-linking contained a mixture of different crRNAs (natural guides) isolated 
from T. thermophilus, therefore the exact cross-linked nucleotide on the crRNA could not be 
identified unambiguously. 








371RLHEALAR378 - UUA 6.3 A 
Csm2 
(Q53WF6) 
35LKSSQFR41 K36 U-H2O, U 6.3 B 
Csm3 
(Q53WF5) 
21IGMSRDQMAIGDLDNPVVR39 - U, UU, UG 6.3 C 
40NPLTDEPYIPGSSLK54 49P-K54* U-H2O, U, UG, UA 6.3 D 
91IFGLAPENDER101 P96 U, UU, UC, UG 6.3 E 
136GGLYTEIKQEVFIPR150 Q144 U, UU, UC, UG, UCG, 
UUC, UUG 
6.3 F 
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Csm3 
(Q53WF5) 
151LGGNANPR158 G153 UA, UC, UG UGG, 
UCA, UUA 
6.3 G 
159TTERVPAGAR168 R162 U, UG, UGG, UUG 6.3 H 
Csm4 
(Q53WF4) 
69LPPVQVEETTLRK81 P71 U, UG, UUA 6.3 I 
126 TRVGVDR132 V128 UU, UC 6.3 J 
Csm5 
(Q53W18) 
132SPLGAYLPGSSVK144 P139 U, UA, UG, UUA 6.3 K 
255MVLLAETFR263 M255 U-H2O, U, UG 6.3 L 
 
Table originally published in [59] and reproduced with permission. 
Protein: Cross-linked protein (Uniprot ID); Peptide: Sequence of the cross-linked peptide, specified with 
the position of the peptide in the protein sequence; Amino acid: One-letter code specified with the 
position of cross-linked amino acid, RNA: composition of the RNAs observed cross-linked. 
For peptides cross-linked to mono- di- or tri-nucleotides depicted in bold, the corresponding MS/MS 
spectra are provided in the Appendix, Figure 6.3.  
* Exact cross-linked residue could not be unambiguously identified; the two potential cross-linked 
amino acid residues are indicated instead. 
 3.2.4.1 Cross-links identified in Csm3 (a Cas7 family protein) 
Three different cross-linked regions were identified in Csm3. In the first protein region 
21IGMSRDQMAIGDLDNPVVRNPLTDEPYIPGSSLK54 two different tryptic peptides 21I-R39 and 40N-
K54 were observed cross-linked to different RNA moieties (Table 3.7). In both the cross-linked 
peptides the exact cross-linked residue could not be identified. However for the latter 49P-K54, 
the six amino acid sequence was identified as the cross-linked peptide. The fragment spectrum 
did not provide sufficient ion signals to identify which of the amino acids carried the RNA mass 
shift (Figure 6.3 D).  
In the second region 91IFGLAPENDER101, P96 was identified as the cross-linked residue. When the 
two regions were mapped on the Tt Csm3 model, it was observed that both regions lie in the 
central cleft of the protein, which is located in the conserved positively charged groove and is 
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Figure 3.13 Cross-linked regions mapped on a Tt Csm3 homology model. 
Cartoon representation of the Tt Csm3 homology model (gray) derived by Phyre2 homology modeling based on E. 
coli Cas7 [PDB 1VY8] [105]. The cross-linked regions are indicated in cyan and the side-chains of cross-linked are 
indicated as sticks (blue). The two universal domains of the Cas7 family proteins are indicated in the two circles.  
 
The third cross-linked protein region identified consisted of 136GGLYTEIKQEVFIPRLGGNAN-
PRTTERVPAGAR168 peptide, which forms the lid-domain of the Csm3 complex. It was observed 
as three separate tryptic peptides 136G-R150, 151L-R158 and 159T-R168 cross-linked to different RNA 
moieties (Table 3.7). The corresponding cross-linked amino acid residue identified for each 
peptide was Q144, G153 and R162 respectively. The lid-domain of the Cas7 family proteins 
constitutes yet another promising region for RNA-interaction, as this has been observed for the 
T. tenax Cas7 (Figure 3.7 B) and also in other Cas7 family proteins [103]. In general all the cross-
linked residues mentioned above cannot be assigned to one single Csm3 subunit, as shown in 
Figure 3.13 because there are in total six Csm3 subunits in the Tt Csm complex.  
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Since the proteins Csm1, Csm2, Csm4 and Csm5 could not be crystallized till date, there was no 
crystal structure available to map the cross-linked amino acid residues identified for these 
proteins.  
Overall, the results of cross-linking studies are very similar for both Type III-A Csm and Type I-E 
Cascade complex with at least one cross-linked region identified in all the Cas proteins in both 
the complexes. In addition, 28 out of 44 cross-links identified for the entire Csm complex, 
corresponded to Csm3, a Cas7 family protein. This result is expected as these proteins are 
present in the highest copy number in a crRNP complex and are in a close proximity to the 
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3.2.5 Protein-RNA cross-linking in Type III-B Cmr complex from T. thermophilus 
Thus far, the protein-RNA cross-linking investigation for multi-subunit crRNP complexes was 
performed only with the endogenous complexes (purified from endogenous sources). In this 
section I report the results from the investigation of protein-RNA interactions in both the 
endogenous and reconstituted Type III-B Cmr complex from T. thermophilus (Tt Cmr). 
 The Tt Cmr complex is composed of six different protein subunits (Cmr1-6) with a 
stoichiometry Cmr11Cmr21Cmr31Cmr41Cmr53Cmr61 and one crRNA. Electron microscopy 
studies revealed that the structure of Tt Cmr complex resembles a sea-worm [52], unlike the 
sea-horse model of Type I-E E. coli Cascade complex [105, 106]. In Tt Cmr, Cmr2 and Cmr3 form 
the tail, Cmr4 (Cas7 family protein), capped by Cmr5, form the helical backbone and Cmr1 and 
Cmr6 form a curled head (Figure 3.14). The overall architecture resembles notwithstanding the 
Type I-E Cascade complex.  
The endogenous complex was purified from the host T. thermophilus HB8 using a genomic tag 
(His-tag) as described in [52]. For the obtention of reconstituted complex, the individual 
components were expressed in E. coli and purified separately; the complex was reconstituted in 
a reaction tube by mixing the components one at a time in the required stoichiometry. The 
complex was reconstituted using two different crRNAs: 
46 nt crRNA 
5’ AUUGCGACCCGUAGAUAAGGCGCCCGGGGACGACCACGUCAAGGCG 3’ 
40 nt crRNA (lacking the six nucleotides at the 3’ end) 
5’ AUUGCGACCCGUAGAUAAGGCGCCCGGGGACGACCACGUC 3’ 
Deep sequencing analysis identified several different crRNAs that bind the endogenous 
complex. In most cases, however, the 40 nt crRNA was the most abundant followed by the 46 
nt crRNA [52]. Due to this reason these two crRNAs were used in the reconstitution of the 
complex in vitro. Nevertheless for the endogenous complex, it cannot be distinguished which of 
the crRNAs is a part of the final complex that was cross-linked, because the complex was 
purified from the endogenous sources i.e., from the T. thermophilus HB8 where several 
different crRNAs are present.  
Both endogenous and reconstituted complexes for this study were provided by Yifan Zhu from 
the group of Prof. John van der Oost (Wageningen University, Wageningen, NL). For both 
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complexes UV cross-linking was performed using one nmol of the respective complex. The 
cross-linking and data analysis was performed as described in (Section 2.2.6.5 and 2.2.9.3). In 
each of the two complexes, four cross-linked regions were identified. Three of these regions 
were observed in both complexes and the cross-linked residue identified in these three regions 
were also the same in both the endogenous and reconstituted complexes as summarized in 
Table 3.8. The corresponding fragment spectra for the cross-links identified are shown in the 
Appendix (Figure 6.4). 
 










160DFAPVSWGSPAYK172 Y171 U 6.4 A 
Cmr3 
(Q53W08) 
156GHEGPVPETRTHVALDPAAQTAR178 - U, UU, UUA 6.4 B 
166THVALDPAAQTAR178 L170 U, UU, UA, UUA, UGC 6.4 C 
Cmr4 
(Q53W06) 
204IRLDDETK211 L206 U, UU, UA 6.4 D 
Cmr6 
(Q53W04) 









34TYTLLTPLFGGGVEPREADPVSVVR58 - U, UC 6.4 F 
Cmr2 
(Q53W09) 
160DFAPVSWGSPAYK172 Y171 U - 
Cmr3 
(Q53W08) 
156GHEGPVPETRTHVALDPAAQTAR178 - UC - 
166THVALDPAAQTAR178 L170 U, UU, UA, UUA, UGC - 
Cmr4 
(Q53W06) 
204IRLDDETK211 L206  UU, UUA - 
 
Protein: Cross-linked protein (Uniprot ID); Peptide: Sequence of the cross-linked peptide, specified with 
the position of the peptide in the protein sequence; Amino acid: One-letter code specified with the 
position of cross-linked amino acid, RNA: composition of the RNAs observed cross-linked. 
For peptides cross-linked to mono- di- or tri-nucleotides depicted in bold, the corresponding MS/MS 
spectra are given in the Appendix, Figure 6.4.  
3. RESULTS  101 
 
 
Figure 3.14 Schematic representation of the cross-linked regions mapped on a model of the Tt Cmr 
complex. 
Model for the Tt Cmr complex based on the stoichiometry and structural organization of the sea-worm model 
reported in [52]. The cross-linked residues identified are mapped on the possible cross-link sites (yellow star) in the 
complex based on the position of the uracil residues in the crRNA sequence (in red). The Cmr subunits predicted to 
cross-link to different uracil residues are indicated below. The Cmr1 in the endogenous complex is depicted as 
transparent red shape because it is speculated that it is loosely attached to the complex. 
In each of the Crm2, Cmr3 and Cmr4 proteins only one cross-linked region/residue was 
identified. Depending on the location of the Cmr subunits in the EM structure and the sequence 
of the crRNA these results were mapped on a model of the Cmr complex (Figure 3.14). In Cmr2, 
Y171 was observed cross-linked to U, which could be any of the uracil residues close to the 5’ 
end of the crRNA as Cmr2 is the tail protein present close to the 5’ end of the crRNA. In Cmr3, 
L170 was observed cross-linked to different RNA moieties, with uracil as the cross-linked 
nucleotides (Table 3.8). The composition of these RNA moieties indicates that the cross-linked 
uracil could be either of the U2 or U3 residues at the 5’ end. In Cmr4, L206 was observed cross-
linked to uracil. As Cmr4 is present in four copies in the complex, the cross-linked residue could 
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not be unambiguously assigned to one of the four copies. Considering that there are only five 
uracil nucleotides in the entire crRNA which are not uniformly distributed, it can be speculated 
that only the Cmr subunits in close proximity to these uracil residues are likely to cross-link as 
shown in a model of the Tt Cmr complex in Figure 3.14.  
In addition to the above mentioned cross-links, one cross-linked region was observed in the 
Cmr1 subunit of the reconstituted complex. The peptide 34TYTLLTPLFGGGVEPREADPVSVVR58 
was cross-linked to a UC RNA dinucleotide, where uracil was the cross-linked nucleotide. 
According to the crRNA sequence U39 is the only uracil with a cytosine residue adjacent to it and 
it is in proximity to the 3’ end of the crRNA which is the position of Cmr1 in the Tt Cmr complex 
as reported in the EM structure [52].  
One significant difference observed between the two complexes was the cross-linked protein 
region 169LHPDILNPHHPDYYGSVK186 in Cmr6 protein of the endogenous complex and the cross-
linked protein region 34TYTLLTPLFGGGVEPREADPVSVVR58 in Cmr1 protein in the reconstituted 
complex. With native MS analysis on the Tt Cmr complex it has been shown that the Cmr1 
subunit is located at the periphery of the complex and has a very lose attachment with the 
complex under in vitro conditions [52]. This gives rise to the ambiguity in identifying the subunit 
cross-linked to the 3’ end of the crRNA.  
The results from this study show high reproducibility between the endogenous and 
reconstituted Cmr complexes, and prove this approach as suitable for studying other complexes 
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3.3 Quantitative and structural investigation of the Type I-B Cascade complex 
from C. thermocellum  
After establishing the protein-RNA cross-linking workflow for the identification of protein-RNA 
interactions in the prokaryotic crRNP complexes, the structural investigations were further 
extended to determine the interactions within different protein subunits constituting the crRNP 
complex. The structural investigation was carried out in combination with a quantitative 
analysis to estimate the absolute amount of the protein subunits present in the complex. In this 
way the interactions identified by MS analysis could be explained with comparison to the 
stoichiometry of the different protein subunits in the complex.  
The project was undertaken in collaboration with Judith Zöphel and Prof. Lennart Randau (MPI 
Terrestrial Microbiology, Marburg). It focused on performing quantitative analysis using iBAQ 
and investigating the interactions between different protein subunits using protein-protein 
cross-linking in Type I-B Cascade-like complex in Clostridium thermocellum_3205.  
Type I-B Cascade complex is one of the least investigated assemblies of the CRISPR-Cas systems. 
The complex used in this study consists of four Cas proteins, Cas5, Cas6, Cas7 and Cas8b in an 
unknown stoichiometry. The presence of the signature protein Cas8b, classifies this complex as 
a Type I-B crRNP complex [21, 22]. For the complex assembly, different components of the 
complex were cloned and expressed separately. The entire complex was reconstituted in vitro 
by addition of the crRNA and the four Cas proteins one at a time, further purification details of 
the assembly and purification of Cascade complex are described in Section 2.2.1.8. The purified 
assembled complex was provided by Judith Zöphel.  
3.3.1 Stoichiometry determination in the C. thermocellum Cascade complex 
To investigate the stoichiometry of Cas5, Cas6, Cas7 and Cas8b proteins in the complex, the 
label-free absolute quantification approach (iBAQ) was performed using the universal protein 
standard UPS2. The same workflow was used for iBAQ as described under Section 3.1.2 for the 
H. volcanii Type I-B Cascade complex. All the proteins that were identified and quantified from 
three technical replicates are listed under Table 6.1 in the Appendix. iBAQ values for three 
replicates of the standard proteins were averaged. A calibration curve was prepared using the 
known amounts of standard proteins in UPS2 and the average iBAQ values. A double 
logarithmic plot where the log (amount) of the standard proteins identified was plotted against 
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the log iBAQ value. The concentration of Cas5, Cas6, Cas7 and Cas8b proteins were calculated 
using the log/log linear regression (Appendix, Figure 6.5).  
The derived protein concentrations indicate a Cas5:Cas6:Cas8b:Cas7 stoichiometry of 1:1:2.5:6 
(Appendix, Table 6.1). This low:low:high ratio for the Cas5, cas6 and Cas7 stoichiometry is in 
agreement with previously observed stoichiometry for Cascade-type protein complexes in H. 
volcanii [89], E. coli [30] and P. aeruginosa [40].  
In addition, from the stoichiometry of 2.5 observed for Cas8b protein, it can be assumed that 
there are two Cas8b subunits in the Cascade complex and one truncated fragment 
corresponding to half a Cas8b subunit. However, when the purified preparation of Cascade 
complex was analyzed by SDS-PAGE (Figure 3.15, Lane1), Cas8b was observed as two bands 
after coomassie staining, one corresponding to the full length version at 72 kDa and a short 
fragment of ~15kDa (Cas8b*) which was also confirmed as Cas8b by MS analysis. This 
conspicuous nature of Cas8b is currently under investigation (Randau Lab, unpublished data). 
In other Type I CRISPR systems, it has been reported that the large subunit protein (Cas8) is 
present in one single copy as depicted in a schematic representation of the Type I crRNP 
complexes in Figure 1.4.  
3.3.2 Protein-protein cross-linking in the C. thermocellum Cascade complex 
The goal of this investigation was to characterize protein-protein interactions within the Cas 
proteins in the Type I-B Cascade complex from C. thermocellum. The project sought to evaluate 
the feasibility of chemical protein-protein cross-linking for the investigation of purified crRNP 
complexes. Although there is not enough protein-protein interaction data available to validate 
the results of this study, the information available from the common architectural features of 
the Type I crRNP complexes was used to explain the outcome from protein-protein cross-linking 
study. 
Chemical cross-linking was performed using BS3, which targets primary amines in the side 
chains of lysine residues on protein surface as well as protein N-termini. In order to optimize 
the cross-linker:protein ratio to be used for cross-linking, the purified Cascade complex was 
incubated with increasing molar excesses of BS3 cross-linker in the cross-linker to protein ratio 
5:1, 10:1, 25:1, 50:1 , 100:1 and 200:1. The results of this titration were analyzed with SDS-
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PAGE as shown in Figure 3.15. The details of the cross-linking reaction are described under 
Section 2.2.7.  
 
Figure 3.15 Analysis of protein-protein cross-linking by SDS-PAGE. 
Coomassie stained SDS-PAGE gel showing the results of protein-protein cross-linking performed in the Cascade 
complex using different concentration of BS3 cross-linker. Lane 1: The purified Cascade complex alone (without 
any cross-linker) consisted of Cas7 (35 kDa), Cas5 (28 kDa), Cas6 (26 kDa) and two fragments for Cas8b the larger 
fragment 72 kDa and a smaller ~15 kDa fragment Cas8b*. Lane 2-7: Optimization of cross-linker to protein complex 
ratio. As the molar excess of BS3 over Cascade increases, the intensity of bands corresponding to Cas proteins 
diminishes. At the same time bands corresponding to protein-protein cross-links appear with even 5:1 cross-linker 
to protein ratio. The ratio 100:1 and later corresponds to high molecular aggregates which can be neglected. lM: 
Protein marker (BioRad). 
Upon the SDS-PAGE analysis it was observed that the purified Cascade complex from C. 
thermocellum comprised four Cas proteins Cas7, Cas5, Cas6 and Cas8b (Figure 3.15 Lane 1). 
Throughout the titration the protein-protein cross-links could be observed in all the cases 
where even a minimal amount (5 molar excess) of BS3 cross-linker was present. With increasing 
amounts of cross-linker the band corresponding to protein-protein cross-links also enhanced 
(Figure 3.15 Lane 2-7). At very high cross-linker amounts there were higher order aggregates 
and artefacts appearing as a smear at high molecular weight (Figure 3.15 Lane 6 and 7).  
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For the MS analysis the cross-linker to protein ratio of 75:1 was selected as the optimal ratio for 
the final cross-linking experiment. This ratio was selected to avoid the complex high-order 
aggregates and at the same time to get enough protein-protein cross-links, for the MS analysis. 
The cross-linked complexes were hydrolyzed with trypsin and the resulting peptide mixture was 
further enriched for cross-linked peptides using size exclusion chromatography (Figure 1.13), 
details in section 2.2.7.3.  
The enriched cross-links were analyzed by LC-MS/MS in DDA mode on an Orbitrap Fusion 
instrument and the cross-linked peptides were identified using pLink, using 1% FDR and the 
results are presented in a cross-link map (Figure 3.16) after applying a score cut-off of 2.0 
(based on the p-value). The spectra for the cross-links identified were also manually checked to 
confirm the assigned cross-link. Further the cross-link species such as mono-links or loop links 
(Figure 1.13) were filtered out from the final list of cross-links, as they carry limited information 
not significant in the investigation of protein-protein interactions. In the end only unique inter-
protein and intra- protein cross-links are reported in this work.  
3.3.2.1 Inter-protein cross-links identified for Cas5, Cas6, Cas7 and Cas8b proteins 
From the MS analysis 126 unique inter-protein cross-links shown in Figure 3.16 were identified 
within the four Cas proteins (Appendix, Table 6.2). However due to a lack of structures available 
for these proteins, it was not possible to map the cross-link sites on three dimensional 
structures. Nonetheless, the cross-links identified in the Cas proteins were in agreement to the 
Cas protein stoichiometry and the position of a particular Cas protein in the Type I Cascade 
complexes [22], as determined in recent studies on the architecture and organization of E. coli 
Cascade complex [105, 106].  
Two inter-protein cross-links were identified for the Cas6 protein, K22 was observed cross-linked 
to K155 in the N-terminal region of Cas7 protein and K106 was observed cross-linked to K73 in the 
N-terminal region of Cas8b. The Cas6 protein forms the head of an assembled Cascade complex 
interacting with the 3’ end of crRNA, as reported earlier in the Type I-E E. coli Cascade complex. 
Further, the head protein interacts with the first Cas7 protein that forms the backbone of a 
Cascade complex and also the large subunit Cas8b which spans the entire length of the 
complex. In addition no cross-link between Cas6 and Cas5 (the tail protein) was observed, 
which is in agreement with the positioning of Cas5 and Cas6 proteins in the Cascade complex as 
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shown in (Figure 1.4 and 1.15) i.e., the head and tail proteins are distant enough for cross-




Figure 3.16 Protein-protein cross-linking map for the C. thermocellum Cascade complex. 
A protein-protein cross-link map made using xiNET. Only the inter-protein cross-links identified for Cas6, Cas5, 
Cas7 and Cas8b proteins are shown. The cross-links were identified using pLink with 1% FDR. The cross-links 
indicated are the one remaining after applying a score cut off 2.0. The gray shaded regions indicate high density of 
cross-links between those regions. The blue shaded regions indicate lysine rich regions of the proteins with a high 
density of cross-links observed for the lysine residues. Further details of all the identified cross-links are provided 
in the Appendix (Table 6.2) 
In Cas5 a higher number of cross-links were identified. There were 12 unique cross-links 
identified between Cas5 and Cas8b and 37 between Cas5 and Cas7. Most of these cross-links 
were confined to a lysine rich region in Cas5 with four residues K72, K84, K85 and K97 as shown in 
Figure 3.16. Cas5 is a part of the tail assembly in Cascade complex [105] which comprises Cas5, 
Cas7 and in this case Cas8b subunits.  
Between Cas7 and Cas8b proteins 75 unique cross-links were identified corresponding to lysine 
residues distributed throughout the protein sequence. In both Cas7 and Cas8b a very high 
number of cross-links were identified in the two lysine rich regions of both the proteins as 
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shown in Figure 3.16. The high number of cross-links identified is in agreement with the 
stoichiometry determined. Both the proteins are present in more than one copy; therefore the 
cross-links identified cannot be assigned to any one subunit of the two proteins. Rather it can 
only be speculated that the regions with high density of cross-links are in close spatial 
proximity, likely to form cross-links in the presence of a chemical cross-linker such as BS3. In 
addition, the Cas7 protein has been reported to form the helical backbone of the Cascade-like 
complexes and is supported by the large subunit Cas8b throughout the length of the complex 
(Figure 1.4), therefore so many protein-protein interactions between the two proteins are likely 
to occur.  
3.3.2.2 Intra-protein cross-links identified for Cas5, Cas6, Cas7 and Cas8b proteins 
In addition to the inter-protein cross-links described above, a large number of intra-protein 
cross-links were also identified for all the four Cas proteins. A total of 16 unique intra-protein 
cross-links were observed in Cas5 and six in Cas6 (Appendix, Table 6.3 and 6.4). Only for these 
two proteins Cas5 and Cas6 protein which are present in a single copy in the Cascade complex, 
the identified cross-links could be mapped unambiguously on the protein sequence (Appendix, 
Figure 6.6).  
In Cas7 there were 112 unique intra-protein cross-links and for Cas8b there were 230 unique 
intra-protein cross-links. However these numbers cannot be assigned to any one subunit of the 
two proteins in particular. Considering the stoichiometry of the two proteins, there is a high 
ambiguity in mapping these cross-link sites to the protein sequence and assigning them to 
different protein subunits. Hence further details of the intra-protein cross-links identified for 
Cas7 and Cas8b are not included in this work. 
These protein-protein cross-linking studies provide the first experimental evidence for the 
protein-protein interactions in Type I-B Cascade complex from C. thermocellum and can be used 





The work presented in this thesis focused on two main mass-spectrometric approaches in the 
investigation of prokaryotic immune defense system. (i) Quantitative approach to compare the 
proteomes of wild-type strains with those of strains that carry deletion mutants of Cas proteins 
and to determine the stoichiometry of Cas proteins in a multi-subunit crRNP complex. (ii) 
Structural mass-spectrometric approach to elucidate protein–RNA contact sites among the 
various single and multi-subunit crRNP complexes from prokaryotes using UV induced cross-
linking and a lysine directed cross-linking approach to look into the protein-protein interactions 
in Type I-B Cascade complex from C. thermocellum. In this chapter the applicability, advantages 
and limitations of both mass spectrometric approaches are discussed in conjunction with the 
implications of results obtained in the different CRISPR-Cas systems. 
4.1 Quantitative approach for the investigation of CRISPR-Cas system 
The two methods used for quantitative analysis in this work allow for a comprehensive 
evaluation of quantitative proteomics using relative quantification at the proteome level and 
absolute quantification at the protein level. 
4.1.1 Relative quantification using dimethyl labeling to investigate the effect of cas7 
deletion on other Cas proteins in H. volcanii 
The quantitative MS based proteome study of H. volcanii revealed how the deletion of cas7 
gene influences the expression of other Cas proteins and the entire cellular proteome. Using 
differential stable isotope dimethyl labeling, approximately 1800 proteins were identified and 
quantified in both forward and reverse experiments. The level of Cas7 protein in the cas7 
deletion strain was observed to be the most downregulated (Table 3.1). The normalized ratio 
H/L of Cas7 in both the experiments indicated a residual level of Cas7 protein against the 
background noise. The quantitation approach showed that the gene deletion was effective as 
only negligible amounts of protein were detected. Therefore the expression of the gene was 
efficiently suppressed. 
One of the proteins remarkably affected by the cas7 deletion was the Cas5 protein. It was the 
only Cas protein other than Cas7 that was observed to be downregulated. It has been recently 
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reported that the proteins Cas5, Cas6 and Cas7 form together a Cascade-like complex in H. 
volcanii for the processing and stabilization of crRNA [89]. Due to the association between Cas7 
and Cas5 protein it can be proposed that in the wild-type strain Cas5 is a part of multi-subunit 
protein complex, hence it might be protected from degradation by cellular proteases. However 
in the deletion strain where an integral part of the Cascade complex, the Cas7 protein is 
missing, it can be speculated that the Cas5 protein is degraded by proteases and therefore it 
appears downregulated with the relative quantification analysis. Additionally, the cas5 gene is 
located just 11 bp downstream of the cas7 gene in the CRISPR loci (Figure 1.14). The removal of 
cas7 sequence could mean that the possible additional promoters [152] in the cas7 gene were 
also removed which adversely affects the production of Cas5 protein. The possible additional 
promoters in cas7 gene are currently under investigation in the Marchfelder lab, University of 
Ulm.  
The Cas proteins which were upregulated upon cas7 deletion, included Cas1, Cas8 and Cas6 
(Table 3.2). In a nutshell all the Cas proteins forming an integral part of the Cascade complex in 
H. volcanii were upregulated upon deletion of cas7 gene, except the Cas5. The CRISPR-Cas 
system plays a very significant role in the prokaryotic immune defense. The removal of cas7 is 
compensated by increased expression level of the cas gene cluster to make up for the 
effectiveness of the immune system. The Cas1 protein was the most upregulated protein, 
which is expected because it is an endonuclease which in conjunction with the Cas2 is 
responsible for the selection of a new protospacer and its incorporation as a spacer in the 
genome in the starting (adaptation) phase of the CRISPR based immune defense [23]. In 
addition, the archaeal specific helicase protein AshA was also observed to be upregulated upon 
cas7 deletion. The protein has not yet been shown to have a direct association with the CRISPR-
Cas system, interference tests performed with a deletion strain of this helicase resulted an 
inadequate immune response against artificially generated invader plasmids (Marchfelder lab, 
unpublished observation). 
Other Cas proteins in H. volcanii, Cas2, Cas3 and Cas4 were not identified in this experiment, 
which could correspond to the levels of these proteins being below the limit of detection of the 
method used. A specialized workflow has been developed earlier in our group, for in-depth 
proteome analysis using 1D-PAGE coupled to pIEF prior to LC-MS/MS, resulting in increased 
protein identification with higher sequence coverage [153]. A similar approach was also 
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developed for the H. volcanii in-depth proteome analysis, to look especially for low abundant 
Cas proteins using the in-depth proteomics approach recently established in the Urlaub lab 
[153].  
Differential stable isotope labeling using dimethyl labels was used for the relative quantification 
study in this thesis. Stable isotope dimethyl labeling performed in-solution is best suited for 
experiments where more than one samples have to be labeled because it is straightforward, 
easy and cheap for the comparison of two or three different samples [84]. 99% percent of the 
proteins quantified in this experiment, had a ratio close to 1:1 for the H119 wild-type and the 
∆cas7KO deletion strain in both forward and reverse experiments. This demonstrates a good 
reproducibility between both the forward and reverse experiments and that the majority of the 
proteome is unaffected by the cas7 deletion. 
As the protein samples were derived from an archaeon and there was no auxotrophic strain 
available for the incorporation of isotopic labels at the cellular level, popular quantification 
methods such as SILAC could not be used in this study. In addition, the labeling was performed 
at the peptide level, and not at the protein level to allow proteolysis with trypsin which in latter 
situation would not be able to cleave the modified lysine residues. Lastly, the dimethyl labeling 
is a faster and cheaper alternative to the strategies routinely used for relative quantification.  
4.1.2 Absolute quantification using iBAQ to determine the stoichiometry of Cas 
proteins in H. volcanii and C. thermocellum Cascade complex 
In this thesis the absolute quantification experiments were performed using iBAQ to determine 
the absolute amount (copy number) of Cas proteins in different multi-subunit protein 
complexes assembled around a crRNA (Cascade-like complexes) from H. volcanii and C. 
thermocellum [89, 127]. These CRISPR associated complexes for antiviral defense are a 
characteristic feature of Type I CRISPR-Cas systems. A well-organized assembly of multiple Cas 
proteins with individual components in different copy numbers. For any investigation related to 
the identification of protein-RNA or protein-protein interactions between different components 
of these complexes and to gain insights into the architectural organization of these complexes it 
is a prerequisite to know the copy number of different proteins present in the complex. With 
the recent discoveries of a Cascade-like complex in H. volcanii and C. thermocellum and limited 
information available on the copy number of individual proteins, the iBAQ approach was used 
to determine the absolute amount of Cas proteins in these complexes.  
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The iBAQ approach was used as the method for absolute quantification for two reasons: (i) it is 
inexpensive in comparison to the use of labeled standard peptides in the AQUA (Absolute 
quantification) method and (ii) it does not require a dedicated MS instrumental set-up or 
method development like in AQUA and/or native MS experiments. However iBAQ exhibits 
limited accuracy in the determination of high stoichiometries in protein complexes due to a 
lower accuracy in the determination of high protein copy numbers [87, 89]. 
In H. volcanii type I-B system a Cascade-like complex was observed, comprised of at least Cas5, 
Cas6 and Cas7 proteins and a crRNA. The purification of FLAG-Cas7 revealed two potential 
interacting partners (Figure 3.3 B) which were identified as Cas5 and Cas6 proteins with MS 
analysis. The co-purification of these proteins indicates the presence of these Cas proteins in 
the Haloferax Cascade complex. The absolute amounts of proteins derived from the iBAQ 
analysis show a Ca6:Cas5:Cas7 stoichiometry 1:1.7:8.5 (Table 3.3). The low:low:high 
stoichiometry fits very well to the previous observations in the Cascade complexes from Type I-
A, Type I-E and Type I-F systems [19, 30, 41]. In all these complexes the Cas7 protein is present 
in multiple copies and forms the backbone of the complex.  
In C. thermocellum the Cascade-like complex was observed to comprise of four proteins, Cas5, 
Cas6, Cas7 and the large subunit Cas8b which is the signature protein of Type I-B systems. The 
protein components were also identified and confirmed with MS analysis. The absolute 
amounts of proteins derived from the iBAQ analysis show a Cas6:Cas5:Cas8b:Cas7 
stoichiometry 1:1:2.5:6 (Appendix, Table 6.1). The ratio of Cas5, Cas6 and Cas7 was similar to 
the previous observations in different Cascade complexes as described above. However, the 
stoichiometry of 2.5 for Cas8b is in contrast to the proposed models for Type I-A, I-C, I-E and I-F 
Cascade complexes where the large subunit Cas8b appears as a single copy [22]. This 
conspicuous behaviour of Cas8b was also observed during the SDS-PAGE analysis (Figure 3.15) 
where the protein was present as a full 72 kDa protein and as a short ~15 kDa fragment. The 
corresponding bands for both protein fragments from the SDS-PAGE were identified as Cas8b 
with the MS analysis. This observation is still under investigation in the Randau lab.  
Nonetheless, the 2.5 stoichiometry of Cas8b can be confirmed with a widely used absolute 
quantification approach, AQUA. It is a targeted approach that makes use of chemically 
synthesized peptide containing stable isotopes which are added to the protein sample as 
internal standards and the absolute amount of proteins (comprising these peptides) can be 
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estimated in a complex mixture [154, 155]. Likewise, two specific labeled peptides can be used 
for determining the absolute amount of Cas8b, with one peptide against the C-terminal part of 
the protein which is speculated to form the short fragment and the second peptide against the 
N-terminal part of the protein. However, a drawback of this method would be the very high 
cost of the labeled peptide standards, requirement of a dedicated MS instrument set-up and in 
the end only two peptides per protein would be quantified.  
4.2 CRISPR-Cas: a mass spectrometry based structural perspective 
The three major types of CRSIPR-Cas systems are divided into eleven subtypes on the basis of 
organization of CRISPR locus and the cas gene content [21]. Each of these comprises a different 
crRNP complex composed of Cas proteins and a crRNA. The building-blocks of these complexes 
are the Cas proteins which vary in their copy numbers in the different complexes. The fully 
assembled complexes are mechanistically very diverse in the three types of CRISPR-Cas 
systems. The Type I and Type III systems have multi-subunit assemblies resembling a sea-horse 
structure as in the Type I-E E. coli Cascade [43] or a sea-worm structure as in the Type III-B T. 
thermophilus Cmr complex [52], in contrast to a single multi-functional protein Cas9 in the Type 
II system. However for all the crRNP complexes the architectural assembly has one thing in 
common, that is the assembly of Cas proteins around a crRNA which acts as a guide for the 
target recognition by the crRNP complex. Moreover, they provide an elaborate platform for the 
investigation of protein-RNA interactions as reported in the recently co-crystallized E. coli 
Cascade complex comprising 11 Cas protein subunits assembled around a crRNA [105, 106]. 
The proteins Cas5, Cas6 and Cas7 contain RNA binding domains such as modified RRMs, belong 
to the RAMP (repeat associated mysterious protein) superfamily and have been shown to 
interact with the crRNA [18, 19, 29, 30, 105]. The structural proteomics studies performed in 
this work using UV induced protein-RNA cross-linking and MS allowed the identification of RNA-
binding sites on a peptide or amino acid level and helped validate some of these interactions. In 
addition, new RNA binding regions were identified in these proteins which were not a part of 
the characteristic RRMs. The details of these investigations are discussed below with respect to 
protein-RNA cross-linking in the individual (recombinant) Cas protein and their cognate crRNA 
and the entire multi-subunit crRNP complexes. In general, the considerations and potentials of 
the protein-RNA cross-linking approach are discussed later in a separate Section 4.3. 
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4.2.1 Cas6b-crRNA cross-linking 
Cas6 is one of the most widely distributed Cas proteins present in both bacteria and archaea. 
The Cas6 proteins are endoribonucleases that catalyze the reaction of pre-crRNA cleavage into 
smaller processed crRNAs [39]. The cleavage reaction yields mature crRNA with a 5’ terminal 
tag of 8 nucleotides derived from the repeat [39, 127, 146]. The crRNA processing activity of all 
the Cas6 proteins is similar but the sequence similarity in these proteins is limited. They 
typically contain two RAMP domains (ferredoxin-like folds, similar to RRM domains) with a 
glycine-rich loop located in between [39, 156, 157]. The sequence of this glycine-rich loop often 
fits the consensus sequence GΦGXXXXXGΦG, where Φ is a hydrophobic residue and X is any 
residue with the variable region containing at least one positively charged residue [15, 24]. An 
alignment for the Cas6b homologues using Clustal W also indicated the presence of a conserved 
glycine rich loop (Figure 3.6) in the two Cas6b proteins used in this work. In both prokaryotes 
and eukaryotes such glycine rich domains like the G-patch domains have been reported to be 
involved in RNA-interactions [100, 158, 159]. However, the cross-linked residues identified for 
the two Cas6b proteins were located in close proximity to the G-rich loop but were not an 
integral part of the loop. 
In the Cas6b protein from archaeon M. maripaludis, M185 residue in its oxidized state was 
identified cross-linked to U15 residue on the cognate crRNA (Figure 3.5 and 3.6). To further 
confirm that M185 played an important role in interaction with the crRNA, mutation studies 
were performed on the Mm Cas6b by Hagen Richter from the group of Prof. Lennart Randau, 
MPI Terrestrial Microbiology, Marburg. The Cas6 protein with a single point mutation of M185A 
was tested for RNA-binding by electrophoretic mobility shift assays (EMSAs) which exhibited a 
significant decrease in the RNA affinity of the mutated protein and the RNA binding was 
considerably affected (Appendix, Figure 6.7). The experiment was performed as a qualitative 
analysis only to confirm the efficacy of UV induced cross-linking in identifying protein-RNA 
interaction sites. Meanwhile, our collaborators were successful in the co-crystallization of Mm 
Cas6b with the cognate crRNA. The co-crystal structure showed that the motif II of the crRNA 
repeat recognized by the Mm Cas6b, comprises a two base pair stem (G16-C29/C17-G28) and an 
adenine-rich loop (A18-A27). The major groove edge of U15, forms a polar interface with the 
protein at which the amino acid residue R206 of G-rich loop interacts with the C29 nucleotide 
residue on the crRNA and the amino acid residue L124, with U15 nucleotide of the crRNA. The 
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base of U15 nucleotide stacks with M185 amino acid residue (Randau lab, unpublished data) in 
agreement to the protein-RNA cross-linking results. 
In the Cas6b protein from bacterium C. thermocellum, M184 was identified as the cross-linked 
amino acid residue. However on the crRNA the cross-linked nucleotide could not be identified 
unambiguously and both U3 and U32 from the 5’end were identified as the possible candidates 
(Figure 3.6). The peptide 184MIGFK188 was observed cross-linked to UGA and UUG and in both 
RNA moieties uracil was the cross-linked nucleotide. When mapped on to the crRNA sequence 
these correspond to the U3 and U32 residues. In this case a cross-link with a longer RNA moiety 
would have been more informative to map the correct uracil residue on the crRNA sequence. 
However the method is developed for identification of the protein region in contact with RNA 
and the presence of longer RNA moieties suppresses the intensity of peptide fragment. The 
RNA length comes at the expense of the identification of the peptide and therefore extensive 
RNAse digestion is performed so that the RNA fragments are not longer than 2-3 nucleotides. 
Further details regarding potentials of UV induced cross-linking are discussed under Section 4.3. 
Despite low primary sequence conservation between Cas6 proteins, there is a structural 
homology between Mm Cas6b and Pyrococcus furiosus (Pf) Cas6 [127]. Both the archaeal and 
bacterial Cas6b proteins were modeled based on the Pf Cas6 crystal structure (Figure 3.6) and 
when the two models were aligned structurally the identified cross-linked residues were 
mapped onto the same location in both proteins (Figure 3.6). The results from sequence 
alignment for Cas6b homologues indicated the presence of a conserved glycine-rich region near 
the C-terminal of the protein, which constitutes the glycine-rich loop that is known for its 
interaction with the RNA. In addition, the methionine residue identified as the cross-linked 
amino acid in both Mm Cas6b and Ct Cas6b proteins is also conserved across the different 
archaeal and bacterial Cas6 (Figure 3.6). Lastly, the co-crystallization studies in Mm Cas6b 
indicate that in addition to the glycine-rich loop, an evolutionary conserved RNA binding region 
comprising the M185 amino acid residue also interacts with the crRNA.  
4.2.2 Protein-RNA interactions in the Cas7 protein family 
In addition to the Cas6 protein family, the Cas7 family also belongs to one of the best 
understood Cas proteins both structurally and functionally. Four different Cas7 proteins were 
used for this investigation. Two recombinant Cas7 proteins, Type I-A Cas7 from T. tenax and 
Type I-D Cas7 (Csc2) from T. pendens were cross-linked to polyU RNA. Both these proteins have 
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been observed before to bind both polyU RNA as well as the cognate crRNA [103, 131]. 
However due to the unavailability of crRNA, the cross-linking was performed with polyU(15). The 
results were compared to the cross-linked regions identified in Cas7 proteins belonging to the 
fully assembled crRNP complexes. These included Type I-E Cas7 in the Cascade complex from E. 
coli and Type III-A Cas7 (Csm3) in the Csm complex from T. thermophilus, the cross-linking was 
performed on fully assembled crRNP complexes where these Cas proteins were bound in 
multiple copies to a single crRNA (Figure 3.7 and 3.8).  
The identified cross-links were mapped onto the crystal structure of E. coli Cas7 (PDB: 1VY8) 
[105] and T. pendens Csc2 (PDB ID: 4TXD) [103] and to the predicted 3D-structure models of T. 
tenax Cas7 and T. thermophilus Csm3, generated using Phyre2 [141]. The results were 
compared with the crRNA-binding surface of Type I-E E. coli Cas7, which was crystallized in 
context of the fully assembled crRNP complex from E. coli [105]. The crystal structure of T. 
pendens Csc2 and the homology models (T. tenax Cas7 and T. thermophilus Csm3) were 
superposed onto two copies of E. coli Cas7 (PDB ID: 1VY8) using secondary-structure matching 
(SSM) superposition in COOT [142]. The structure of two copies of E. coli Cas7 bound to crRNA 
was used for the superposition (Figure 4.1). 
E. coli Cas7 
In the E. coli Cas7 protein, due to a right hand shaped structure, different structural domains 
are referred to as thumb, finger and palm domains (Figure 3.10), however to follow a uniform 
nomenclature for all the Cas7 homologues these domains are named here as insertion 
domain1, insertion domain2 and the central cleft respectively. Two out of seven cross-links 
amino acid residues K27 and M166 were present in the central cleft region of the protein. The 
universal central cleft is a positively charged groove on the protein surface and is important in 
mediating the binding to RNA as also observed in T. pendens Csc2 [103] and T. tenax Cas7. 
However, five out of seven cross-linked amino acid residues identified K86, K98, K137, K141 and 
K144 were present in the finger domain i.e., the insertion domain 2 of the Cas7 protein (Figure 
4.1). All the cross-links were observed in the lysine-rich helix. Although there have been no 
earlier reports for RNA interaction in this domain, the results described here provide a strong 
indication that this region also has a role in RNA interaction. Moreover, it should be noted that 
the Cascade complex was cross-linked in solution and therefore there is a strong possibility that 
in solution the RNA can flip over the Cas7 protein, interacting with these lysine residues in the 
insertion domain 2, allowing in this manner for the identification of novel RNA binding regions. 
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Figure 4.1 Mapping the protein-RNA cross-links identified in different Cas7 proteins to the crystal and 
modeled structures. 
Predicted Cas7 3D-models (Type I-A T. tenax Cas7 and Type III-A T. thermophilus Cas7) and Type I-D T. pendens 
Cas7 (Csc2) crystal structure (PDB ID: 4TXD) [103] superposed to two copies of crRNA-bound Type I-E Cas7 (PDB ID: 
1VY8) [105]. The front copy is shown in cartoon, the back copy additionally in surface representation. The crRNA is 
colored black, the protein structures are colored grey, the cross-linked peptide yellow and cross-linked sites are 
highlighted in red. The universally present central cleft defined by the RRM and the insertion domain 1 and 2 
(circles) are labeled in Type I-E Cas7. Modified from Sharma, K. et al., manuscript under revision. 
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T. pendens Csc2 
In Type I-D T. pendens Csc2 all the three cross-linked amino acid residues M83, C131 and W346 
were observed in the universal central cleft region. When compared to the surface structure of 
the protein depicting the electrostatic potential, it was observed that the central cleft region is 
a positive charged patch on the protein surface and therefore likely to interact with the 
negatively charged RNA moiety. These results were also mapped on a model of four Tp Csc2 
protein subunits arranged in a chain. When the three residues were mapped on each of the 
four subunits, the location of the cross-links coincided with a positively charged channel along 
the four proteins (Figure 3.8) indicating that this constitutes an RNA binding patch on the 
surface of these proteins. In addition, the biochemical analysis shows that conserved residues 
in these positively charged grooves contribute significantly to RNA binding [103]. 
T. tenax Cas7 
In the superimposed model of the Type I-A T. tenax Cas7, the crRNA uniformly contacts 
secondary structure elements of the lid domain as well as the central cleft defined by the core 
RRM. Four out of five cross-linked amino acid residues, G28, V148, F155 and M172 were located in 
the lid-domain (insertion domain 1) and one cross-linked amino acid residue Y7 was located in 
the universally present central cleft.  
T. thermophilus Csm3 
In Type III-A T. thermophilus Csm3 the cross-linked amino acid residues Q144, G153 and R162 were 
present in the lid domain and P96 was present in the central cleft. Previous studies on the 
respective Type I-A and Type III-A homologues Sulfolobus solfataricus Cas7 [19] and 
Methanopyrus kandleri Csm3 [55] also report similar RNA binding properties in the insertion 
domain 1 (lid domain) of Cas7 proteins in full agreement with the cross-links observed in this 
study.  
In conclusion, the positively charged surface groove appears to be a conserved functional site 
for crRNA recognition and the influence of the lid domain in crRNA interaction varies with 
respect to specific Cas7 family proteins. Also it can be hypothesized that the Cas7 family 
proteins constituting the backbone of crRNP complexes harbor the active sites for RNA binding.  
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4.2.3 Structural insights into the protein-RNA interactions in multi-subunit crRNP 
complexes 
The protein-RNA cross-linking approach was extended to investigate protein-RNA interactions 
in fully assembled multi-subunit crRNP complexes. The three crRNP complexes investigated in 
this work included Type I-E E. coli Cascade complex, Type III-A T. thermophilus Csm complex and 
Type III-B T. thermophilus Cmr complex.  
Type I-E Cascade complex from E. coli 
The E. coli Cascade complex comprising 11 protein subunits (corresponding to five different Cas 
proteins) and a crRNA was recently crystallized (Figure 1.15) [105], providing a major 
breakthrough in the understanding of molecular interactions within a crRNP complex. With the 
protein-RNA cross-linking investigation of E. coli Cascade complex, 70 different cross-linked 
peptide-RNA heteroconjugates were identified (Table 3.6), corresponding to 17 unique cross-
linked regions across the five different Cas proteins in the complex. The high yield of cross-links 
is indicative of the significant contribution of the protein-RNA cross-linking approach. Two 
important points were taken into consideration during the interpretation of these results when 
mapped on the crystal structure of E. coli Cascade complex: (i) The cross-linking experiments 
were performed in solution, which would result in a conformational variability of the complex 
in solution and (ii) The crystal structure used to map the cross-links was obtained from the 
Cascade complex comprising a different crRNA (with a different spacer) than the one used in 
the cross-linking study, therefore the mode of RNA binding would be different in the two 
complexes. Together these two considerations were helpful in interpreting the differences 
between the co-crystallization and the in solution protein-RNA interactions studies. 
In Cas6e, the head of the Cascade complex, two cross-linked regions were observed (Figure 
3.9B). Firstly, K106 present in the positive charged groove-loop in the C-terminal RRM domain 
was identified as a cross-linked residue. This region has been reported to present extensive 
contacts with the 3’ crRNA stem-loop and the results of protein-RNA cross-linking validate this 
interaction. In the second cross-linked region 145R-Y148 the exact cross-linked residue could not 
be identified. Nonetheless, this region is a part of a flexible loop in close spatial proximity to 
uracil residue and therefore it is likely to interact with the RNA in solution. 
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 In Cse1, the largest protein in Cascade complex, one cross-linked amino acid residue F403 was 
identified (Figure 3.9C). The cross-linked region is located at C-terminal of Cse1 that connects 
with C-terminal of Cse2.2. To date there have been no reports on the RNA binding properties of 
this domain. However, in the cross-linking study F403 was found to interact with a uracil residue 
in close spatial proximity indicating that in addition to providing a structural bridge between 
Cse1 and Cse2.2 the C-terminal part of Cse1 is also involved in RNA interaction.  
In Cas5e, the tail protein with a right-hand fist-shape, four different cross-linked amino acid 
residues were identified. The W16, Y145 and P200 were observed in the palm domain of the 
protein. From the crystal structure it can be observed that the side-chain of U2 nucleotide 
residue is adjacent to the side-chain of amino acid residues W16 and Y145 which makes it highly 
possible that these residues form a cross-link (Figure 3.9 D). The Y85 amino acid residue present 
in the arch of the thumb domain was also observed cross-linked to a uracil residue. It has been 
postulated that the Y85 amino acid residue stabilized the RNA-DNA duplex formation between 
the crRNA and the target DNA [106]. Considering the structural variability of the Cascade 
complex in solution it can be speculated that the cross-linked nucleotide residue U10 is in close 
spatial proximity to this amino acid residue. In addition, the arch is a modified RRM which is a 
characteristic RNA binding domain.  
In Cas7 proteins, which form the backbone of Cascade complex, six cross-linked residues were 
identified corresponding to five different cross-linked regions (Table 3.6). However the cross-
linked residues could not be assigned to a specific residue or protein in the crystal structure 
because there are six copies of Cas7 present in the Cascade complex. Nevertheless possible 
protein-RNA interactions were mapped on the crystal structure depending on the location of 
uracil residues on the crRNA which were in close proximity to the possible cross-linked residues 
in Cas7 proteins. The location of these cross-linked residues/regions has been discussed earlier 
(Section 4.2.2) with comparison to other Cas7 family proteins. The K27 amino acid residue in the 
palm domain of the Cas7 protein lies in the universal central cleft that interacts with the RNA as 
observed in other Cas7 homologues. According to the crystal structure, in the proteins Cas7.1, 
Cas7.2, Cas7.4 and Cas7.6 the K27 residue is in close spatial proximity to a uracil residue making 
it highly likely that these result in protein-RNA cross-links upon UV irradiation. In addition, an 
interesting observation was made with regard to the M166 amino acid residue. Approximately, 
40 out of 70 cross-links observed for the entire Cascade complex corresponded to the cross-
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linked region 166MATSGMMTELGK177. The peptide was observed in eight different modified 
versions with one or more of the three methionine residues oxidized and each of the eight 
peptides was observed cross-linked to a wide range of RNA moieties (Table 3.6). In 25 out of 40 
cross-links it was the M166 amino acid residue identified as the cross-linked residue, however in 
the remaining 15 exact residue could not be identified due to a lack of fragment ions in that 
region of the ion series. When mapped to different Cas proteins on the crystal structure, the 
M166 residue in Cas7.1, Cas7.2 and Cas7.5 was observed to be in close spatial proximity to a 
uracil residue (Figure 3.10 and 3.11). Although with the protein-RNA cross-linking approach it is 
not possible to identify exactly in which of these Cas proteins M166 residue was cross-linked, 
from the considerably high number of cross-links identified it can nonetheless be speculated 
that in all the three Cas proteins the M166 amino acid residue interacts with the RNA. This result 
validates the previous observation that the M166 amino acid interacts with the crRNA, and the 
side chain of methionine intercalates between the 3rd and 4th base of the crRNA segment in 
close proximity to the respective Cas7 protein [105]. 
In Cse2 proteins, the belly of the Cascade complex, five different cross-linked regions were 
identified. As there are two Cse2 subunits present in the Cascade complex, the cross-linked 
amino acid residues cannot be unambiguously assigned to either of these subunits. Novel RNA 
binding regions were identified in the Cse2 proteins in contrast to the previous X-ray studies 
where direct contacts between the crRNA and Cse2 proteins were not reported (Figure 3.12). 
All the identified cross-linked residues were located on the protein surface opposite to the one 
facing the crRNA. However, both the surfaces of the Cse2 dimer are positively charged as 
determined by electrostatic calculations [43, 151] suggesting that both surfaces constitute 
potential RNA binding regions. 
Overall, the Cascade complex is an excellent platform to study protein-RNA interactions 
especially with the recently published crystal structure of the Cascade complex now available. 
The crystal structures do not represent an active structure as in solution, because a crystal 
structure is obtained only after the flexibility is reduced. However the experiments performed 
in this study were in solution and the results reflect the conformational variability the complex 
can have in solution. The protein-RNA cross-linking helps validate the interactions determined 
by co-crystallization e.g., the Y145 amino acid residue in Cas5e cross-linked to the U2 nucleotide 
residue on the crRNA at the 5’ end. In addition new RNA interaction sites were identified in 
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Cse1, Cse2 and Cas7 proteins, by in solution protein-RNA cross-linking approach that might 
correspond to a different conformation than the one showed in X-ray studies.  
Type III-A Csm complex from T. thermophilus 
In the Type III-A Csm complex composed of twelve different protein subunits corresponding to 
five proteins (Csm1-Csm5), 43 different peptide-RNA cross-links were observed. Overall these 
corresponded to ten different cross-linked protein regions across the five Csm proteins  
(Table 3.7), with at least one cross-linked region identified in every protein. 
In Csm3 (a Cas7 family protein) alone 28 cross-links were identified, corresponding to three 
cross-linked protein regions and within these regions four cross-linked amino acid residues 
could be identified. The results of Csm3 protein-RNA cross-linking have been discussed earlier 
(Section 4.2.2) in comparison with other Cas7 homologues. The cross-linked amino acid 
residues Q144, G153 and R162 were present in the lid-domain and P96 and 49P-K54 in the central 
cleft and both these regions have been observed to interact with RNA e.g., in the T. tenax Cas7 
and Tp Csc2. However, there are six copies of the Csm3 protein in the Csm complex and it was 
therefore not possible to assign these cross-linked regions/residues to a single Csm3 subunit.  
In the E. coli Cascade complex the sequence of the crRNA present in the crRNP complex was 
known, therefore most of the cross-linked nucleotide residues could also be mapped on the 
crRNA sequence. However, the Tt Csm complex is known to bind crRNAs of variable lengths as 
verified by the deep sequencing analysis [59] and it could not be unambiguously determined 
which of the crRNAs was present in the final assembled Csm complex used for cross-linking 
experiments. As the sequence of crRNA present in the Csm complex was not known the cross-
linked nucleotide residues could not be mapped on the RNA level.  
In addition, the results from protein-RNA cross-linking studies are more explanatory when 
analyzed in conjunction with a high resolution crystal structure like in the E. coli Cascade 
complex, so that all the identified residues can be mapped on the protein structure and the 
predicted protein-RNA interactions can be visualized in three-dimension. Nonetheless, the 
extensive number of cross-links observed in Tt Csm complex reveals a strong potential of 
protein-RNA cross-linking in determining protein-RNA interactions in vitro and as a source for 
constrains when modelling RNA strands on crystal structures of proteins. 
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Type III-B Cmr complex from T. thermophilus 
The protein-RNA cross-linking investigations in the Tt Cmr complex were carried out in both 
endogenous and reconstituted complexes. Five cross-linked protein regions were identified in 
both the complexes. In the endogenous complex the cross-linked regions were observed in 
proteins Cmr2, Cmr3, Cmr4 and Cmr6 and in the reconstituted complex in proteins Cmr1, Cmr2, 
Cmr3 and Cmr4 (Table 3.8). In all the observed cross-links a uracil residue was identified as the 
cross-linked nucleotide. Based on the location of the uracil residues in the 46 nt crRNA (the 
crRNA used in the assembly of reconstituted Cmr complex), the cross-links were mapped on the 
Cmr proteins in close proximity to these uracil residues as shown in the model of Tt Cmr 
complex (Figure 3.14). 
The results of cross-linking analysis were reproducible for the cross-links identified in 
endogenous complex and the same cross-links identified in reconstituted complex, with only 
one exception in each case. A cross-linked protein region 34T-R58 was identified in the Cmr1 
protein in the reconstituted complex however no cross-link was identified for the Cmr1 protein 
in the endogenous complex, the cross-linked nucleotide residue was identified as the U39 
residue close to the 3’ end of the crRNA. Similarly, a cross-linked protein region 169L-K186 was 
identified in the Cmr6 protein in the endogenous complex and not in the reconstituted 
complex, however here the cross-linked residue could not be mapped on the crRNA.  
The electron microscopy studies have shown that both Cmr1 and Cmr6 together form a ‘curled-
head’ of the ‘sea-worm’ shaped Cmr complex (Figure 1.17) [52]. From these observations it can 
be speculated that Cmr1 protein cross-links to the U39 residue at the 3’ end of crRNA. However, 
due to Cmr1 being weakly associated with the complex it can dissociate in solution [52]. When 
Cmr1 dissociates from the complex, Cmr6 is able to form a cross-link to the U39 residue as it is 
also in close proximity to this uracil residue at the 3’ end of crRNA (Figure 3.14). Furthermore, 
this hypothesis is in agreement with the previous reports from the native MS analysis, showing 
that Cmr1 protein has a loose association with the Cmr complex under in vitro conditions [52]. 
The protein-RNA cross-linking studies performed with the endogenous and reconstituted Tt 
Cmr complex demonstrate both complexes interact with RNA in an equivalent manner, to the 
level of cross-linked nucleotide and amino acid. In addition, these results revealed the first five 
direct protein-RNA contacts in the multi-subunit Tt Cmr complex, providing valuable structural 
information for further structural and functional studies. 
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4.2.4 Protein-protein interactions in Type I-B C. thermocellum Cascade complex 
In addition to the protein-RNA interactions discussed so far, the protein-protein interactions in 
a multi-subunit crRNP complex were also investigated as a part of the structural proteomics 
studies in this work. Type I-B C. thermocellum Cascade complex, a ~330 kDa comprising four Cas 
proteins Cas5, Cas6, Cas8b and Cas7 was used for this study. The stoichiometry of 
Cas6:Cas5:Cas8b:Cas7 in this complex was determined as low:low:medium:high with iBAQ 
analysis (further details of the quantitative analysis have been discussed earlier in Section 
4.1.2).  
The protein-protein interactions were investigated using a lysine directed chemical cross-linker 
BS3, because of the high reactivity of primary amines and high abundance and extensive 
distribution of lysine residues over the protein surface. However, it is not possible to identify all 
theoretically possible lysine-lysine cross-links because all the lysine residues might not be 
equally reactive or accessible to the cross-linker. They could be involved in cross-links that result in 
very long or very short peptides that do not fly/fragment well in the mass spectrometer and also not all 
cross-linked peptides are detectable by MS. The molar excess of cross-linker (75:1) was selected 
to avoid formation of higher-order aggregates and refrain from interactions deriving from 
experimental artifacts.  
From the MS analysis, 126 unique inter-protein cross-links were identified within the four Cas 
proteins (Appendix, Table 6.2). The number of inter-protein cross-links was in agreement with 
the stoichiometry determined for the complex. The Cas7 protein which is speculated to be 
present in six copies in the Cascade complex was observed to form inter-protein contacts with 
all the other proteins. No inter-protein cross-link was identified between the two proteins Cas5 
and Cas6 which are present in single copies and this is also in agreement with their position in 
the Cascade complex, as Cas6 forms the head and Cas5 the tail which are unlikely to interact.  
In addition, from the crystal structure of a fully assembled Cascade complex such as the Type I-
E E. coli Cascade, it can be observed that Cas7 forms the helical backbone of the complex which 
interacts with the head protein Cas6, the tail protein Cas5 and across the length of the complex 
the Cas7 backbone is supported by a belly of two Cse2 proteins (Figure 1.15) [43, 105]. The 
Cse2 dimer in case of Type I-B complexes is replaced by a single large subunit Cas8b (Figure 1.4) 
[22]. The protein-protein cross-links identified are also in agreement with this structural 
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arrangement, with 75 inter-protein cross-links identified between the Cas7 backbone and 
Cas8b, 37 between Cas7 and Cas5 (tail) and one between the Cas7 and Cas6 (head). 
The intra-protein cross-links identified did not provide much information as the stoichiometry 
of Cas7 and Cas8b indicate multiple copies of these proteins are present and there it is not 
possible to distinguish the intra-protein cross-links from inter-protein cross-links. Nonetheless 
for the Cas5 and Cas6 proteins which are present in a single copy in the complex, the intra-
protein cross-links identified were mapped on the respective protein sequence (Appendix, 
Figure 3.7).  
An overall higher number of cross-links were identified for Cas7 and Cas8b which might indicate 
a high structural flexibility of these proteins in solution. In addition the presence of lysine rich 
regions distributed across the protein length also indicates a high possibility of protein-protein 
interactions.  
A high number of protein-protein cross-links were identified in this investigation (126) which 
has become possible at present due to the availability of high sequencing speed such as that 
provided by the Orbitrap Fusion mass spectrometer and advanced search engines such as pLink 
used in this study. The cross-links identified show a heterogeneous distribution indicating 
different protein interaction networks within the Cascade complex. This information in 
conjunction with additional structural data can be used to propose a structural model for the 
three dimensional description of the protein complex.  
4.3 Considerations in the identification of protein-RNA interactions by UV 
induced cross-linking and MS 
A major part of the presented work focused on the investigation of protein-RNA interactions in 
crRNP complexes using UV induced protein-RNA cross-linking and MS. Some important 
considerations and potentials of the protein-RNA cross-linking approach will be discussed in this 
section in reference to the results obtained during this work.  
1. Fragmentation mode: The fragmentation of peptide-RNA heteroconjugates was performed 
using high-energy collision dissociation (HCD) in Orbitrap instruments where the MS/MS 
fragmentation occurs in the Orbitrap, therefore benefiting from the high-mass accuracy. In 
addition the limitations of ion traps could be overcome because here the spectra obtained do 
not exhibit a low mass cut-off and the important ions like RNA marker ions, a2-b2 pairs and 
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immonium ions (usually located in the lower m/z region) were detected. Furthermore, as the 
yield of a cross-linking reaction is low and cross-links have a poor ionization efficiency 
compared to linear peptides, the MS analysis were performed using instruments with high 
resolution, high mass accuracy and better sequencing speeds such as LTQ-Orbitrap Velos and Q 
Exactive HF. This would provide a stronger likelihood that a peptide-RNA precursor would be 
picked for fragmentation out of a complex sample. 
2. Identification of cross-link: The spectra for cross-links are poor quality compared to standard 
peptides because of low signal intensities. The automated proteomics search engines are 
directed toward peptide identification considering a cross-linked RNA moiety as a modification 
on the peptide. Also, a large number of potential RNA oligonucleotides can form a cross-link 
and together these two aspects make the data analysis difficult. The basic principle applied in 
cross-link identification was that the mass of a peptide-RNA cross-link precursor is purely 
additive of the masses of peptide and RNA moieties [160]. A new data analysis tool, RNPxl 
(Section 2.2.9.3) was used for the analysis which followed a precursor variant approach for 
automated identification of cross-linked heteroconjugates by subtraction of calculated RNA 
masses from the experimental precursor mass. The results were further checked manually to 
validate the cross-link identification.  
3. Cross-linked nucleotides: The cross-linked nucleotide is determined by calculating the mass 
difference between the mass of cross-linked heteroconjugate and the mass of cross-linked 
peptide. There is a substantial difference in the reactivity of uridine and other nucleotides as 
observed in the cross-links reported in this work, in previous studies related to protein-RNA 
cross-linking in the Urlaub lab and also in the studies where the cross-linking yields of different 
amino-acids and nucleotides were investigated by Shetlar et al. [59, 108, 109, 160-163]. 
Conversely, if a cross-linked heteroconjugate comprise adenosine, guanosine or cytidine cross-
linked to the amino acid residue it is less likely to be identified by the MS analysis. In the cross-
links observed for the E. coli Cascade complex, the peptide 51SGYYAQNIGESSLRTIHLAQLR72 was 
observed cross-linked to UG-H2O, where G nucleotide was identified as the cross-linked 
nucleotide residue (Appendix, Figure 6.2 I). This was the only example of a cross-link where a 
nucleotide other than uracil was observed to be cross-linked. Considering that uracil is the most 
reactive nucleotide, some of the cross-linking experiments in this work were also performed 
with polyU oligonucleotide, but the aim was only to identify regions on the protein level that 
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interact with RNA. In addition, the information derived from protein-RNA cross-linking studies 
is limited when attempting to unambiguously map the cross-linked nucleotide at the level of 
RNA because in most cases the cross-linked RNA was a single nucleotide residue. Nonetheless, 
there were cross-links identified with longer RNA moieties, but the current cross-linking 
workflow only provides information about the composition of the cross-linked RNA moiety and 
not their position in the sequence. 
4. RNA marker ions: A typical observation in the cross-link spectra reported in the work was 
presence of distinct marker ions of the intact nucleotides with a neutral loss of water (C = 
306.05, U = 307.03, A = 330.06, G = 346.05) or the nucleic acid bases (C’ = 112.05, U’ = 113.03, 
A’ = 136.06, G’ = 152.06) in the lower m/z region of the spectrum. In previous studies 
fragmentation of pure RNA also has been observed to produce nucleobases due to the cleavage 
of N-glycosidic bond [164]. When only one nucleotide was cross-linked to a peptide, no marker 
ion signal is visible and the MS/MS spectra are dominated by peptide fragments. Some of the 
examples where marker ions were observed include A’ marker ion as depicted in C. 
thermocellum Cas6b peptide 184MIGFK188 cross-linked UGA and G’ and C’ marker ions in M. 
maripaludis Cas6b peptide 182NQNM(ox)VGFR189 cross-linked to UUGC-PO3 and (Figure 3.5).  
5. Cross-linked amino acids: In the previous studies all amino acids except E, N and D have been 
demonstrated to cross-link with RNA moieties [59, 108, 161]. In this work 12 different amino 
acids have been reported to cross-link with RNA and these include M, Y, L, P, F, W, K, C, V, G, Q 
and R as shown in different examples in the Appendix, Figure 6.1-6.5. The aromatic residues are 
the most commonly observed cross-linked amino acid residues. Usually the cross-linked amino 
acid residues were identified when the fragment ions comprising this amino acid within the b- 
or y- series show a mass-shift corresponding to the mass of an RNA adduct and the other 
fragment ions are observed without any mass shifts e.g., amino acid residue M83 in the peptide 
82LMAVTR87 cross-linked to uracil (Figure 6.1 A). In addition, when the fragment ion information 
was not sufficient, the immonium ion of the cross-linked amino acid was observed with a mass-
shift corresponding to mass of RNA adducts e.g., amino acid residue W346 in the peptide 
346WVEELKGGGQK356 cross-linked to uracil (Figure 6.1 C). However, for nine peptide-RNA cross-
links out of the 48 reported in this work, the cross-linked amino acid residue could not be 
identified e.g., the peptide 136VEDVHPISERPQYFSGDGK154 cross-linked to uracil (Figure 6.2 B). 
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When all considerations above are taken into account, the MS approaches have been very 
helpful in identifying interactions which are otherwise very difficult to do. In this work, 
approximately 50 protein-RNA cross-links and 126 inter-protein cross-links were identified and 
the stoichiometries of Type I-B Cascade complexes from H. volcanii and C. thermocellum were 
determined. These results when integrated with other structural techniques in collaboration 
resulted in three dimensional views of the complexes, as demonstrated by the more than five 
joint publications. 
4.4 Conclusions and future perspectives 
In this work, the prokaryotic immune defense system was investigated using both quantitative 
and structural aspects of mass spectrometry. With relative quantitation using dimethyl labeling 
the effect of deletion of a significant cas7 gene on the regulation of other Cas proteins could be 
determined. It provides a strong indication that removal of an essential cas gene is 
compensated by increased expression of other cas genes in the system. In addition, the 
absolute amounts of different Cas protein components in H. volcanii and C. thermocellum 
Cascade complex were determined using iBAQ. These results provide a straightforward and first 
step in determining the stoichiometry of Cas proteins in multi-subunit crRNP complexes for 
further investigation of molecular interactions in this system. The presented protein-protein 
cross-linking investigation provides molecular insights into the interactions between different 
Cas proteins subunits in the C. thermocellum Cascade complex. The limitation in the assignment 
of exact cross-link sites in some of the proteins provides a scope for future improvements that 
could be implemented in the investigation of such multi-subunit complexes by MS. 
Furthermore, the protein-RNA interactions in both single (recombinant) protein-RNA 
complexes and multi-subunit crRNP complexes were investigated using UV induced cross-
linking. The extensive amounts of protein-RNA cross-links reported in this work are the first 
reported evidence of such interactions to be determined in the different CRISPR-Cas systems by 
MS. Although this study mainly focused on the structural investigations in Type I and Type III 
crRNP complexes, a well-established workflow is available and ready to explore the widely 
popular Type II CRISPR-Cas system comprising a single player Cas9. Moreover, the cross-linking 
approach can be further extended to investigate protein-DNA interactions between the fully 
assembled crRNP complexes and the target DNA for an improved understanding of the CRISPR 
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6.1 Additional Information  
 
Figure 6.1 Protein-RNA cross-link spectra identified in T. tenax Cas7 cross-linking with poly(U)15 and T. pendens Csc2 cross-linking with poly(U)15. 
An overview of the cross-links identified and the corresponding mass values is provided in the table below. In each spectrum, the cross-linked peptide sequence and its 
corresponding y- and b- type fragment ions are indicated at the top. These refer to ions which retain the charge on the N-terminus or C-terminus, respectively. All the fragment ion 
peaks are marked with their corresponding m/z values. Ions with a mass shift corresponding to the cross-linked nucleotides are indicated with #: C3O, #
2: U’, #3: U-H3PO4, #
4: U-H2O 
and #5: U. Mass shifts in the sequence tags help identify the site of cross-linking and are indicated for the corresponding fragments. The cross-linked amino acid highlighted in 
yellow. Adducts or maker ions corresponding to RNA component of the cross-link are indicated in blue. U’: Base of U, 112.02 Da, IM: Immonium ion. 
Protein 
(Uniprot ID) 
Peptide aa RNA m(Peptide) m(RNA) m(XL) Calc z m/z m(XL) Exp Fig 
Tp Csc2 
(A1RZU2) 
82LMAVTR87 M83 UU 689.3894 630.0612 1319.4596 2 660.7323 1319.4490 (A) 
124KVSEEWNCTIQPPLAEFGEK143 C131 U 2304.1905 324.0359 2628.2246 3 877.0552 2628.1442 (B) 




3VAPPYVR9 Y7 U 800.4544 324.0359 1124.4903 2 536.2520 1124.4884 (D) 
14FEAQLSVLTGAGNMGNYNMHAVAK37 28G-N29 U 2522.2045 324.0359 2846.2404 3 949.7532 2846.2362 (E) 
127VSFAVPVLEEK137 - U 1216.6702 324.0359 1540.7061 2 771.3601 1540.7046 (F) 
145FAVVHNR151 V148 UU 841.4558 630.0612 1471.5170 2 736.7654 1471.5152 (G) 
152VDPFKR158 F155 U 760.4231 324.0359 1084.4590 2 543.2367 1084.4578 (H) 
164SKEEQEGTEMMVFK177 M173 U 1671.7483 324.0359 1995.7842 3 666.2685 1995.7821 (I) 
Protein: Name of the protein (Uniprot ID), Peptide: amino acid sequence of the cross-linked peptide, aa: position of cross-linked amino acid residue, RNA: composition of cross-
linked RNA, m: mass, m(Peptide): calculated mass of cross-linked peptide, m(RNA): calculated mass of cross-linked RNA, m(XL) Calc: calculated mass of cross-link 
[m(Peptide)+m(RNA)], z: charge state in which cross-link was observed, m/z: experimentally observed mass to charge ratio, m(XL) Exp: experimentally observed mass of cross-link 
[(m/z) * z) - ((mass of proton) * z] and Fig: reference to figure of the annotated MS/MS fragment spectrum. 
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Figure 6.2 Protein-RNA cross-link spectra identified in Type I-E E. coli Cascade complex. 
An overview of the cross-links identified and the corresponding mass values is provided in the table below. In each spectrum, the cross-linked peptide sequence and its 
corresponding y- and b- type fragment ions are indicated at the top. These refer to ions which retain the charge on the N-terminus or C-terminus, respectively. All the fragment ion 
peaks are marked with their corresponding m/z values. Ions with a mass shift corresponding to the cross-linked nucleotides are indicated with #: C3O, #
1: U’-H2O, #
2: U’, #3: U-
H3PO4, #
4: U-H2O and #
5: U. Mass shifts in the sequence tags help identify the site of cross-linking and are indicated for the corresponding fragments. The cross-linked amino acid 
highlighted in yellow. Adducts or maker ions corresponding to RNA component of the cross-link are indicated in blue. U’: Base of U, 112.02 Da; A‘: Base of A, 136.06 Da; C’: Base of 
C, 112.05 Da, G’: Base of G, 152.05 Da, IM: Immonium ion.  
Protein 
(Uniprot ID) 
Peptide aa RNA m(Peptide) m(RNA) m(XL) Calc z m/z m(XL) Exp Fig 
Cas6e 
(Q46897) 
103LDSKGNIK110 K106 U-H2O 873.4919 306.0253 1179.5172 2 590.7661 1179.5166 (A) 
136VEDVHPISERPQYFSGDGK154 145R-Y148  U 2159.0823 324.0359 2483.1182 3 828.6961 2483.0649 (B) 
Cse2  
(P76632) 
13AWQQLDNGSCAQIR26 C22 U 1588.7416 324.0359 1912.7775 2 957.3967 1912.7778 (C) 
43LVQPFGWENPR53 W49 U 1341.6829 324.0359 1665.7188 2 833.8672 1665.7188 (D) 
61M(Ox)VFCLSAGK69 F63 U 970.4616 324.0359 1294.4975 2 648.2559 1294.4962 (E) 
78KSEQTTGISLGR89 K78 U-H2O 1275.6782 306.0253 1581.7035 2 791.8590 1581.7024 (F) 
136MLTWWGK142 W139 U 920.4578 324.0359 1244.4937 2 623.2540 1244.4924 (G) 
Cas7  
(I2ZSV0) 
21DDMNMQKDAIFGGK34 K27 U-H2O 1568.6962 306.0253 1874.7215 2 938.3693 1874.7230 (H) 
51SGYYAQNIGESSLRTIHLAQLR72 - UG-H2O 2476.2822 651.0727 3127.3549 3 1043.4525 3127.3341 (I) 
83FDQKIIDK90 K86 U-H2O 1005.5494 306.0253 1311.5747 2 656.7949 1311.5742 (J) 
91TLALLSGKSVDEAEK105 97G-K98 U-H2O 1559.8406 306.0253 1865.8659 2 933.9406 1865.8656 (K) 
129AEADNLDDKK138 K137 U-H2O 1117.5250 306.0253 1423.5503 2 712.7828 1423.5500 (L) 
139LLKVLK144  K141 U-H2O 712.5210 306.0253 1018.5463 2 510.2805 1018.5454 (M) 
142VLKEDIAAIR151 K144 U-H2O 1126.6709 306.0253 1432.6962 2 717.3553 1432.6950 (N) 
166MATSGMMTELGK177 M166 U 1255.5610 324.0359 1579.5969 2 790.8062 1579.5968 (O) 
Cas5e 
(H0Q9G2) 
9LAGPMQAWGQPTFEGTRPTGR29 W16 U 2257.1061 324.0359 2581.1420 3 861.3889 2581.1433 (P) 
84DYHTVLGAR92 Y85 U 1030.5195 324.0359 1354.5554 2 678.2844 1354.5532 (Q) 
142YTPYLGR148 Y145 UA 868.4442 653.0884 1521.5326 3 508.1855 1521.5331 (R) 
198DEPMITLPR206 P200 U 1070.5430 324.0359 1394.5789 2 698.2974 1394.5792 (S) 
Cse1(Q46901) 395ALYTFAEGFK404 F403 U 1145.5756 324.0359 1469.6115 2 735.8139 1469.6122 (T) 
Protein: Name of the protein (Uniprot ID), Peptide: amino acid sequence of the cross-linked peptide, aa: position of cross-linked amino acid residue, RNA: composition of cross-
linked RNA, m: mass, m(Peptide): calculated mass of cross-linked peptide, m(RNA): calculated mass of cross-linked RNA, m(XL) Calc: calculated mass of cross-link 
[m(Peptide)+m(RNA)], z: charge state in which cross-link was observed, m/z: experimentally observed mass to charge ratio, m(XL) Exp: experimentally observed mass of cross-link 
[(m/z) * z) - ((mass of proton) * z] and Fig: reference to figure of the annotated MS/MS fragment spectrum. 
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Figure 6.3 Protein-RNA cross-link spectra identified in Type III-A T. thermophilus Csm complex. 
An overview of the cross-links identified and the corresponding mass values is provided in the table below. In each spectrum, the cross-linked peptide sequence and its 
corresponding y- and b- type fragment ions are indicated at the top. These refer to ions which retain the charge on the N-terminus or C-terminus, respectively. All the fragment ion 
peaks are marked with their corresponding m/z values. Ions with a mass shift corresponding to the cross-linked nucleotides are indicated with #: C3O; #
1: U’-H2O; #
2: U’; #3: U-
H3PO4; #
4: U-H2O; #
5: U and #6: U-H2O + U-H3PO4. Mass shifts in the sequence tags help identify the site of cross-linking and are indicated for the corresponding fragments. The 
cross-linked amino acid highlighted in yellow. Adducts or maker ions corresponding to RNA component of the cross-link are indicated in blue. U’: Base of U, 112.02 Da; A‘: Base of 




Peptide aa RNA m(Peptide) m(RNA) m(XL) Calc z m/z m(XL) Exp Fig 
Csm1 
(Q53W19) 
371RLHEALAR378 - UUA 964.5566 959.1137 1923.6703 3 642.2306 1923.6684 (A) 
Csm2 
(Q53WF6) 
35LKSSQFR41 K36 U-H2O 864.4817 306.0253 1170.5070 2 586.2637 1170.5118 (B) 
Csm3 
(Q53WF5)  
21IGMSRDQMAIGDLDNPVVR39 - UU 2086.0299 630.0612 2716.0911 3 906.3689 2716.09112 (C) 
40NPLTDEPYIPGSSLK54 49P-K54 UG 1629.8249 669.0833 2298.9082 3 767.3115 2298.9189 (D) 
91IFGLAPENDER101 P96 U 1259.6145 324.0359 1583.6504 2 792.8327 1583.6498 (E) 
136GGLYTEIKQEVFIPR150 Q144 UC 1748.9460 629.0772 2378.0232 3 793.6842 2378.0292 (F) 
151LGGNANPR158 G153 UA 797.4143 653.0884 1450.5027 2 726.2637 1450.5118 (G) 
159TTERVPAGAR168 R162 U 1056.5675 324.0359 1380.6034 3 461.2064 1380.5958 (H) 
Csm4 
(Q53WF4) 
69LPPVQVEETTLRK81 P71 UG 1508.8562 669.0833 2177.9395 3 726.9895 2177.9253 (I) 
126 TRVGVDR132 V128 UU 801.4456 630.0612 1431.5068 2 716.7577 1431.4998 (J) 
Csm5 
(Q53W18) 
132SPLGAYLPGSSVK144 P139 U 1274.6870 324.0359 1598.7229 2 800.3674 1598.7192 (K) 
255MVLLAETFR263 M255 U 1078.5844 324.0359 1402.6203 2 702.3160 1402.6164 (L) 
Protein: Name of the protein (Uniprot ID), Peptide: amino acid sequence of the cross-linked peptide, aa: position of cross-linked amino acid residue, RNA: composition of cross-
linked RNA, m: mass, m(Peptide): calculated mass of cross-linked peptide, m(RNA): calculated mass of cross-linked RNA, m(XL) Calc: calculated mass of cross-link 
[m(Peptide)+m(RNA)], z: charge state in which cross-link was observed, m/z: experimentally observed mass to charge ratio, m(XL) Exp: experimentally observed mass of cross-link 
[(m/z) * z) - ((mass of proton) * z] and Fig: reference to figure of the annotated MS/MS fragment spectrum. 
Figure originally published in [59] and reproduced with permission. 
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Figure 6.4 Protein-RNA cross-link spectra identified in Type III-B T. thermophilus Cmr complex. 
An overview of the cross-links identified and the corresponding mass values is provided in the table below. In each spectrum, the cross-linked peptide sequence and its 
corresponding y- and b- type fragment ions are indicated at the top. These refer to ions which retain the charge on the N-terminus or C-terminus, respectively. All the fragment ion 
peaks are marked with their corresponding m/z values. Ions with a mass shift corresponding to the cross-linked nucleotides are indicated with #: C3O; #
1: U’-H2O; #
2: U’; #3: U-
H3PO4; #
4: U-H2O and #
5: U. Mass shifts in the sequence tags help identify the site of cross-linking and are indicated for the corresponding fragments. The cross-linked amino acid 
highlighted in yellow. Adducts or maker ions corresponding to RNA component of the cross-link are indicated in blue. U’: Base of U, 112.02 Da; C’: Base of C, 112.05 Da, IM: 





Peptide aa RNA m(Peptide) m(RNA) m(XL) Calc z m/z m(XL) Exp Fig 
Cmr2 
(Q53W09) 
160DFAPVSWGSPAYK172 Y171 U 1423.6771 324.0359 1747.7130 2 874.5654 1747.1152 (A) 
Cmr3 
(Q53W08) 
156GHEGPVPETRTHVALDPAAQTAR178 - U 2409.2148 324.0359 2733.2507 3 912.0919 2733.2523 (B) 
166THVALDPAAQTAR178 L170 UU 1349.7051 630.0612 1979.7663 2 990.8915 1979.7674 (C) 
Cmr4 
(Q53W06) 
204IRLDDETK211 L206 U 988.5189 324.0359 1312.5548 2 657.2855 1312.5554 (D) 
Cmr6 
(Q53W04) 




Peptide aa RNA m(Peptide) m(RNA) m(XL) Calc z m/z m(XL) Exp Fig 
Cmr1 
(Q53W07) 
34TYTLLTPLFGGGVEPREADPVSVVR58 - UC 2672.4172 629.0772 3301.4944 3 1101.5060 3301.4946 (F) 
Protein: Name of the protein (Uniprot ID), Peptide: amino acid sequence of the cross-linked peptide, aa: position of cross-linked amino acid residue, RNA: composition of cross-
linked RNA, m: mass, m(Peptide): calculated mass of cross-linked peptide, m(RNA): calculated mass of cross-linked RNA, m(XL) Calc: calculated mass of cross-link 
[m(Peptide)+m(RNA)], z: charge state in which cross-link was observed, m/z: experimentally observed mass to charge ratio, m(XL) Exp: experimentally observed mass of cross-link 
[(m/z) * z) - ((mass of proton) * z] and Fig: reference to figure of the annotated MS/MS fragment spectrum.






























Figure 6.5 iBAQ calibration curve of UPS2 proteins used in determining the stoichiometry of Cas5, 
Cas6, Cas7 and Cas8b in C. thermocellum Cascade complex. 
Double logarithmic plot of log(iBAQ) vs log(amount) using 22 out of 48 UPS2 proteins observed in all three 
technical replicates for the absolute quantification. The log (iBAQ) and log (amount) for all the 22 proteins is 






y = 1.1365x + 5.0248 
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Table 6.1 iBAQ quantitative mass spectrometry analysis of C. thermocellum Cascade complex. 









UPS2 Standard 5 62227 0.699 4.794  
>P01008ups| 
ANT3_HUMAN 
UPS2 Standard 5 333550 0.699 5.523 
>P08263ups| 
GSTA1_HUMAN 
UPS2 Standard 5 341790 0.699 5.534 
>P01344ups| 
IGF2_HUMAN 
UPS2 Standard 5 3559200 0.699 6.551 
>P02753ups| 
RETBP_HUMAN 
UPS2 Standard 50 6824400 1.699 6.834 
>Q15843ups| 
NEDD8_HUMAN 
UPS2 Standard 50 9824600 1.699 6.992 
>P06732ups| 
KCRM_HUMAN 
UPS2 Standard 50 1.2E+07 1.699 7.088 
>P16083ups| 
NQO2_HUMAN 
UPS2 Standard 50 1.3E+07 1.699 7.106 
>P63279ups| 
UBC9_HUMAN 
UPS2 Standard 50 1.4E+07 1.699 7.142 
>P61626ups| 
LYSC_HUMAN 
UPS2 Standard 50 1.5E+07 1.699 7.177 
>P00709ups| 
LALBA_HUMAN 
UPS2 Standard 50 1.6E+07 1.699 7.201 
>P01133ups| 
EGF_HUMAN 
UPS2 Standard 500 7E+07 2.699 7.845 
>P02144ups| 
MYG_HUMAN 
UPS2 Standard 500 1.8E+08 2.699 8.267 
>P15559ups| 
NQO1_HUMAN 
UPS2 Standard 500 2.3E+08 2.699 8.360 
>P04040ups| 
CATA_HUMAN 
UPS2 Standard 500 2.4E+08 2.699 8.383 
>Q06830ups| 
PRDX1_HUMAN 
UPS2 Standard 500 3.4E+08 2.699 8.529 
>P00918ups| 
CAH2_HUMAN_UPS 
UPS2 Standard 5000 8.4E+08 3.699 8.925 
>P68871ups| 
HBB_HUMAN 
UPS2 Standard 5000 8.8E+08 3.699 8.945 
>P41159ups| 
LEP_HUMAN 
UPS2 Standard 5000 1.2E+09 3.699 9.089 
>P01031ups| 
CO5_HUMAN 
UPS2 Standard 5000 1.3E+09 3.699 9.112 
>P69905ups| 
HBA_HUMAN 
UPS2 Standard 5000 1.3E+09 3.699 9.126 
>P00915ups| 
CAH1_HUMAN 
UPS2 Standard 5000 1.9E+09 3.699 9.277 
C. thermocellum Cas6 Cascade  788.860 2.1E+08 2.897 8.317 1.0 
C. thermocellum Cas5 Cascade  1009.253 2.7E+08 3.004 8.439 1.28 
C. thermocellum Cas8b Cascade  1896.706 5.6E+08 3.278 8.750 2.40 
C. thermocellum Cas7 Cascade  4731.513 1.6E+09 3.675 9.201 5.99 
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Table 6.2 Inter-protein cross-links identified in C. thermocellum Cascade complex. 
Protein1 and Protein2 are the two proteins in which the inter-protein cross-link was identified, 
Residue1: Cross-linked residue in protein1, Residue2: Cross-linked residue in protein2, Peptide1: Cross-
linked peptide corresponding to protein1 and Peptide2: Cross-linked peptide corresponding to protein2 
Cross-linked lysine residues in the peptides, are highlighted in blue. 





Cas7 Cas8b K76 K73 EIESEKGGIK KGSAR 
Cas7 Cas8b K76 K190 EIESEKGGIKDGK YGKTSK 
Cas7 Cas8b K76 K230 EIESEKGGIK IGFVTGGFKQENAWK 
Cas7 Cas8b K76 K378 EIESEKGGIKDGK NLPGKDNATYDLK 
Cas7 Cas8b K76 K391 EIESEKGGIKDGK FGFDKIR 
Cas7 Cas8b K76 K400 EIESEKGGIK TFFPNNKTEGNFDK 
Cas7 Cas8b K76 K421 EIESEKGGIK KISYK 
Cas7 Cas8b K76 K523 EIESEKGGIKDGK LLNIQYKER 
Cas7 Cas8b K80 K190 GGIKDGK YGKTSK 
Cas7 Cas8b K83 K65 DGKAR KINNYAYK 
Cas7 Cas8b K83 K72 DGKAR INNYAYKK 
Cas7 Cas8b K83 K190 DGKAR YGKTSK 
Cas7 Cas8b K83 K400 DGKAR TFFPNNKTEGNFDK 
Cas7 Cas8b K87 K65 AKDFNENVDEILQK KINNYAYK 
Cas7 Cas8b K87 K73 AKDFNENVDEILQK KGSAR 
Cas7 Cas8b K87 K373 AKDFNENVDEILQK VDETVLFKNLPGK 
Cas7 Cas8b K133 K421 SLNKVNLK KISYK 
Cas7 Cas8b K133 K425 SLNKVNLK ISYKFLLGR 
Cas7 Cas8b K133 K470 SLNKVNLK GKEVQK 
Cas7 Cas8b K133 K538 VNLKHIK LNGLKLNK 
Cas7 Cas8b K140 K65 HIKGTGAFASGEGK KINNYAYK 
Cas7 Cas8b K140 K73 HIKGTGAFASGEGK KGSAR 
Cas7 Cas8b K140 K92 HIKGTGAFASGEGK YTDSMKTLNK 
Cas7 Cas8b K140 K400 HIKGTGAFASGEGK TFFPNNKTEGNFDK 
Cas7 Cas8b K140 K528 HIKGTGAFASGEGK GSKPFYSR 
Cas7 Cas8b K140 K538 HIKGTGAFASGEGK LNGLKLNK 
Cas7 Cas8b K140 K541 HIKGTGAFASGEGK LNKNIVK 
Cas7 Cas8b K140 K554 HIKGTGAFASGEGK IYTEAINKLNEYNK 
Cas7 Cas8b K140 K560 HIKGTGAFASGEGK LNEYNKNYYK 
Cas7 Cas8b K151 K33 GTGAFASGEGKAQK STDTEEYLQVIENPNDKGNYNHVLK 
Cas7 Cas8b K151 K64 GTGAFASGEGKAQK GVEYEEFSSKK 
Cas7 Cas8b K151 K65 GTGAFASGEGKAQK KINNYAYK 
Cas7 Cas8b K151 K73 GTGAFASGEGKAQK KGSAR 
Cas7 Cas8b K151 K92 GTGAFASGEGKAQK YTDSMKTLNK 
Cas7 Cas8b K151 K187 GTGAFASGEGKAQK ILNEQYYNKYGK 
Cas7 Cas8b K151 K193 GTGAFASGEGKAQK TSKGK 
Cas7 Cas8b K151 K236 GTGAFASGEGKAQK QENAWKNYPVCSCCAQK 
Cas7 Cas8b K151 K253 GTGAFASGEGKAQK KYIR 
Cas7 Cas8b K151 K357 GTGAFASGEGKAQK VKNILR 
Cas7 Cas8b K151 K378 GTGAFASGEGKAQK NLPGKDNATYDLK 
Cas7 Cas8b K151 K400 GTGAFASGEGKAQK TFFPNNKTEGNFDK 
Cas7 Cas8b K151 K421 GTGAFASGEGKAQK KISYK 
Cas7 Cas8b K151 K482 GTGAFASGEGKAQK TEKNKK 
Cas7 Cas8b K151 K484 GTGAFASGEGKAQK TEKNK 
Cas7 Cas8b K151 K523 GTGAFASGEGKAQK LLNIQYKER 
Cas7 Cas8b K151 K528 GTGAFASGEGKAQK GSKPFYSR 
Cas7 Cas8b K151 K538 GTGAFASGEGKAQK LNGLKLNK 
Cas7 Cas8b K151 K545 GTGAFASGEGKAQK NIVKR 
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Cas7 Cas8b K151 K554 GTGAFASGEGKAQK IYTEAINKLNEYNK 
Cas7 Cas8b K151 K606 GTGAFASGEGKAQK FFNEEKKDGEDEELEHHHHHH 
Cas7 Cas8b K151 K607 GTGAFASGEGKAQK FFNEEKKDGEDEELEHHHHHH 
Cas7 Cas8b K154 K64 AQKTFR GVEYEEFSSKK 
Cas7 Cas8b K154 K65 AQKTFR KINNYAYK 
Cas7 Cas8b K154 K73 AQKTFR KGSAR 
Cas7 Cas8b K154 K187 AQKTFR ILNEQYYNKYGK 
Cas7 Cas8b K154 K252 AQKTFR LEQGKK 
Cas7 Cas8b K154 K357 AQKTFR VKNILR 
Cas7 Cas8b K154 K400 AQKTFR TFFPNNKTEGNFDK 
Cas7 Cas8b K154 K482 AQKTFR TEKNKK 
Cas7 Cas8b K154 K523 AQKTFR LLNIQYKER 
Cas7 Cas8b K154 K528 AQKTFR GSKPFYSR 
Cas7 Cas8b K154 K538 AQKTFR LNGLKLNK 
Cas7 Cas8b K154 K554 AQKTFR IYTEAINKLNEYNK 
Cas7 Cas8b K154 K560 AQKTFR LNEYNKNYYK 
Cas7 Cas8b K221 K65 VVYKPGENFFIGDLQNR GVEYEEFSSKKINNYAYK 
Cas7 Cas8b K245 K541 ISLNFDVEEEKIR LNKNIVK 
Cas7 Cas8b K245 K545 ISLNFDVEEEKIR NIVKR 
Cas7 Cas8b K250 K73 SIKDFSIK KGSAR 
Cas7 Cas8b K250 K554 SIKDFSIK IYTEAINKLNEYNK 
Cas7 Cas8b K286 K65 LSYKGR KINNYAYK 
Cas7 Cas8b K286 K554 LSYKGR IYTEAINKLNEYNK 
Cas7 Cas8b K293 K73 EINLKDIK KGSAR 
Cas7 Cas8b K296 K252 DIKDIR LEQGKK 
Cas7 Cas8b K296 K538 DIKDIR LNGLKLNK 
      
Cas7 Cas5 K65 K84 GFDGSNGKDIFVR ISENLINTKK 
Cas7 Cas5 K65 K85 GFDGSNGKDIFVR KSMNIIHER 
Cas7 Cas5 K76 K84 EIESEKGGIKDGK ISENLINTKK 
Cas7 Cas5 K76 K85 EIESEKGGIKDGK KSMNIIHER 
Cas7 Cas5 K76 K97 EIESEKGGIKDGK TQIKIEFLK 
Cas7 Cas5 K80 K19 EIESEKGGIKDGK KPYTTTSPLTYSIPTR 
Cas7 Cas5 K80 K84 EIESEKGGIKDGK ISENLINTKK 
Cas7 Cas5 K80 K85 GGIKDGK KSMNIIHER 
Cas7 Cas5 K80 K97 GGIKDGK TQIKIEFLK 
Cas7 Cas5 K83 K84 DGKAR ISENLINTKK 
Cas7 Cas5 K83 K85 DGKAR KSMNIIHER 
Cas7 Cas5 K87 K84 AKDFNENVDEILQK ISENLINTKK 
Cas7 Cas5 K87 K85 AKDFNENVDEILQK KSMNIIHER 
Cas7 Cas5 K133 K72 SLNKVNLK NPVKK 
Cas7 Cas5 K133 K84 SLNKVNLK ISENLINTKK 
Cas7 Cas5 K133 K102 SLNKVNLK IEFLKDACYR 
Cas7 Cas5 K137 K72 VNLKHIK NPVKK 
Cas7 Cas5 K137 K84 VNLKHIK ISENLINTKK 
Cas7 Cas5 K137 K97 VNLKHIK TQIKIEFLK 
Cas7 Cas5 K137 K176 VNLKHIK KGDIEFEDDREYFTETIPVEMDAER 
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Cas7 Cas5 K140 K72 HIKGTGAFASGEGK NPVKK 
Cas7 Cas5 K140 K84 HIKGTGAFASGEGK ISENLINTKK 
Cas7 Cas5 K140 K85 HIKGTGAFASGEGK KSMNIIHER 
Cas7 Cas5 K140 K97 HIKGTGAFASGEGK TQIKIEFLK 
Cas7 Cas5 K140 K102 HIKGTGAFASGEGK IEFLKDACYR 
Cas7 Cas5 K140 K176 HIKGTGAFASGEGK KGDIEFEDDREYFTETIPVEMDAER 
Cas7 Cas5 K151 K72 GTGAFASGEGKAQK NPVKK 
Cas7 Cas5 K151 K84 GTGAFASGEGKAQK ISENLINTKK 
Cas7 Cas5 K151 K85 GTGAFASGEGKAQK KSMNIIHER 
Cas7 Cas5 K151 K97 GTGAFASGEGKAQK TQIKIEFLK 
Cas7 Cas5 K154 K84 AQKTFR ISENLINTKK 
Cas7 Cas5 K154 K85 GTGAFASGEGKAQKTFR KSMNIIHERTQIK 
Cas7 Cas5 K154 K97 AQKTFR TQIKIEFLK 
Cas7 Cas5 K207 K84 SKMGHMPR ISENLINTKK 
Cas7 Cas5 K207 K85 SKMGHMPR KSMNIIHER 
Cas7 Cas5 K269 K126 LDELIDELANYGDKIEK ESLKEHR 
Cas7 Cas5 K279 K85 VVFVADKNLR KSMNIIHER 
      
Cas7 Cas6 K151 K22 GTGAFASGEGKAQK DIPKIR 
      
Cas8b Cas5 K73 K72 KGSAR NPVKK 
Cas8b Cas5 K187 K84 ILNEQYYNKYGK ISENLINTKK 
Cas8b Cas5 K190 K84 YGKTSK ISENLINTKK 
Cas8b Cas5 K193 K84 TSKGK ISENLINTKK 
Cas8b Cas5 K193 K85 TSKGK KSMNIIHER 
Cas8b Cas5 K230 K85 IGFVTGGFKQENAWK KSMNIIHER 
Cas8b Cas5 K236 K84 QENAWKNYPVCSCCAQK ISENLINTKK 
Cas8b Cas5 K236 K85 QENAWKNYPVCSCCAQK KSMNIIHER 
Cas8b Cas5 K236 K97 QENAWKNYPVCSCCAQK TQIKIEFLK 
Cas8b Cas5 K400 K84 TFFPNNKTEGNFDK ISENLINTKK 
Cas8b Cas5 K400 K85 TFFPNNKTEGNFDK KSMNIIHER 
Cas8b Cas5 K421 K72 KISYK NPVKK 
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Table 6.3 Intra-protein cross-links identified in the Cas5 protein in C.thermocellum Cascade complex. 
Residue1 and Residue2: The two residues in the protein which were observed to be cross-linked. 
Peptide1 and Peptide2: The two peptides which were observed to be cross-linked. Cross-linked lysine 
residues in the peptides, are highlighted in blue. 
Residue 1 Residue 2 Peptide1 Peptide2 
K18 K84 YLVFDISASYGHFKK ISENLINTKK 
K18 K85 YLVFDISASYGHFKK KSMNIIHER 
K19 K84 KPYTTTSPLTYSIPTR ISENLINTKK 
K19 K97 KPYTTTSPLTYSIPTR TQIKIEFLK 
K58 K176 EDYQEHFTKPQAK KGDIEFEDDREYFTETIPVEMDAER 
K62 K157 EDYQEHFTKPQAKIAIGIR EVKGNK 
K72 K84 NPVKK ISENLINTKK 
K72 K102 NPVKK IEFLKDACYR 
K84 K97 ISENLINTKK TQIKIEFLK 
K84 K102 ISENLINTKK IEFLKDACYR 
K85 K85 KSMNIIHER KSMNIIHER 
K85 K97 KSMNIIHER TQIKIEFLK 
K85 K102 KSMNIIHER IEFLKDACYR 
K115 K122 IYFTHTDKQIYER LKESLK 
K115 K126 IYFTHTDKQIYER ESLKEHR 
K157 K176 EVKGNK KGDIEFEDDR 
 
Table 6.4 Intra-protein cross-links identified in the Cas6 protein in C.thermocellum Cascade complex. 
Residue1 and Residue2: The two residues in the protein which were observed to be cross-linked. 
Peptide1 and Peptide2: The two peptides which were observed to be cross-linked. Cross-linked residues 
in the peptides, are highlighted in blue. 
Residue 1 Residue 2 Peptide1 Peptide2 
M1 K106 MDIK ELKTTER 
K22 K87 DIPKIR EIDMKDK 
K22 K89 DIPKIR DKVMSILEK 
K101 K106 GYVLKTR ELKTTER 
K101 K219 GYVLKTR VGKGFVLEHHHHHH 
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Figure 6.6 Intra-protein cross-links identified in Cas5 and Cas6 protein in the Type I-B Cascade complex 
from C. thermocellum. 
Intra-protein cross-links for the Cas5 and Cas6 protein (as summarized in Table 5.3 and 5.4), mapped on the 






Figure 6.7 EMSA to confirm M185 residue in Mm Cas6b binds the cognate crRNA. 
The Mm Cas6b proteins (Wild-type and mutated) were analyzed for binding with their cognate crRNA using EMSA 
and visualized by autoradiography. Lane - C: Control only γ-[32P]-ATP labeled crRNA, Lane - WT: Cas6b Wild-type 
binding to the labeled crRNA, Lane - M185A: Cas6b protein with M185A mutation binding to the labeled crRNA. 
Figure provided by Hagen Richter (MPI Terrestrial Microbiology, Marburg). 
 




AGC automatic gain control 
APS  ammonium per sulfate 
ATP adenosine-5’triphosphate 
AQUA  absolute quantification 
bp base pairs 
BS3  bis(sulfosuccinimidyl)suberate 
BSA bovine serum albumin 
Cas CRISPR associated 
Cascade CRISPR associated antiviral defense 
CID collision induced dissociation 
COOT Crystallographic Object-Oriented Toolkit 
CRISPR clustered regulatory interspaced short palindromic repeats 
crRNA CRISPR RNA 
crRNP CRISPR ribonuceloprotein 
DDA data dependent acquisition 
DHB dihydroxy benzoic acid 
DML dimethyl labeling 
DNA deoxyribonucleic acid 
DTT dithiothreitol 
e.g. for example, exempli gratia  
EDTA ethylene diamine tetraacetic acid 
EM electron microscopy 
EMSA electrophoretic mobility shift assay 
ESI electrospray ionization 
et al and others, et alli 
FA formic acid 
FDR false discovery rate 
FLAG-tag FLAG-octapeptide of sequence DYKDDDDK for labeling and purification of 
fusion proteins 
FTMS Fourier-Transform mass spectrometer 
HCD high energy collision dissociation 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HPLC high performance liquid chromatography 
170   
i.e. that is, id est 
IAA iodoacetamide 
IPG Immobiline DryStrip gel 
IPTG isopropyl β-D-1-thiogalactopyranoside 
KO knock-out (deletion) 
KH domain K homology domain 
iBAQ intensity based absolute quantification 
IM immonium ion 
LC liquid chromatography 
LTQ linear trap quadrupole 
M Molar, mol/l 
m/z mass-to-charge (ratio) 
MALDI matrix assisted laser desorption/ionization 
MS mass spectrometry 
MS/MS tandem mass spectrometry 
NMR nuclear magnetic resonance 
OMSSA Open Mass Spectrometry Search Algorithm 
ORF open reading frame 
PAGE  polyacrylamide gel electrophoresis 
PAM protospacer adjacent motif 
PDB protein data bank 
PCI phenol-chloroform-isoamyl alcohol 
PCR polymerase chain reaction 
Phyre Protein Homology/analogY Recognition Engine 
pIEF peptide isoelectric focusing 
ppm parts per million 
Q Exactive HF Q Exactive High Field 
RAMP repeat associated mysterious protein 
RBD RNA binding domain 
RF radio frequency 
RNA ribonucleic acid 
RNase ribonuclease 
RNP ribonucleoprotein 
rpm rounds per minute 
RRM RNA recognition motif 
SDS sodium dodecyl sulfate 
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SILAC stable isotope labeling with amino acid in cell culture 
STAGE-Tips Stop and Go Extraction - Tips 
TFA trifluoroacetic acid 
Tof time-of-flight 
UHPLC ultra high performance liquid chromatography 
UniPROT universal protein resource 
UPS2 universal protein standard 2 




WT wild type 
XIC extracted ion chromatogram 
YPC yeast-peptone casaminoacids 
∆ delta (deletion) 
µ micro 
  
Ct Clostridium thermocellum 
Mk Methanopyrus kandleri 
Mm Methanococus maripaludis 
Pf Pyrococcus furiosus 
Ss Sulfolobus solfataricus 
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